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 Zusammenfassung 
Die Freisetzung vieler Hüllviren findet an der Plasmamembran (PM) statt. Der 
Viruspartikelzusammenbau hängt von der Anreicherung viraler Untereinheiten in spezifischen 
Domänen der PM ab. Es wird vorgeschlagen, dass Membran-Rafts – geordnete, Sphingomyelin- und 
Cholesterin-reiche Mikrodomänen in der PM – als lokale Rekrutierungsstellen dienen. 
Hämagglutinin (HA) ist ein homotrimeres Glykoprotein in der Hülle des Influenzavirus. Es 
vermittelt die Bindung an die Wirtszelle und die Fusion mit der endosomalen Membran. Es wird 
angenommen, dass HA eine wichtige Rolle bei der Abschnürung neuer Viruspartikel von der Zelle 
spielt. Zwei Hauptbeobachtungen führten zu der Hypothese, dass sich HA in Lipid-Mikrodomänen 
einlagert: HA wurde biochemisch in Detergens-resistenten Membranen nachgewiesen und die 
Virushülle ist mit Lipiden angereichert, die Rafts bilden. Um die Rolle der HA-
Transmembrandomäne für die Lipid-Raft-Inkorporation aufzuklären, wurde ein Konstrukt 
entwickelt, das den C-Terminus von HA, mit dem gelb fluoreszierenden Protein YFP fusioniert, und 
die Transmembrandomäne, nicht aber die N-terminale Ektodomäne von HA enthält. In transfizierten 
Säugetierzellen wurde der Förster-Resonanz-Energie-Transfer (FRET) zwischen diesem Konstrukt 
und einem GPI-verankerten cyan fluoreszierenden Protein CFP (Raft-Marker) durch Fluoreszenz-
Lebenszeit-Mikroskopie (FLIM) gemessen. Die Ergebnisse zeigen, dass sich HA-Konstrukte in 
Cholesterin-abhängigen Lipiddomänen anreichern, was durch eine erhöhte FRET-Effizienz 
nachgewiesen wurde. Zudem führen der Entzug von Cholesterin aus der PM und die Deletion der 
drei hochkonservierten Palmitylierungsstellen von HA zu einer signifikanten Verringerung der 
FRET-Effizienz. Schließlich wurde ein sehr stark verringerter Energietransfer zwischen dem HA-
Konstrukt und einem Marker für Nicht-Raft-Bereiche gemessen. Darüber hinaus konnte mit Hilfe 
von ortsspezifischer Mutagenese gezeigt werden, dass die verwendeten HA-Konstrukte 
Disulfidbrücken-verbundene Oligomere bilden und dass dies eine Voraussetzung für den Transport 
der Konstrukte an die PM ist. Zeitaufgelöste Anisotropiemessungen ergaben für diese ein starkes 
Homo-FRET-Signal, welches für eine lokale Anhäufung spricht und somit die 
Oligomerisierungshypothese bestätigt.  
 
Schlagwörter: Influenzavirus, Hämagglutinin, FLIM-FRET, Lipid Rafts, Zusammenbau. 
 Abstract 
Numerous enveloped viruses bud from the host cell plasma membrane (PM). The assembly of the 
new viral particles depends on the accumulation of the viral subunits at specific sites of the cell 
membrane. Lipid domains or “rafts” enriched of sphingomyelin and cholesterol have been suggested 
as sites for local recruitment of viral components. Hemagglutinin (HA) is a homotrimeric 
glycoprotein embedded in the envelope of influenza virus. It mediates binding of the virus to the 
host cell as well as fusion between the viral envelope and the endosomal membrane. HA might play 
an important role in budding of the new viral particles from the host cell. Two main observations led 
to the suggestion that HA entraps in lipid microdomains. First, HA was rescued in DRM fractions, 
second the viral envelope was found to be enriched in lipids generally forming rafts. 
To elucidate the role of the HA transmembrane domain in lipid raft localization we expressed 
constructs harboring the transmembrane domain and the cytoplasmic tail but lacking the N-terminal 
ectodomain of HA in the PM of mammalian cells (CHO-K1). We studied energy transfer (FRET) 
between these constructs and a GPI anchored CFP as a raft marker by fluorescence lifetime imaging 
microscopy (FLIM). Our results suggest that HA constructs are indeed sorted and enriched into 
cholesterol-dependent lipid domains indicated by enhanced FRET efficiency. This is supported by 
the observation that cholesterol depletion of the PM caused a significant decrease of FRET. 
Likewise, deletion of the three highly conserved palmitoylation sites of HA is also accompanied by a 
reduction of FRET efficiency. Finally, very low energy transfer was measured upon coexpression of 
the HA construct with a non-raft marker protein.  
In addition, site directed mutagenesis demonstrated that TMD-HA constructs form disulfide linked 
oligomers and that oligomerization is a prerequisite for the transport to the plasma membrane. This 
result was corroborated by time resolved anisotropy measurements that revealed strong homoFRET 
between TMD-HA-YFP molecules, thus indicating protein clustering. Oligomerization of TMD-HA 
contructs is in agreement with the observation that the trimerization of full length HA is fundamental 
for the stability of the glycoprotein and the subsequent delivery of the protein to the cell surface. 
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1 INTRODUCTION 
Influenza is one of the most studied viruses with respect to its structure and pathogenicity. However 
whereas the mechanism of infection has been elucidated in details, the assembly of the new viral 
progeny still remains a controversial topic. Several studies suggested that cholesterol-enriched lipid 
microdomains or “rafts”, might recruit viral subunits, e.g. the spike protein hemagglutinin (HA), at 
specific site of the plasma membrane. In this study FLIM-FRET and time resolved anisotropy 
measurements were employed to investigate in vivo the lateral organization of HA. Since these are 
not conventional techniques, our approach will be extensively elucidated in the following section. 
1.1 Influenza Virus 
Every 30 to 40 years an aggressive flu virus emerges, one that has changed just enough that people 
natural defences are caught totally unprepared. First worldwide pandemics of influenza were 
reported already in 1889 and 1898 but the largest outbreak occurred in 1918 (Spanish influenza), 
infecting 500 million people and killing about 40 millions. Extensive studies on tissues isolated from 
victims of the 1918 epidemic, demonstrated that this virus (H1N1) was an avian influenza virus, able 
to adapt itself enough to replicate in human cells. Indeed this virus had a high level of similarity to 
the first human influenza A virus isolated (A/WSN/33), placing the 1918 virus amongst the Influenza 
A swine or human viruses. Other pandemics have followed in 1957 and 1968. More recently, in 
1997, an avian influenza A virus (H5N1) was recovered in the samples derived from victims of a 
small influenza episode in Hong Kong. This event raised not only the fear for a new mortal 
pandemic of influenza, but also evidenced the possibility that avian influenza viruses could break 
through the species barrier and infect humans [1]. 
Influenza is an enveloped virus that belongs to the family of Orthomyxoviridae. This family includes 
the three influenza subtypes, A, B and C and the Thogotovirus and Isavirus. The most studied and 
widespread among animal species is the Influenza A subtype, while Influenza B and C represent 
only a minor population of circulating viruses and normally cause very mild respiratory diseases. 
Influenza virus is highly pleiomorphic even if generally it presents a spherical shape with a diameter 
of about 100 nm. Influenza A and B contain eight single strands of RNA with negative polarity that 
encode all the proteins of the virus. Influenza C virus contains only seven ssRNAs. 
Ribonucleoproteins (RNPs) are helical-shaped complexes that comprise the genomic RNA segments 
in association with a trimeric polymerase (PB1, PB2 and PA subunits) and several copies of 
nucleoproteins (NP). NPs form a proteinaceous core around which the RNA is wrapped. Underlying 
the membrane is the matrix protein M1, the major structural component of the virion, which is 
thought to act as an adaptor between the lipid envelope and the internal RNP particles. Embedded 
into the envelope are three proteins, two glycoproteins, hemagglutinin (HA) and neuraminidase 
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(NA) involved in cell entry and exit, respectively, and a low abundance ion channel, the protein M2, 
involved in uncoating and HA maturation [2] (Figure 1). Whereas the internal components of the 
different influenza subtypes are very similar, the envelope presents a quite different composition. 
Indeed in the influenza C virus, the hemagglutinin-esterase-fusion glycoprotein (HEF) supersedes 
both HA and NA and an alternative form of the M2 ion channel, named CM2 [3], is present. In the 
influenza B virus this channel is substituted by the protein NB, a protein much smaller than M2 [4] 
but with the same function. Finally, the proteins NS1 and NS2 are produced by alternative splicing 
of the eight gene fragment. NS1 plays a critical role in mRNA splicing and translation, while NS2 
mediates the export of newly synthesized RNPs from the nucleus [5,6]. 
 
Figure 1: Influenza A virus structure. Influenza is an enveloped virus whose genome is constituted of 8 
ssRNAs with negative polarity, encoding for all the viral proteins (indicated as PB2, PB, PA, HA, NP, N, M, 
NS).The RNA segments are complexed with the 3 subunits of a polymerase (PA, PB1 and PB2) and with 
nucleoproteins (NP) to form ribonucleoproteins (RNP). The proteins NS1 and NS2 are involved in mRNA 
splicing and in export of RNPs from the nucleus, respectively. Embedded into the envelope of the virus are 
two glycoproteins, hemagglutinin (HA) and neuraminidase (NA) and an ion channel, the protein M2. Finally, 
the protein M1 forms a proteinaceous shell under the envelope. Adapted from [7]. 
 
Influenza type A viruses are classified based on the antigenic properties of both the glycoproteins, 
HA and NA. In avian viruses 15 subtypes of HA and 9 subtypes of NA have been identified, of these 
viruses subtype H1, H2 and H3 infect humans. The amino acidic sequence can vary from 30 to 70% 
between different subtypes and up to 20% within the same subtype.   
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1.1.1 Influenza Virus replication 
Influenza virus infections in humans are caused by inhalation of the aerolized virus in droplets. The 
inhaled viruses replicate in the respiratory epithelium and the new viral progeny buds into the airway 
lumen. Since the respiratory epithelium is polarized, entry of the virus as well as the release, takes 
place only at the apical membrane of the cells, precluding in this way the systemic spread of the 
virus [8]. The infection cycle begins with the receptor-mediated endocytosis of the virus, followed 
by the fusion between the endosomal and viral envelope (Figure 2). Both these events are 
accomplished by HA (see 1.1.3.3). The endosomal acidic environment is fundamental not only for 
triggering the fusion of the membranes, but the ionic flux into the viral envelope through the ion 
channel M2, allows also the disruption of the M1-vRNPs complexes. The viral genome is then 
imported into the nucleus through nuclear pores by dint of nuclear localization signals (NLS) 
localized on the NPs [9]. Both, NP and polymerase, accompany the RNA into the nucleus where 
they are essential for transcription and replication. The synthesis of positive-sense antigenomic 
RNAs (or cRNAs) and the subsequent transcription of the cRNAs into the gene segments (vRNAs), 
as well as the transcription into mRNAs are controlled by the three subunits of the polymerase [10]. 
Likewise eukaryotic mRNAs, the viral mRNA contains a 5’ cap (a 7-methylguanosin added to the 5’ 
and necessary for recognition by the ribosomes and protection from RNases) and the termination of 
the transcription is due to the presence of a poly-A signal (polyadenylation) [11]. New incapsidated 
vRNPs and mRNAs are then exported out of the nucleus. In the cytosol mRNA undergoes 
translation, while the viral genome migrates directly to the plasma membrane where assembly takes 
place. In particular, NP and M1 are produced in the cytosol whereas HA, NA and M2 are 
synthesized in the rough endoplasmic reticulum and transported to the cell surface via the Golgi 
apparatus.  
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Figure 2: Influenza virus replication. The binding of influenza virus to the host cell (1) is mediated by the 
spike protein hemagglutinin (HA). The internalization of the virus occurs in endosomes (2) where, upon 
acidification (3), HA undergoes a conformational change which leads to the fusion between the viral envelope 
and the endosomal membrane (4). Thus the viral genome enters the nucleus (5) where it is both replicated and 
duplicated (6). Despite of HA, NA and M2, whose synthesis occurs in the ER, the other viral components are 
synthesized in the cytosol, where also RNPs are formed (7). The viral subunits accumulate at the budding site 
for the subsequent assembly and release of the new viral progeny (9). Adapted from [12].   
1.1.2 The glycoprotein Neuraminidase 
Neuraminidase is a homotetrameric glycoprotein forming mushroom-like projections on the surface 
of influenza virus. To date, nine antigenic subtypes of NA have been characterized. NA plays an 
important role in facilitating the spread of the viral infection since it cleaves the terminal sialic acid 
from different glycoconjugates, particularly abundant in the mucosal secretions. Therefore it helps 
the penetration of the virus into the respiratory epithelium. Furthermore, Neuraminidase assists the 
release of the new viral progeny avoiding the aggregation mediated by the interaction between 
hemagglutinin and sialic acid on the surface of the host cells and on the particle envelope (Figure 7) 
[13]. 
1.1.3 The glycoprotein Hemagglutinin 
Fifteen different subtypes of Hemagglutinin, the most abundant spike protein on the virus surface, 
have been described. This cylindrical homotrimeric glycoprotein has a length of about 135 Å and a 
diameter varying between 35 and 70 Å [14]. The three identical monomers, each consisting of about 
560 amino acids, are non-covalently linked and they are constituted of a globular head (HA1, 
globular domain, Figure 3) connected to a stem-like domain (HA2, fibrous domain, Figure 3) by 
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two disulfide bonds. HA1 and HA2 subunits originate upon proteolytical cleavage of the non-
fusogenic precursor HA0 (Figure 4 A) [15]. 
 
 
Figure 3: Hemagglutinin structure. Hemagglutinin is a homotrimeric glycoprotein formed of three identical 
monomers (A). Each monomer (B) is divided in two domains, HA1, the globular domain and HA2, the fibrous 
domain. HA1 and HA2 are connected by two disulfide bonds. In red the fusion peptide is indicated.  
 
The cleavage of HA0 is essential for triggering HA fusion properties, thus it determines the 
infectivity of the viral strain. In highly pathogenic avian influenza strains the cleavage site (Figure 4 
A) is constituted of several basic residues located in the linker between HA1 and HA2. These 
residues form the consensus sequence R-X-K/R-R (Figure 4 B), which is recognized by intracellular 
proteases in a broad range of host cells [16]. In contrast, mammalian and apathogenic avian viruses 
present HA subtypes with only an arginine as cleavage site between the two HA subunits (Figure 4 
B). Due to this, few extracellular proteases, secreted by a restricted range of cells, are able to 
recognize the cleavage site of the HA0 precursor. Therefore these viruses cause usually only local 
infections. 
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Figure 4: HA0 cleavage. A) The cleavage of HA0, the HA precursor, leads to the formation of the HA1 and 
HA2 subunits that remain disulfide linked. In this process the fusion peptide (FP in yellow) is also generated as 
N-terminus of the HA2 subunit. TM indicates the transmembrane domain. B) Intracellular proteases 
responsible of the HA0 cleavage recognize specific sequences, either consisting of few amino acids (left side) 
or of a single residue (right side).  
 
The antigenic properties of HA reside into the HA1 domain where the receptor binding site, formed 
by Tyr 98, His 183, Glu 190, Trp 153 and Leu 194, is localized (Figure 3 A). These highly 
conserved amino acids build a pocket whose perimeter is surrounded by several other residues 
responsible for the antigenic variation of the protein. The globular head consists of about 340 
residues and contains at the N-terminus a hydrophobic sequence referred to as signal peptide 
(Figure 4). This signal is necessary for the translation of the protein occurring on ER-bound 
ribosomes and it mediates the subsequent transfer of the polypeptide across the membrane [17]. 
About 220 amino acids form the HA2 domain, the most highly conserved sequence in 
hemagglutinin. The proteolytical cleavage, by which HA1 and HA2 are separated, forms a new 
hydrophobic amino-terminus on the HA2 subunit, the fusion peptide (Figure 3 and Figure 4 A). The 
transmembrane domain, anchoring the glycoprotein to the plasma membrane is also part of HA2 
(Figure 5). Finally the C-terminal cytoplasmic tail is about 11 amino acids long. Hemagglutinin 
undergoes extensive post-translational modifications during the transport through the Golgi 
apparatus to the plasma membrane, indeed despite of proteolytical cleavage, the protein becomes 
also glycosylated and palmitoylated. Glycosylation occurs at seven asparagine residues, four in the 
globular head and three localized in the stem region (see 1.1.3.1). Three cysteine residues (Cys-551, 
Cys-559 and Cys-562) are palmitoylated: two resides in the cytoplasmic tail and the third at the 
border between transmembrane domain and cytoplasmic tail (see 1.1.3.1).  
Hemagglutinin plays a central role in virus entry since it recognizes the sialic acid residues covering 
the surface of the target cells. After internalization and acidification of the endosomes, HA 
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experiences a conformational change, which leads to the formation of the fusion peptide, essential 
for mediating the fusion between endosomal and viral membrane (see 1.1.3.3).  
1.1.3.1 Folding, trimerization and transport of Hemagglutinin 
The synthesis of HA takes place in the ER and the transport to the cell surface proceeds through the 
Golgi apparatus. The precursor HA0 is synthesized on membrane-bound ribosomes and 
cotranslationally inserted into the ER where it is core glycosylated on five to seven sites and 
deprived of the signal peptide. Attachment of oligosaccharides to asparagine residues is important 
for promoting successive correct folding, maintenance of conformation and stability, protection 
against proteolysis or degradation and modulation of biological activities [18]. Three of these 
glycosylation sites, Asn-12, Asn-28 and Asn-478, localized in the stem region, are highly conserved 
and they act cooperatively to enhance the folding and trimerization rate. Loss of these carbohydrates 
affects stability, trimerization and transport of the protein [18,19]. Indeed oligomerization is a critical 
step, necessary for the transport of the glycoproteins from the ER to the Golgi complex [20]. During 
its transport through the Golgi apparatus to the cell surface, HA undergoes several posttranslational 
modifications including trimming of carbohydrate side chains and terminal glycosylation. 
Furthermore, in the H5 and H7 influenza virus subtypes, HA is proteolytically cleaved into the HA1 
and HA2 subunits before integration into the plasma membrane [21], whereas tipically this cleavage 
takes place extracellularly by means of the protease CLARA [2]. Ester-bound fatty acids, in 
particular palmitic acid, are linked to the three cysteine residues localized in the HA transmembane 
domain and cytoplasmic tail (see 1.1.3). Palmitoylation occurs in the cis-Golgi and it is an 
irreversible post-translational modification [22]. Still, the role of palmitoylation has to be clarified; 
however it has been proposed that it might function as a signal for targeting HA to the cell surface. 
Furthermore, the insertion of these hydrocarbon chains into the membrane bilayer, it might be 
responsible of the HA association with lipid microdomains also named "rafts" (see 1.3) [23].     
1.1.3.2 The Hemagglutinin anchor   
The C-terminal peptide of Hemagglutinin, the transmembrane domain, is a predominantly 
hydrophobic peptide that anchors the glycoprotein to the membrane (Figure 5). This domain is 
probably α-helical and consists of 27 uncharged residues spanning the lipid bilayer. In particular, it 
has been reported that a 17 amino acid long transmembrane domain is strictly required in order for 
Hemagglutinin to mediate complete fusion [24]. Indeed, it has been demonstrated that HA mutants 
anchored to the plasma membrane by a lipid anchor spanning only the outer leaflet promote 
exclusively hemifusion. Thus, the transmembrane domain might function to stabilize the HA trimers 
surrounding the nascent fusion pore, or it might also be important in driving membrane hemifusion 
to full fusion [25]. Finally the transmembrane domain might stabilize the trimers interacting with 
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other transmembrane domains and it might also correctly orient the subunits in the membrane 
enhancing the stability of the final complex [20]. 
 
Figure 5: HA transmembrane domain. The HA transmembrane domain (TM) anchors the ectodomain 
spanning the viral envelope bilayer. Despite of mediating the binding to the host cell (pre-fusion 
conformation), the transmembrane domain cooperates with the fusion peptide (post-fusion conformation) to 
mediate fusion between the viral envelope and the endosomal membrane (see 1.1.3.3). Picture adapted from 
[26]. 
 
1.1.3.3 Hemagglutinin functions 
An important determinant for influenza virus infection is the HA binding to the epithelial cells of the 
airway. Hemagglutinin interacts with glycoproteins and glycolipids containing oligosaccharides 
terminating in 5-N-acetyl-neuraminic acid (sialic acid) residues. Human influenza virus subtypes, 
whose HA contains a leucine at position 226, target preferentially sialic acid α-2,6-galactose β-1,4-
N-acetyl glucosamine, avian and equine influenza viruses, having a glutamine at position 226, bind 
sialic acid α-2,3-galactose β-1,4-N-acetyl galactosamine, finally swine viruses appear to recognize 
both [27]. It has also been reported that in humans, where the influenza virus symptomatology is 
mainly confined to the respiratory tract, lung cells are abundant in α(2,6) linkage, while in pig 
intestine cells are enriched in α(2,3) linkages and influenza is normally associated to an enteric 
infection. The receptor binding site is a depression localized in the globular region at the top of the 
HA1 subunit, formed by polar and non polar amino acids displaced to make direct contact with the 
receptors [28]. Mutation of specific amino acids surrounding the receptor binding site not only 
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influences the tropism and specificity of host infection, but might also contribute to the antigenic 
variation that is cause of new epidemics [15].  
Besides receptor binding, Hemagglutinin is responsible for the fusion between viral and endosomal 
membranes (Figure 6). At neutral pH, HA is found to be in a metastable state, whose stability is 
maintained by electrostatic interactions between HA1 and HA2 monomers [29,30]. This 
conformation, referred to as native (Figure 5, pre-fusion monomer and Figure 6), is subjected to 
extensive changes upon acidification of the endosomal lumen to pH 5,5 (Figure 5, post-fusion 
monomer and Figure 6). In this form, the HA2 subunit assumes the shape of a helical-hairpin 
structure, whose N-terminus, the fusion peptide, resembles a hook and it is buried within the coiled 
coil of the three HA2 segments (Figure 6 A) [31]. Due to acidification, the HA1 subunit connected to 
HA2 by a disulfide bond, dissociates from the top of the polypeptide and the fusion peptide is 
unleashed and boosted towards the target membrane where it inserts to promote fusion (Figure 6 B) 
[31]. While the transmembrane α-helix spans the lipid bilayer almost perpendicular [32], the fusion 
peptide enters the target membrane with an oblique angle. The heptad-repeat regions (HR1 and 
HR2), linking the fusion peptide to the transmembrane domain, undertake an extensive refolding at 
acidic pH, forming a hairpin structure that brings the two membranes proximal (Figure 6 A) [32]. 
The fusion is awaited by hemifusion [33], an intermediate step in which the lipids of the external 
leaflets of both, endosome and viral envelope, are pulled in proximity and bulged out due to the 
refolding and strong interactions between HR1 and HR2 (Figure 6 C). In this process terminating 
with the coalescence of the two membranes, the TMD-homotrimer approaches the fusion peptide 
forming the TMD-FP complex (Figure 6 C and D). In this way the FP is even more inserted into the 
membrane and destabilizes further the bilayer leading to the formation of a fusion pore and final 
fusion of the inner layers [32]. It has been proposed that clustering of at least six trimers is necessary 
to initiate fusion since their radial outward bending would force the interacting bilayers to bend as 
well [34]. Subsequently, the hemifusion diaphragm breaks due to the tension imposed by HA and the 
fusion pore opens irreversibly releasing the viral content into the cytoplasm [33]. 
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Figure 6: Fusion mechanism. In the pre-fusion conformation, the fusion peptide is buried within the three HA 
transmembrane domains (A). Upon endosomal acidification, HA undergoes an extensive rearrangement that 
leads to the insertion of the fusion peptide into the endosomal membrane bilayer (B). The heptad repeat 
regions HR1 and HR2 pull the two membranes together and mediate the hemifusion between the endosome 
and envelope external leaflets (C). This process terminates with the complete fusion of the apposing 
membranes and the generation of the fusion pore. This final step is due to the formation of the transmembrane 
domain-fusion pore (TMD-FP) complex (D). Adapted from [35]. 
 
1.1.3.4 Assembly and budding of influenza virus 
After synthesis, all the viral components, namely, the envelope proteins HA, NA and M2, the matrix 
protein M1 and the viral genome, vRNPs, are delivered to the assembly site where they start 
interacting in order to form the new viral particles (Figure 7). Furthermore, viral proteins promote 
the outward bending of the plasma membrane, which terminates with the scission of the new viral 
progeny from the host plasma membrane and their release into the extracellular environment. The 
very first step in assembly is the delivery and accumulation of all the sub-viral constituents at the 
plasma membrane and specifically at the apical domain of the plasma membrane in polarized cells. 
The new synthesized genome, the vRNPs, is exported from the host nucleus via the Crm1-mediated 
nuclear export pathway [6,36,37], helped also by the viral proteins M1, NS1 and NP. However it still 
remains unclear how the vRNPs and M1 either together or separately reach the budding site. HA, 
NA and M2 posses different signals for the targeting to the apical membrane. A glycan attached to 
the ectodomain of both NA and HA has been identified as apical sorting determinant while the M2 
sorting signal remains to be elucidated [18]. Furthermore, it has been demonstrated that the two 
glycoproteins interact with detergent resistant membranes (DRMs or lipid rafts, see 1.3) and that 
point mutations in the transmembrane domain or the deletion of the cytoplasmic tail resulted in 
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reduced raft affinity [38], thus it is likely that the determinant for lipid raft association is held into 
the transmembrane domain [39]. Still it remains controversial whether association of HA and NA 
with lipid microdomains occurs prior to the transport to the plasma membrane. However, there are 
evidences that the viral envelope is enriched of those lipids commonly found in lipid rafts [38,40] 
and since viral glycoproteins normally accumulate at the budding site, it has to be assumed that HA 
and NA determines the viral assembly and budding site. The role of lipid rafts in viral assembly and 
budding will be further discussed below. In order to produce infective and functional viral particles, 
eight (or seven) vRNAs need to be incorporated into the virions. One hypothesis suggests that 
vRNAs are randomly inserted given that viruses with more than eight genomic segments have been 
rescued [41]. Another hypothesis assumes that vRNAs contain specific structural features enabling 
the selective recruitment of the eight fragments into the nascent viral particles. Once accumulated, 
the viral envelope, the vRNPs and the protein M1 need to interact with each other. A major role in 
assembly is played by the matrix protein that not only forms a bridge between the envelope proteins 
and the vRNPs, thus associating with both of them, but it is also responsible for the recruitment of 
the viral components at the assembly site and it triggers the budding process. Indeed, mutant viruses 
lacking the protein M1 did not show any budding [42]. M1 might generate lipid asymmetry upon 
binding to the inner leaflet of the plasma membrane, therefore inducing outward bending of the 
membrane followed by bud formation. After assembly, bud formation and fission of the new particle 
from the plasma membrane, the virus employs NA for the complete release (Figure 7). Indeed this 
glycoprotein removes the sialic acid residues from the cell surface glycocalyx and from the 
glycoproteins of the viral particles, thus preventing self-aggregation and reattachment of the new 
progeny to the host cell [43].  
 
Figure 7: Influenza virus assembly and budding. The assembly of the new viral particles takes place at the 
plasma membrane of the host cell. The accumulation of the viral subunits promotes bending of the membrane 
and final budding of the viruses (1). The release of the virions is controlled by the glycoprotein neuraminidase 
(NA) that cleaves the sialic acid residues both from the particles and from the host cell (2). Thus NA prevents 
the self aggregation of the virions or even the attachment to the previous infected cell. Adapted from [44]. 
 
  INTRODUCTION 
12 
1.2 GPI Membrane anchors 
Glycosylphosphatidylinositol anchors attach proteins to the external leaflet of the plasma membrane 
(Figure 8 A). The addition of the GPI anchor to a protein is a posttranslational modification that 
occurs in the ER. GPI-anchored proteins display two signal sequences, one at the N-terminus, 
responsible of the targeting of the polypeptide to the ER and the second, the GPI signaling sequence 
(GSS) at the C-terminus, that directs the attachment of the GPI-anchor. In the ER, the transamidase 
enzyme complex (GPIT) recognizes those proteins containing the GPI signaling sequence and 
allows the attachment of the preformed GPI anchor to the C-terminus of the protein upon cleavage 
of GSS [45]. The mechanism is regulated by the translocon that discriminates between the stop 
transfer sequence of integral proteins and the GSS, which needs to be fully translocated into the 
lumen of the ER for recognition by the transamidase [46]. The new GPI-anchored proteins leave the 
ER in COPII coated vesicles, they travel through the trans-Golgi network and they are finally 
delivered to the plasma membrane. Normally GPI anchors are connected to the C-terminus of the 
protein (referred to as ω-residue) via a phosphoethanolamine group, followed by three mannose 
residues and a non-acetylated glucosamine attached to a phosphatidylinositol moiety, which interacts 
with the lipids of the plasma membrane through acyl or alkyl fatty acids, or ceramide residues 
(Figure 8 B) [47].  
 
Figure 8: GPI-anchor structure. A wide variety of proteins are attached to the external leaflet of membranes 
through glycosylphosphatidylinositol (GPI)-anchors (A). A GPI-anchor is constituted of three main 
components, a phospholipid tail interacting with the lipids of the bilayer, a glycan core and a 
phosphoethanolamine that links the anchor to the protein C-terminus (B). 
 
GPI-anchored proteins absolve many physiological functions, including transmembrane signalling, 
cell surface protection, cell adhesion and cell wall synthesis [45]. Examples of GPI-anchored 
proteins include hydrolases, like alkaline phosphatase, or 5´-Nucleotidase; cell surface receptors, 
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like the transferrin receptor, the folate receptor or CD14; complement regulatory proteins like the 
decay-accelerating factor DAF; cell adhesion proteins like NCAM or even prions like PrPC or PrPSc 
[48]. The biosynthesis of the GPI-anchor occurring on the cytoplasmatic face of the ER, involves the 
action of about 20 proteins, whose exact mechanism has not been elucidated, yet [49]. In general, 
GPI-anchored proteins are apically sorted in several epithelial cell lines and they use their GPI 
anchor to associate with lipid microdomains or rafts (see 1.3). This association is probably due the 
saturated acyl chain of the GPI moiety that penetrate exclusively one leaflet of the membrane bilayer 
[50]. Since GPI-anchors can be extensively modified by the addition of phosphoethanolamine 
groups and other sugars to the phosphoinositol, glucosamine and mannose residues, it is likely that 
beside of a role in membrane attachment, apical sorting and lipid rafts partitioning, GPI-anchors 
might have many other biological and functional capabilities. 
1.3 Lipid microdomains 
In 1972 S. Jonathan Singer and Garth Nicholson proposed the “fluid mosaic model”, a theory 
describing the biological membranes as a “sea” of lipids in which integral proteins are randomly 
distributed and move freely. Thus, the fluid mosaic model suggests that the lipid bilayer of biological 
membranes is simply a barrier between the extracellular environment and the cytosol or between the 
lumen of the different organelles and the cytoplasm. Therefore the role of membrane lipids was 
believed to be rather passive and aimed on acting just as a solvent for the embedded proteins [51]. 
However this simplistic model has been revised since not only a high variety of lipids constitute 
membranes, but lipids are also spatially organized and asymmetrically distributed within the two 
monolayers. Indeed cell membranes are formed by different amounts and kinds of lipids that define 
also their biological properties and functions [52]. Glycerolipids, sterols and sphingolipids are the 
most abundant lipids in biological membranes, distributed differently among the cellular 
membranes. As well as proteins, lipids can rapidly diffuse laterally in the plane of the membrane and 
they are also transported across the bilayer in a process named “flip-flop”. Whereas diffusion is a 
spontaneous process, the latter is protein mediated. However no ATP is required in both 
mechanisms. Lipid flip-flop is a very slow movement since the polar head of the lipid needs to be 
translocated through the highly hydrophobic bilayer. Flippases (e.g. scramblases) might be 
responsible for the bidirectional lipid translocation across the membranes. Finally translocases use 
ATP hydrolysis to promote the unidirectional movement of lipids across the membranes. Tipically, 
aminophospholipid translocases and ABC transporters mediate the inward and outward translocation 
of phospholipids, respectively. In the plasma membrane of eukaryotic cells, almost all the 
glycerophospholipids such as phosphatidylinositol (PI), phosphatidylserine (PS) and 
phosphatidylethanolamine (PE) are predominantly localized in the inner leaflet, whereas lipids with 
large glycosylated headgroups such as sphingomyelin (SM) and phosphatidylcholine (PC), distribute 
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preferentially in the external leaflet. Finally, cholesterol has been described to be more abundant in 
the external leaflet since it has higher affinity for sphingolipids [53]. In 1988, Simons and van Meer 
[54] proposed that beside transverse lipid asymmetry, lipids might also present lateral asymmetry. 
This hypothesis arose from the observation that in epithelial cells apical and basolateral membranes 
have a different lipid composition and that proteins assigned to those two cell domains are 
selectively sorted. Indeed the redirection of the new glycoproteins either to the apical or to the 
basolateral membrane occurs in the trans-Golgi network, where also the synthesis of sphingolipids 
takes place. Therefore it was proposed that sorting of proteins and lipids might be correlated and that 
their transport to the cell surface might occur in common “carriers”. These transporting vesicles may 
be formed by clustering of sphingolipids in the inner leaflet of the trans-Golgi network, followed by 
the association of the apical proteins. Vesicles destined to the basolateral domain might be the result 
of those membrane portions excluded from apical transport [54]. In agreement with this model, it has 
been reported that GPI-anchored proteins use their glycophospholipid anchor as an apical sorting 
signal [50]. These lipid domains, functioning as potential sorting centres, have been named 
microdomains or “membrane rafts” (Figure 9).  
 
Figure 9: Lipid microdomains. In biological membranes saturated phospholipids, glycerosphingolipids and 
cholesterol are organized in small domains defined as “lipid rafts”. The saturated acyl chain of these lipids, 
together with the presence of cholesterol is responsible not only of the high packaging of rafts, but it also 
increases the thickness of the lipid bilayer, with respect to the rest of the membrane. GPI-anchored proteins are 
in general enriched in those domains, but many other kind of transmembrane proteins (such as glycosylated 
proteins) have beend described to localize into rafts. 
 
According to Simons and Ikonen [55], membrane raft organization is determined by the lateral 
association of sphingolipids and saturated PC, whose head groups exposed to the external 
environment interact rather weakly with each other, whereas the long saturated acyl chains forming 
the core of the bilayer are highly extended and more packed. Cholesterol functions as filler 
occupying the spaces between the sphingolipids. These highly packed domains are surrounded by 
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the more fluid regions formed by unsaturated phospholipids. Thus, membrane microdomains are 
defined as “small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched 
domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form 
larger platforms through protein-protein and protein-lipid interactions” [56]. Rafts have been 
reported to exist in both of the leaflets of the plasma membrane [57]; however since the two layers 
of the membrane are formed of different lipids, rafts in the inner and outer layer might differ not 
only in their composition but also in size and lifetime. Microdomains in the external leaflet are 
supposed to be small and very unstable, showing a very short lifetime; nevertheless they might 
merge in a bigger and more stable domain upon cell activation. Indeed, constitutive raft residents 
such as GPI-anchored proteins or transmembrane proteins might induce coalescence of unstable 
domains leading to the formation of a more lasting platform. This process might also trigger the 
recruitment of smaller rafts localized in the inner leaflet of the membrane. Anyway whether these 
microdomains are symmetrically distributed in the two leaflets still remains unclear [58,59]. Rafts 
are often considered to belong to the so called liquid ordered domains (lo), extensively characterized 
in model membranes [60,61,62]. Liquid ordered domains display properties normally associated to 
both the solid, gel (so) state and to the fluid, liquid disordered (ld) state. Indeed, on one side the tight 
packaging of the long stretched acyl chains resembles the behaviour of so, on the other, lateral 
diffusion of molecules in the lo state is as rapid as in ld. This intermediate state is due to the high 
amount of cholesterol in lo domains. Cholesterol induces higher compacting of the lipid acyl chains 
leading also to an increase bilayer thickness but at the same time allows the free movement of the 
lipids in the domain [63,64].  
How the plasma membrane maintains its lateral organization still remains unclear. However it has 
been reported that the actin cytoskeleton might play a role in modulating this organization [65]. 
Actin filaments might either directly interact with lipid complexes or they could induce transient 
confinement of proteins and their subsequent clustering in response to extracellular signals [66]. The 
formation of such platforms has been proposed to play a central role in signal transduction. Indeed 
the coalescence of small rafts carrying specific proteins might create a suitable environment that 
would facilitate the action of kinases or phosphatases resulting in downstream signalling. The IgE 
signalling during an allergic immune response is only one of the many signalling pathways 
involving microdomains [67]. Rafts might also serve as carriers for proteins destined to the apical 
membrane in epithelial cells (see above and [55]), or they might be involved in the transport of 
proteins in the endocytotic pathway [68]. Finally, lipid rafts are apparently associated with viral 
infection [45]. Influenza as well as HIV virus engages lipid rafts during entry and budding. It has 
been reported that influenza virus buds from specific sites of apical membrane enriched in raft lipids. 
Furthermore the influenza virus envelope is constituted of lipids typically localized in lipid rafts 
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[40]. HIV virus uses lipid microdomains during entry and exit from the host cells and its envelope is 
enriched in raft lipids [69]. 
Caveolae represent perhaps the only tangible example of structurally defined domains isolated from 
biological membranes. These microdomains are composed mainly of sphingomyelin, 
glycosphyingolipids and cholesterol, they are resistant to extraction in cold, non-ionic detergent and 
they colocalize with the light-density fractions upon sucrose gradient centrifugation. Caveolae are 
mainly found in the endothelial cell plasma membrane, forming invaginations about 55 nm large and 
they are associated to the cytoplasmic surface through the interaction with caveolin -1 and -2. As 
well as membrane microdomains, caveolae might be involved in signalling or transport processes 
[70]. 
1.3.1 Methods for detecting membrane microdomains 
Pioneering experiments demonstrating the existence of microdomains and microdomain-associated 
proteins were based on the insolubility of raft lipids and proteins in non-ionic detergents (typically, 
1% Triton X-100 at 4 °C). This approach generated low-density detergent resistant membranes 
(DRMs), which were considered to resemble the lo phases in model membranes as well as potential 
lo-like domains in biological membranes [64]. Together with GPI-anchored proteins, influenza virus 
HA was one of the first proteins rescued in DRMs [71]. However, since the employment of such 
detergents is rather aggressive, the aggregation of lipids and proteins in the resulting DRM might be 
forced, therefore producing artefacts not reflecting the real lateral organization of the membrane 
[72,73]. Thus, since conventional optical microscopy has failed to visualize such small and dynamic 
domains, new approaches aimed at proving the existence of membrane microdomains in vivo have 
emerged. Lateral diffusion measurements using single particle tracking (SPT) demonstrated the 
formation of large lipid rafts upon cross-linking of GPI-anchored proteins [74], or even that lipids 
can be confined for an average of 11 ms in 230 nm compartments [74]. Fluorescence correlation 
spectroscopy (FCS) revealed that cholesterol-sensitive microdomains and the cytoskeleton 
meshwork regulate the dynamic compartmentalization of raft markers [65,75]; finally the 
combination of homo- and hetero-FRET (Förster Resonance Energy Transfer) microscopy provided 
the evidence that GPI-anchored proteins exist in extremely small cholesterol-sensitive structures that 
consist of only few molecules [76,77]. Therefore, FRET measurements, sensitive to distances 
between molecules in the order of few nanometers, seem to be very suitable for studying the lateral 
organzation of biological membranes in vivo.  
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1.4 Time resolved fluorescence spectroscopy 
Fluorescence spectroscopy, which includes steady-state and time-resolved measurements, is a 
technique widely used to study dynamic processes in vivo. In steady state experiments the emission 
intensity of the probe is measured upon excitation with a continuous light source. In contrast, for 
time resolved measurements pulsed light, having a pulse width smaller than the decay time of the 
probe, is employed to record the intensity decay of the fluorophore. The relationship between the 
steady state fluorescence intensity (I) and the time decay of a molecule (I0e-t/τ) is described by the 
equation [78]: 
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It is clear, that the steady state intensity, being the integral over the time of the decay, represents 
simply an averaged intensity over all fluorophores of the sample at all times, thus neglecting 
important information which arose from the intensity decay and accessible to time-resolved 
measurements. Indeed, macromolecules immersed in a heterogeneous environment, e.g. a 
membrane, generally exist in different conformations. Upon excitation, fluorescent molecules might 
display intensity decays more complex than single exponentials depending on conformation states 
or/and on the environment of the molecule itself. Time resolved measurements can reveal the 
existence of these different decays allowing retrieving information not available from simple steady 
state measurements. Furthermore, time resolved measurements are independent from the excitation 
intensity, the local concentration of the fluorophore and from light scattering, but they are highly 
sensitive to changes in the local environment, changes in pH or temperature and calcium 
concentration [78,79]. Due to these advantages time-resolved are preferred over steady-state 
measurements. The lifetime or decay time of a fluorophore is described as the average time a 
fluorophore remains in the excited state prior to return to the ground state. For a single exponential 
decay this average time would be the same as the lifetime. However in a sample containing 
fluorophores the lifetime is not always equal to the decay time of every single molecule. Indeed 
fluorophores having different conformations or sensing different environments can emit either with 
shorter or longer lifetimes than the calculated one. Therefore it is important to underline that since 
the physical meaning of the different exponentials forming a decay is not easy to interpret, the 
measured lifetime of a sample is simply a statistical average of lifetimes due to different decays.  
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This mean or average lifetime, is described as  
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Where τi is the lifetime of the component i and αi represents the normalized pre-exponential relative 
to the fraction of molecules showing the decay time i. However in cases in which lifetimes are used 
to describe phenomena dependent on the steady state intensity (e.g. FRET, see 1.4.1), the so called 
amplitude weighted lifetime (τ ), described in the reported equation, should be used [80]. 
i
i
iτατ ∑=  
Time resolved fluorescence measurements are carried out in the time domain using the time 
correlated single photon counting (TCSPC) technique. Briefly, in TCSPC the sample is excited with 
a pulse of light and the first emitted photon is measured. Only one photon for about 100 laser pulses 
is detected, hence in order to acquire a number of photons enough for drawing a reliable histogram 
of the arrival times, the procedure has to be repeated many times [80].  
1.4.1 Förster resonance energy transfer (FRET) 
FRET, named after Theodor Förster, who first described the phenomena in 1946, is a process 
involving the radiationless transfer of energy from a fluorophore to another neighbouring 
fluorophore [78]. In order for FRET, or more precisely hetero-FRET, to occur the emission spectrum 
of the transferring fluorophore, named donor, must significantly overlap the excitation spectrum of 
the other fluorophore, referred to as acceptor, which does not need necessarily to be fluorescent. 
Furthermore, the emission dipole of the donor and the excitation dipole of the acceptor should not be 
perpendicular to each other since this would result in the mutual avoidance of the donor emission- 
and the acceptor excitation- oscillating dipoles. The last critical factor is the distance between the 
two fluorophores, which has to be in the order of less than 10 nm (about 100 Å). Energy transfer (E) 
depends on to the sixth power of the distance r between the two fluorophores as shown in the 
equation below (Figure 10). 
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where R0 is the Förster distance defined as the distance at which energy transfer equal 50%, and r is 
the distance between the two molecules [81]. The efficiency E represents the number of photons 
absorbed by the donor and transferred to the acceptor.  
 
Figure 10: FRET principle. For Förster resonance energy transfer to occur, three parameters have to be 
fulfilled. A) The emission spectrum (Dem) of the donor should overlap significantly the excitation spectra 
(Aex) of the acceptor. B) The distance between the two fluorophores has to be in the order of 10 nm. Finally 
the donor emission and the acceptor excitation dipoles should be in a favourable conformation. 
 
The fact that FRET can reveal distances in the order of a few nanometers, made this technique one 
of the most powerful tools to investigate unknown interactions between proteins as well as 
conformational changes of the proteins or of the surrounding environment. Hence, through 
calculating the distance between proximal molecules it is possible to obtain spatial and structural 
information otherwise inaccessible. This is why FRET is also defined as “spectroscopic ruler” [78].  
Since energy transfer affects different properties of the fluorophores participating in the phenomena, 
different methods for detecting FRET have been developed. Steady state fluorescence emission 
methods are used to measure donor intensity quenching, acceptor sensitized emission, increased 
donor fluorescence emission, anisotropy or depolarization of sensitized acceptor emission. Time 
resolved methods measure the reduction of donor lifetime in presence of acceptor [82]. One of the 
biggest problems faced in steady state fluorescence measurements, with respect to FRET, is the 
spectral bleed through (SBT) of the donor emission spectrum that can contaminate the FRET signal. 
In particular, since the overlapping of donor emission and acceptor excitation spectra is strictly 
required for FRET, the acceptor might be directly excited by the donor excitation wavelength, 
leading to signal contamination. Furthermore, acceptor-photobleaching experiments, in which the 
complete bleaching of the acceptor is required, might lead to an underestimation or even to 
neglecting low FRET efficiencies due to partial bleaching of the donor. Measuring FRET by 
detecting the shortening in the donor lifetime is neither affected by SBT nor by belaching, therefore 
this technique is widely used for studying protein-protein interactions in vivo [83]. 
Energy transfer occurs also between identical flurorophores, so called homo-FRET or energy 
migration resonance energy transfer. Anisotropy measurements allow the detection of homoFRET, 
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which unlike heteroFRET does not affect the lifetime of the fluorophores [84]. The theory of 
anisotropy is discussed below in details (see 1.4.3 and 1.4.4). 
1.4.2 Fluorescence Lifetime Imaging FRET Microscopy 
(FLIM-FRET) 
Fluorescence Lifetime Imaging Microscopy (FLIM) combines the advantages of the time resolved 
technique with advanced microscopy, providing information in high spatial (nanometers) and 
temporal (nanosecond) resolution. Typically, in a FLIM-FRET experiment the lifetime of the donor 
is measured in presence and in absence of the acceptor. Energy transfer from the donor to the 
acceptor results in a faster decay of the donor, hence in a decrease of its lifetime. The efficiency of 
energy transfer is calculated as 
D
DAE
τ
τ
−= 1  
where τDA and τD are the lifetimes of the donor measured in presence or in absence of acceptor, 
respectively [78].  
Donor lifetimes obtained from FLIM-FRET measurements are usually a mixture of quenched 
donors, i.e. FRET donors, and unquenched donors or non-FRET donors. In principle one might be 
able to distinguish between those two donor populations using a multicomponent analysis, in order 
to precisely calculate distances between molecules based only on the FRET donors. However when 
FRET efficiencies are low and differences in lifetimes are not very big, this kind of analysis is rather 
difficult. Therefore FRET efficiency calculated without distinguishing between quenched and 
unquenched donors should be referred to as apparent FRET efficiency, since it is due to the 
contribution of both donor populations [79]. 
1.4.3 Steady-State Anisotropy 
Fluorescence anisotropy is a very sensitive biophysical approach to assess important characteristics 
of a biological sample such as the size and shape of proteins, the effect of the environment on the 
mobility and diffusion, the flexibility and wobbling or even the physical properties of the 
surrounding milieu. This technique is based on the physical principle describing that upon excitation 
a fluorophore absorbs preferentially those photons showing electric vector parallel to its absorption 
transition dipole. Therefore when a sample is excited with a polarized source, only a portion of the 
total fluorophores absorbs the energy, resulting in an oriented or polarized emission. This 
phenomenon is called photoselection and includes fluorophores either precisely or only partially 
aligned with the excitation dipole. Usually, samples are excited with vertically polarized light along 
  INTRODUCTION 
21 
the z-axis (Figure 11 A, assuming z-axis symmetry) and the anisotropy (r) of a sample is calculated 
as: 
VHVV
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where IVV and IVH are the fluorescence intensities of the parallel and horizontally polarized emission 
[78].  
 
Figure 11: Dipole formation upon excitation along the vertical or z-axis. When a sample is excited with 
vertically polarized light (along the z-axis), the emission is also polarized. However the polarization of the 
emission is not exactly the same as the one of the incident source since molecules are not fixed in the 
environment, but they rotate (A). The polarized emission is measured along the z-axis (IVV) and along the 
perpendicular axes, x and y (IVHX and IVHY). The polarization is symmetrical along the y- and x- axes 
therefore they are considered to be equivalent (B). IT = total intensity; IVV = vertically polarized intensity; 
IVH = horizontally polarized intensity; IVHY = horizontally polarized intensity along the y-axis; IVHX = 
horizontally polarized intensity along the x-axis. 
 
Parallel and horizontal emissions are measured through a polarizer. The anisotropy is strictly 
dependent on the total intensity (IT) of the sample, since the difference IVV-IVH is normalized to this 
parameter. IT is calculated as the sum of the vertical emission intensity, along the z-axis (IVV) with 
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the horizontal intensity emissions along the x- and y-axis (IVHX and IVHY), considered to be 
equivalent (Figure 11 B) [78]. 
VHVVVHyVHVVT IIIIII X 2+=++=  
When absorption and emission moments are parallel and the system is in absence of depolarization 
processes (e.g. rotational diffusion or energy transfer, see below), the fundamental anisotropy (r0) of 
a molecule is 0,4. On the contrary when the fluorophore is randomly distributed in solution and 
totally depolarized, the calculated anisotropy is -0,2. However biological samples are not immobile 
and fluorophores immersed in such an environment are free to move. In other terms, the particular 
orientation presented by a molecule at the moment of excitation can change during the time in which 
the molecule remains in the excited state. The extent of orientation rearrangement is determined by 
the rotational diffusion (φ) of the molecule. Therefore, anisotropy (r) describes the rotation of a 
molecule during the excited state, i.e. it unveils the average angular displacement occurring between 
the excitation and the emission of a fluorophore. Hence, the rotational diffusion is one of the most 
critical parameters lowering the maximal theoretical anisotropy value of a molecule. When the 
rotational diffusion time of a flurophore is much faster than its decay time (φ >> τ), the molecule can 
rotate several times while remaining in the excited state, resulting in an almost randomly oriented 
fluorescence emission and thus in an anisotropy value close to 0. Thus, the anisotropy (r) of a 
molecule is strictly related to its lifetime as shown by the Perrin equation: 
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where r0 indicates the fundamental anisotropy of the molecule that would be measured in absence of 
any rotational diffusion, τ is the lifetime of the molecule and φ the rotational correlation time relative 
to the diffusion process [78]. On the other hand, if the rotational correlation time is much longer than 
the lifetime of the fluorophore r is equal to r0.  
The rotational correlation time φ can be used to determine the steric organization of a protein. 
Considering a protein in its monomeric conformation it is easy to determine changes in its 
oligomerization state since this would be reflected in fluctuations of the rotational correlation time. 
Indeed a protein forming a dimer or complexed with other proteins would displace a higher 
rotational correlation time, indicating a slower motion. Furthermore modifications of the viscosity of 
the medium, or the proximity to a membrane can affect the behaviour of a protein and thus its 
rotational rate.  
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For a sphere φ is described as  
RT
Vηφ =  
where η is the viscosity, V the molecular volume, R is the gas constant and T the temperature [78]. 
Another mechanism influencing the anisotropy of a sample is energy transfer. Indeed FRET between 
proximal like-fluorophores results in the depolarization of the fluorophore emission, i.e. 
depolarization due to homotransfer (see 1.4.4). Finally, light scattering represents also a critical 
factor affecting anisotropy. For example in a biological sample containing membranes, the 
fluorescence intensity should be high enough to overcome the scattered light coming from the lipid 
content. Indeed light scattering might increase the anisotropy even to values greater than 0,4, thus 
producing disturbing artefacts. As for steady-state intensity measurements, also in steady-state 
anisotropy measurements important information are neglected due to the averaging process of the 
anisotropy decay over the intensity decay. Due to this, time-dependent anisotropy decay 
measurements are preferable when studying the behaviour of molecules in the space. 
1.4.4 Time resolved anisotropy decays 
When a sample is continuously excited with vertically polarized light, steady state anisotropy is 
measured. Anisotropy is also described as the sum of the time dependent decays of the polarized 
components. The time-resolved decay of anisotropy r(t) for a spherical molecule is calculated as 
φtertr −= 0)(  
where r0 is the anisotropy at time t = 0 and φ the rotational correlation time [78]. Since the form of 
the anisotropy decay is determined by the size, shape and flexibility of the fluorophore as well as by 
the characteristics of the environment in which it resides, much information can be obtained by 
analyzing these decays. However, biological samples are not simply spherical entities, free to rotate 
in water, in contrast they show multiexponential decays, whose components arise not only from the 
rotation of the molecule along the different axes, but they are also the result of phenomena like 
homotransfer or due to the proximity of the fluorophore to a membrane. In this regard, the 
anisotropy of proteins bound to membranes never decays completely to zero since the presence of 
the bilayer averts a free and fast (in the order of ns) rotation of the molecule. For a multiexponential 
decay the anisotropy is given by: 
jt
j
jertr
φ−∑= 0)(  
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where r0j are the fractional anisotropies that decay with correlation times φj [78]. In Figure 12 B the 
decay curve relatives to a bi-exponential decay is shown. The decay curve is the result of the two 
decays, one faster and the second slower. These two components can be then associated to properties 
of the protein under study, e.g. in the case of a dimeric protein carrying two identical fluorophores in 
conditions of homotransfer (Figure 12 A). In this case the fast rotational correlation time (φ1) could 
be related to the extent of homotransfer between the fluorophores (i.e. the lower the value, the higher 
the proximity), whereas the slow component (φ2) could be associated to the wobbling of the 
fluorophores in the medium [85]. In general, rapid segmental motions are associated with an initial 
rapid decrease in anisotropy decay, followed by the slower anisotropy decay at longer times, due to 
overall rotational diffusion. 
 
Figure 12: homoFRET detection by time resolved anisotropy. In absence of homoFRET, the excitation and 
emission polarization of a sample (hypothetically containing only monomers of a protein) excited with 
vertically polarized light are more or less parallel since the rotational correlation time (φ) is longer than the 
decay time (A, upper panels and B, monomer). In case in which in the samples dimers or oligomers are 
formed, energy transfer causes a decrease of anisotropy values or loss of polarization (A, lower panels and B, 
dimer/multimer). The anisotropy decay in case of FRET is the result of two decays, a short decay due to 
energy transfer and a long decay due to the wobbling of the fluorophores in the medium (B). Adapted from 
[84]. 
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2 AIM OF THE THESIS 
Assembly of enveloped viruses requires the selective recruitment of viral components at distinct 
sites of the host cell plasma membrane from which viruses bud. This enrichment is due to two non-
excluding mechanisms, the association of the viral components with subdomains of the plasma 
membrane (lipid-rafts) and specific interactions between viral proteins. One of the most intense 
studied enveloped viruses with respect to assembly is the influenza virus whose budding takes place 
at the plasma membrane of epithelial cells. Three membrane proteins are embedded into the 
influenza virus envelope: hemagglutinin (HA), which mediates binding of the virus to the host cell 
and fusion with cell target membrane [86], neuraminidase (NA) and the proton channel M2. The 
inner viral membrane leaflet is covered by the matrix protein M1, which is supposed to mediate 
binding of the eight viral RNA-nucleoprotein complexes harbouring the genetic information of the 
virus. Several studies support a role of lipid domains as a platform for enrichment of viral 
components. HA, the most abundant envelope protein of influenza virus, has been found to be 
enriched in detergent resistant membrane (DRM) fractions [40,87,88]. Typical lipid components of 
those fractions are saturated phospholipids, glycosphingolipids and cholesterol which are known to 
form liquid-ordered (lo) domains [89]. This has led to the idea that so-called lipid rafts, which 
resemble lo domains, could function as assembly sites. Support for this hypothesis was given by the 
observation that the lipid composition of the influenza virus envelope is more similar to that of a raft 
than to the overall plasma membrane [38,40]. However, since it has been shown that DRM fractions 
may not resemble the native state of lipid domains, in particular of rafts [63,72], subsequent efforts 
have focussed on other techniques to assess the lateral organization of HA. Electron microscopy 
studies using immunogold labelling [88,90], FRET measurements between fluorescent HA 
antibodies in fixed cells [90] and investigations on photoactivatable HA in living cells [91] revealed 
cholesterol sensitive clustering of HA in the plasma membrane of mammalian cells at length scales 
between 20 and 900 nm. A specific problem encountered in studying the lateral organization of 
proteins in the plasma membrane is that lipid domains as rafts are typically organized at a 
submicroscopic level. Indeed, several attempts to image raft domains in biological membranes 
suggested that rafts are very small and highly dynamic [62,92]. A guiding study in characterization 
of lipid domains in biological membranes has been performed by Mayor and colleagues on the 
plasma membrane of CHO-K1 cells [77]. Based on homoFRET measurements they have shown that 
about 20 to 40% of GFP tagged glycosylphosphatidylinositol (GPI) [93] and other GPI-anchored 
proteins are organized with about three to four copies in small cholesterol sensitive clusters. 
Mathematical modelling of those experimental data is consistent with a domain diameter of about 5 
nm [77].  
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In the present study the lateral organization of the HA C-terminus corresponding to the 
transmembrane domain (TMD) and the cytoplasmic tail (CT) of the protein in the plasma membrane 
of CHO-K1 cells was investigated. Lateral organization was studied essentially by FLIM based 
FRET between CFP (donor) and YFP (acceptor) (Figure 13). For this purpose, the ectodomain of 
HA was replaced by YFP and FRET between this construct and GPI-CFP, whose lateral organization 
in the plasma membrane of CHO cells have been well characterized [77], was studied. As a 
complementary approach, ensemble measurements in suspensions of plasma membranes purified 
from cells expressing fluorescent GPI and HA constructs were performed. HomoFRET was 
measured by time-resolved fluorescence anisotropy providing information on the 
aggregation/clustering state of the fluorescent constructs which is important to rationalize the FLIM-
FRET data. 
 
Figure 13: FRET between TMD-HA-YFP and GPI-CFP. Cartoon of the strategy used to study the lateral 
organization of the HA transmembrane domain and cytoplasmic tail fused to YFP (TMD-HA-YFP) and of the 
glycosylphohsphatidylinositol-anchored CFP (GPI-CFP) in the plasma membrane of CHO cells. 
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3 MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Apparatuses 
35-mm-glass-bottom dishes MaTek Corp., Ashland, MA, USA 
Biophotometer plus Eppendorf, Hamburg, Germany 
Centrifuge Avanti J-20XP (Rotor JLA10.500) 
Ultracentrifuge Optima L-100K (Rotors: 45Ti, 70.1Ti, SW40Ti, 
SW60) 
 
Backmann Coulter GmbH, 
Krefeld, Germany 
Confocal Microscope Fluo View-1000 Olympus, Hamburg, Germany 
Gel-dryer Uniequip, Martinsried, Germany 
Hyperfilm ECL, PVDF-membrane Amersham Biosciences, Freiburg, 
Germany 
Incubator Heraeus, Berlin, Germany 
Kodak “X-Omat Ar”-Film Sigma-Aldrich, Taufkirchen, 
Germany 
Luminescence counter “1600 RT” Packard Perkin Elmer, Jügesheim, 
Germany 
“µ-Slide VI” Ibidi dishes Ibidi GmbH, Martinsried, 
Germany 
Plate-reader FluoStar Optima BMG Labtechnologies GmbH 
Semi-Dry Transfer cell “TransBlot SD” 
Thermal Cycler “MyCycler” 
BioRad, Munich, Germany 
SLM Aminco Spectrophotometer Aminco Bowman 
Time resolved LSM upgrade Kit PicoQuant, Berlin, Germany 
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3.1.2 Tissue culture reagents 
DMEM 
DMEM without phenol red 
DPBS with Ca2+ Mg2+ 
DPBS without Ca2+ Mg2+ 
Trypsin 
 
 
PAN, Aidenbach, Germany 
L-Glutamine Biochrom AG, Berlin, Germany 
Fetal Bovine Serum, FBS Invitrogen, Karlsruhe, Germany 
 
Antibiotic 
Penicillin/Streptomycin PAN, Aidenbach, Germany 
Kanamycin 
Neomycin 
Sigma-Aldrich, Taufkirchen, 
Germany 
 
3.1.3 Chemicals  
APS 
Cytochalasin D 
DMSO 
EDTA 
Jodacetamid 
Methyl-β-cyclodextrine 
NA-Deoxycholat (DOC) 
Protease Inhibitor cocktail (PIC) 
Protein-A-Sepharose 
Salicilic Acid 
TEMED 
Tween-20 
 
 
 
Sigma-Aldrich, Taufkirchen, 
Germany 
Acetic acid 
Acrylamide/Bisacrylamid (Rothiophorese 30) 
Glycerin 
Glycin 
 
Roth, Karlsruhe, Germany 
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fat-free dry milk 
NaCl 
SDS (Na-Dodecylsolfat) 
TBE 50X 
tricloracetic acid (TCA) 
Tris 
PMSF 
Sucrose 
Applichem, Darmstadt, Germany 
Nycodenz Axis-Schield PoC, Oslo, Norway 
Agarose Biozym scientific GmbH, 
Oldendorf, Germany 
dNTPs New England Biolabs, 
Schwalbach/Taunus, Germany 
ECL plus western blotting detection system Amersham Biosciences, Freiburg, 
Germany 
1kb DNA ladder, “Page Ruler Prestained” protein ladder Fermentas, St.Leon-Rot, Germany 
100bp DNA ladder Promega, Mannheim, Germany 
DAPI nucleic acid stain 
Lipofectamine 2000 
Lipofectin 
R18 
SYBR safe DNAgel stain 
 
Invitrogen, Karlsruhe, Germany 
Bacto Agar 
Bacto Tryptone 
Bacto Yeast 
BD, Becton, Dickinson and 
company, Lepont de Claix, France 
Rhodamine-Phalloidin Tebu-bio, Offenbach, Germany 
Scintillation Cocktail Microscint™ 20 Ultima Gold, 
Perkin Elmers Life ans Analytical 
Sciences, Boston, USA 
 
Radioactive compounds 
[3H]-Cholesterol GE-Healthcare, Buckinghamshire, 
UK 
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[35S]-Methionin (Tran35S-Label) MP Biomedicals, Heidelberg, 
Germany 
[3H]-Palmitic acid: MT 845 Palmitic acid [9,10-3H] Hartmann Analytic, 
Braunschweig, Germany 
 
3.1.4 Enzymes and antibodies 
Restriction enzymes 
BglII 
BsrGI 
DpnI 
NotI 
SacII 
 
 
New England Biolabs, 
Schwalbach/Taunus, Germany 
Glycosidase 
Endoglycosidase H New England Biolabs, 
Schwalbach/Taunus, Germany 
Phosphatase 
CIP New England Biolabs, 
Schwalbach/Taunus, Germany 
Ligase 
T4-DNA ligase New England Biolabs, 
Schwalbach/Taunus, Germany 
Polymerase 
Phusion High-Fidelity DNA Polymerase Finnzymes, Oldendorf, Germany 
Taq DNA polymerase Peqlab, Erlangen, Germany 
Kinase 
T4-polynucleotide Kinase New England Biolabs, 
Schwalbach/Taunus, Germany 
Antibodies 
αIgG (mouse) peroxidase-conjugated 
αIgG (rabbit) peroxidase-conjugated 
BioRad, Munich, Germany 
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anti-β-actin, mouse monoclonal Sigma-Aldrich, Taufkirchen, 
Germany 
anti-calreticulin, rabbit pAb Calbiochem, Darmstadt, Germany 
anti-caveolin 1, rabbit pAb BD Biosciences, Heidelberg, 
Germany 
anti-GFP, mouse Roche Diagnostics, Idianapolis, 
USA 
anti-membrine, mouse monoclonal Abcam, Cambridge, UK 
 
3.1.5 Kits 
QIAprep Spin Miniprep kit 
QIAquick gel extraction kit 
QIAgen Plasmid Maxiprep kit 
 
Quiagen, Hilden, Germany 
Micro BCA protein assay kit PIERCE, Rockford, IL,USA 
 
3.1.6 Cells  
CHO-K1 cells (chinese hamster ovary cells) ATCC number: CCL-61 
MDCKII (madin darby canin kidney cells) ATCC number: CCL-34 
 
3.1.7 Bacteria 
DH5α (E. coli) F- endA1 recA1 hsdR17(rk- mk+) supE44 λ- thi-1 gyrA(Na1) relA1 Φ80 
lacZ∆M15∆(lacZY A-argF)    
 
3.1.8 Plasmids and oligonucleotides 
Plasmids pEYFP-N1 (Invitrogen), pECFP-N1 (Invitrogen) and pECerulean-N1 [94] were used for 
cloning. These plasmids contain a multiple cloning site (MCS) immediately before the N-terminus 
of the fluorophore (Figure 14). Restriction sites within the MCS were used for cloning of the 
different HA-transmembrane domain and cytoplasmic tail fusion proteins (TMD-HA) and for the 
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GPI-anchored raft markers. For simplicity, in the text the abbreviation XFP (X fluorescent protein) 
was used to indicate the fluorophore variants employed for the production of the diverse fusion 
proteins. 
 
Figure 14: pEYFP-N1 vector. Plasmids pECFP-N1, pEYFP-N1 and pECer-N1 were used for cloning of all 
the TMD-HA and GPI- anchored fluorescent proteins. The restriction sites BglII and SacII within the multiple 
cloning site (MCS) were used for insertion of the different singnal peptides. The restriction sites BsrGI and 
NotI at the C-terminus of the fluorophore were used for fusing the HA transmembrane domain and 
cytoplasmic tail. 
The vector containing the HA sequence corresponding to the HA7 subtype of influenza virus 
A/FPV/Rostock/34 (H7N1), as well as the vector containing the same HA sequence but carrying the 
point mutations C551S, C559S and C562S were kindly provided by Stephanie Engel (Free 
University, Berlin). Four different HA transmembrane domain and cytoplasmic tail fragments 
(TMD), including also 38 residues of the ectodomain, were obtained as PCR products. The four 
fragments differ for the presence of linkers at the N-terminus of the sequence (see Table 1). The 
forward primer (Fw) contains the restriction site BsrGI, whereas the reverse (Rw) NotI (see plasmid 
map in Figure 14). TMD-HA-XFPs carrying the mutation C537S in the transmembrane domain were 
made adapting the "quick change mutagenesis" protocol from Stratagene (see 3.2.1.3). Finally, the 
VIL3A mutation, corresponding to the mutation of amino acids 527, 528 and 529 to alanines, in the 
transmembrane domain was inserted using as templates the plasmids HA-mYFP-AAA and HAC3S-
mYFP-AAA gently provided by Stephanie Engel (Free University, Berlin). The numbers relative to 
the point mutations, i.e. C537S, V527A, I528A, L529A, refer to the position that the amino acids 
occupy in the complete HA sequence. 
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The HA signal peptide (SpHA) was designed as an oligonucleotide and cloned into the plasmids 
pECFP-TMD-HA, pEYFP-TMD-HA and pECerulean-TMD-HA using the restriction sites BglII and 
SacII (refer to plasmid map in Figure 14). Alternatively, the rabbit lactase phlorizin hydrolase (LPH) 
signal peptide (SpLPH) derived form the protein GPI-CFP [95] was synthesized as an 
oligonucleotide and cloned into the different XFP-TMD-HA plasmids. The HA signal peptide 
carrying the C22S mutation (SpHA-CS), was synthesized as oligonucleotide and ligated into the 
different TMD-HA-XFP plasmids using the restriction sites BglII and SacII. All oligonucleotides 
were purchased from Biotez, Berlin, Germany. 
The mutation A206K [96] was inserted into the plasmid pECFP-N1, using "quick change 
mutagenesis" adapted from the Stratagene protocol (see 3.2.1.3) generating the plasmid pEmCFP-
N1. All TMD-HA and GPI- variants were subsequently cloned into the pEmCFP-N1 and pEmYFP-
N1 (provided by Stephanie Engel, Free University, Berlin) plasmids. The number relative to the 
point mutation C22S refers to the position that the amino acid occupies in the complete HA 
sequence. mCFP and mYFP indicate the non dimerizing counterparts of CFP and YFP, respectively.  
The mutations C49S and C71S were introduced in TMD-HA-mCFP and TMD-HA-mYFP using 
"AB-PCR" (described in 3.2.1.2). Primers and oligonucleotides for the production of the above 
described fusion proteins are reported below and summarized in Table 1. In brackets the restriction 
enzymes used for the subsequent cloning are indicated. The numbers relative to the point mutations, 
i.e. C49S, C71S, refer to the position that the amino acids occupy in the fluorophore sequence. 
Fw-mCFPA206K CTG AGC ACC CAG TCC AAA CTG AGC AAA GAC CCC  
Rw-mCFPA206K GGG GTC TTT GCT CAG TTT GGA CTG GGT GCT CAG  
Fw-TMD GGC TGT ACA AGA GTA GTG GCT ACA AAG ATG TG (BsrGI) 
Rw-TMD GCG CGG CCG CTT ATA TAC AAA TAG TGC ACC GC (NotI) 
Fw-TMD(NNT) GGC TGT ACA AGG CTA GTA TAA GGA ACA ATA CT (BsrGI) 
Fw-TMD(GS) GGC TGT ACA AGG GCT CTG CTA GTA TAA GGA ACA ATA CT 
(BsrGI) 
Fw-TMD(LRPEA)GGC TGT ACA AGC TCC GGC CTG AAG CTG CTA GTA TAA GGA 
ACA (BsrGI) 
Rw-TMD(C3S) GCG CGG CCG CTT ATA TAG AAA TAG TGG ACC GC (NotI) 
Fw-TMD-CS AGC TTC GGG GCA TCA TCT TTT TTG CTT CTT GCC  
Rw-TMD-CS GGC AAG AAG CAA AAA AGA TGA TGC CCC GAA GCT  
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FwC49S ACC CTG AAG TTC ATC TCT ACC ACC GGC AAG CTG 
RwC49S CAG CTT GCC GGT GGT AGA GAT GAA CTT CAG GGT 
Fw-mCFPC71S ACC TGG GGC GTG CAG TCT TTC AGC CGC TAC CCC 
Rw-mCFPC71S GGG GTA GCG GCT GAA AGA CTG CAC GCC CCA GGT 
Fw-mYFPC71S GGC TAC GGC CTG CAG TCT TTC GCC CGC TAC CCC 
Rw-mYFPC71S GGG GTA GCG GGC GAA AGA CTG CAG GCC GTA GCC 
Fw-SpHA GAT CTC ATG AAC ACT CAA ATC CTG GTT TTC GCC CTT GTG GCA GTC 
ATT CCC ACA AAT GCA GAC AAA ATT TGT CTT CCG C (BglII-SacII) 
Rw-SpHA GGA AGA CAA ATT TTG TCT GCA TTT GTG GGA ATG ACT GCC ACA AGG 
GCG AAA ACC AGG ATT TGA GTG TTC ATG A (BglII-SacII) 
Fw-SpLPH GAT CTC ATG GAG CTC TTT TGG AGT ATA GTC TTT ACT GTC CTC 
CTG AGT TTC TCC TGC CGG GGG TCA GAC TGG GAA TCT CTG CCG C (BglII-
SacII) 
Rw-SpLPH GGC AGA GAT TCC CAG TCT GAC CCC CGG CAG GAG AAA CTC AGG 
AGG ACA GTA AAG ACT ATA CTC CAA AAG AGC TCC ATG A (BglII-SacII) 
FwSpHA-CS GAT CTC ATG AAC ACT CAA ATC CTG GTT TTC GCC CTT GTG GCA 
GTC ATT CCC ACA AAT GCA GAC AAA ATT TCT CTT CCG C (BglII-SacII) 
RwSpHA-CS GGA AGA GAA ATT TTG TCT GCA TTT GTG GGA ATG ACT GCC ACA 
AGG GCG AAA ACC AGG ATT TGA GTG TTC ATG A (BglII-SacII) 
Fw-GPI(DAF) GTA CAA GCC AAA TAA AGG AGG TGG AAC CAC TTC AGG TAC TAC 
CCG TCT TCT ATC TGG GCA CAC GTG TTT CAC GTT GAC AGG TTT GCT TGG GAC 
GCT AGT AAC CAT GGG CTT GCT GAC TTA GC (BsrGI-NotI) 
Rw-GPI(DAF) GGC CGC TAA GTC AGC AAG CCC ATG GTT ACT AGC GTC CCA AGC 
AAA CCT GTC AAC GTG AAA CAC GTG TGC CCA GAT AGA AGA CGG GTA GTA CCT 
GAA GTG GTT CCA CTT CCT TTA  TTT GGC TT (BsrGI-NotI) 
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Table 1: Fusion proteins. Summary of plasmids, primers and oligonucleotides used for the production of the 
TMD-HA variants and GPI-anchored fluorophores. Fw = forward, Rw = reverse. Sp= SpHA; SpCS=SpHA-
CS. 
Protein name Plasmid template N- (Fw) and C- (Rw) terminus 
primers 
pEmCFP-N1 pECFP-N1 Fw-mCFPA206K  
Rw-mCFPA206K 
TMD-HA-YFP PA11sv13-HA 
pEYFP 
Fw-TMD 
Rw-TMD 
TMD(NNT)-HA-YFP PA11sv13-HA 
pEYFP 
Fw-TMD(NNT) 
Rw-TMD 
TMD(GS)-HA-YFP PA11sv13-HA 
pEYFP 
Fw-TMD(GS) 
Rw-TMD 
TMD(LRPEA)-HA-YFP PA11sv13-HA 
pEYFP 
Fw-TMD(LRPEA) 
Rw-TMD 
Sp-TMD(NNT)HA-YFP TMD(NNT)-HA-YFP 
Oligonucleotide 
Fw-SpHA 
Rw-SpHA 
Sp-TMD(NNT)HA-CFP Sp-TMD(NNT)HA-YFP  
pECFP-N1 
YFP substituted with CFP (SacII and 
BsrGI) 
Sp-TMD(NNT)HA-mCer Sp-TMD(NNT)HA-YFP  
pEmCerulean-N1 
YFP substituted with mCerulean 
(SacII and BsrGI) 
SpLPH-TMD(NNT)HA-YFP TMD(NNT)HA-YFP 
Oligonucleotide 
Fw-SpLPH 
Rw-SpLPH 
Sp-TMD(NNT)C3S-HA-YFP PA11sv13-HA-M3 
Sp-TMD(NNT)HA-YFP  
Fw-TMD(NNT) 
Rw-TMD(C3S) 
Sp-TMD(NNT)C3S-HA-CFP PA11sv13-HA-M3 
Sp-TMD(NNT)HA-CFP 
Fw-TMD(NNT) 
Rw-TMD(C3S) 
Sp-TMD(NNT)-HA-mYFP Sp-TMD(NNT)HA-YFP  
pEmYFP 
YFP substituted with mYFP (SacII 
and BsrGI) 
SpCS-TMD(NNT)-HA-YFP Sp-TMD(NNT)HA-YFP  
Oligonucleotide 
Fw-SpHA-CS 
Rw-SpHA-CS 
SpCS-TMD(NNT)-HA-mYFP Sp-TMD(NNT)HA-mYFP  
Oligonucleotide 
Fw-SpHA-CS 
Rw-SpHA-CS 
SpCS-TMD(NNT)C3S-HA-YFP Sp-TMD(NNT)C3S-HA-YFP 
Oligonucleotide 
Fw-SpHA-CS 
Rw-SpHA-CS 
Sp-TMD(NNT)HA-mCFP 
 
Sp-TMD(NNT)HA-CFP 
pEmCFP-N1 
CFP substituted with mCFP (SacII 
and BsrGI) 
GPI-mCFP GPI-CFP Fw-mCFPA206K  
Rw-mCFPA206K 
Sp-GPI(DAF)-CFP Sp-TMD(NNT)HA-CFP 
Oligonucleotide 
Fw-GPI(DAF) 
Rw-GPI(DAF) 
  MATERIALS AND METHODS 
36 
Protein name Plasmid template N- (Fw) and C- (Rw) terminus 
primers 
Sp-GPI(DAF)-YFP Sp-TMD(NNT)HA-YFP 
Oligonucleotide 
Fw-GPI(DAF) 
Rw-GPI(DAF) 
Sp-GPI(DAF)-mCFP Sp-GPI(DAF)-CFP Fw-mCFPA206K  
Rw-mCFPA206K 
Sp-TMD(NNT)C3S-HA-mCFP Sp-TMD(NNT)C3S-HA-CFP Fw-mCFPA206K  
Rw-mCFPA206K 
Sp-TMD(NNT)-CS-HA-mYFP Sp-TMD(NTT)HA-mYFP 
 
Fw-TMD-CS 
Rw-TMD-CS 
SpCS-TMD(NNT)C3S-CS-HA-
YFP 
SpCS-TMD(NNT)C3S-HA-YFP Fw-TMD-CS 
Rw-TMD-CS 
Sp-TMD(NNT)-HA-mYFP 
C49S 
Sp-TMD(NNT)-HA-mYFP 
Sp-TMD(NNT)-HA-mYFP 
 
(AB-PCR) Fw-SpHA/ 
Rw-TMD 
Fw-C49S/ Rw-C49S 
Sp-TMD(NNT)-HA-mYFP 
C49S-C71S 
Sp-TMD(NNT)-HA-mYFP 
C49S 
Sp-TMD(NNT)-HA-mYFP 
 
(AB-PCR) Fw-SpHA/ 
Rw-TMD 
Fw-mYFPC71S/ Rw-mYFP 
C71S 
Sp-TMD(NNT)-HA-mCFP 
C49S 
Sp-TMD(NNT)-HA-mCFP 
Sp-TMD(NNT)-HA-mCFP 
(AB-PCR) Fw-SpHA/ 
Rw-TMD 
Fw-C49S/ Rw-C49S 
Sp-TMD(NNT)-HA-mCFP 
C49S-C71S 
Sp-TMD(NNT)-HA-mCFP 
C49S 
Sp-TMD(NNT)-HA-mCFP 
(AB-PCR) Fw-SpHA/ 
Rw-TMD 
Fw-mCFPC71S/ Rw-mCFP 
C71S 
Sp-TMD(NNT)-VIL3A-HA-
mYFP 
HA-L-YFP-VIL3A 
Sp-TMD(NNT)-HA-mYFP 
Fw-SpHA  
Rw-TMD 
Sp-TMD(NNT)C3S-VIL3A-HA-
mYFP 
HA-C3S-L-YFP-VIL3A 
Sp-TMD(NNT)-HA-mYFP 
Fw-SpHA  
Rw-TMD 
 
3.1.8.1 SFV-E2-mCFP 
The SFV-E2-mCFP protein was kindly provided by Bastian Thaa (Free University, Berlin). The 
sequence fused to the N-terminus of the mCFP fluorescent protein is  
5'-PVRLWSNLTTEGKPHGWPHQIVQYYYGLYPAATVSAVVGMSLLALISIFASSYMLVAARSKSLT 
PYALTPGAAVP-3' 
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The glycosylation site is single underlined, the TMD is in bold letters and the serine residues 
substituting the palmitoylation sites are double underlined. This fragment was substituted to the 
TMD-HA fragment in the plasmid containing the TMD-HA-mCFP protein.  
3.1.9 Cell culture media and buffers 
Culture medium  
DMEM, 10% FBS, 5% Penicillin-Streptomycin 
DMEM phenol-red free, 10% FBS, 5% Penicillin-Streptomycin, 2 mM L-Glutamine 
Freezing medium 
20% FBS, 10% DMSO, 70% DMEM 
Labelling medium 
MEM with EBSS, 4 mM L-Glutamine 
Selection medium 
DMEM, 10% FBS, 5% Penicillin-Streptomycin, 250-500 µg/ml Neomycin 
Bacteria medium and plates 
LB-medium  1% Bacto™ Tryptone, 0,5% Bacto™ Yeast Extract, 0,5% NaCl, in ddH2O, 
pH 7 
Kanamycin-LB-plates 1% Bacto™ Tryptone, 0,5% Bacto™ Yeast Extract, 0,5% NaCl, 1,5% 
Agar, 50 µg/ml Kanamycin, in ddH2O, pH 7. 
Buffers 
105% Nycodenz 
Solution 
10,5 g Nycodenz in gradient buffer to 15,6 g (density=1,56 g/ml) 
58% Nycodenz 
Solution 
5,8 g Nycodenz in gradient buffer to 13,1 g (density=1,31 g/ml) 
8% Nycodenz 
Solution 
0,8 g Nycodenz in gradient buffer to 10,4 g (density=1,04 g/ml) 
10x PAGE-Buffer 30 g Tris-Base, 144 g Glycin, 10 g SDS in 1 l ddH2O 
10x PBS 40 g NaCl, 1 g KCl, 7,1 g Na2HPO4  2H2O, 1 g KH2 PO4 in 500 ml ddH2O 
4x SDS-PAGE-
sample Buffer 
25% β-mercaptoethanol, 5% SDS, 0,05% Blue Bromophenol, 25% Glycerin, 
12,5% 1 M Tris-HCl buffer pH 6,8 
4x SDS-PAGE-
sample Buffer (non-
reducing) 
5% SDS, 0,05% Blue Bromophenol, 25% Glycerin, 12,5% 1 M Tris-HCl 
buffer pH 6,8 
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Blocking-Buffer 0,1% Tween-20, 5% dry Milk, 1x PBS in ddH2O 
Fixative solution 
(for polyacrylamide 
gels) 
10% Ethanol, 10% Acetic Acid in ddH2O 
Giant Plasma 
Membrane Vescicles 
(GPMV)-Buffer 
2 mM CaCl2, 10 mM Hepes, 0,15 M NaCl, 25 mM formaldehyde, 2 mM 
DTT, pH 7,4 
Gradient-Buffer 20 mM Tris-HCl pH 7,5, 100 mM NaCl, 1 mM EDTA in ddH2O 
Lysis-Buffer 1 mM Tris-HCl pH 7,4, 0,1 mM MgCl2, 1 mM PMSF, 1% PIC in ddH2O 
Resolving gel (12%) 4 ml Acrylamid/Bisacrylamid (30%), 2,5 ml 1,5 M Tris-HCl pH 8,8, 100 µl 
SDS (10%), 3,3 ml ddH2O, 4 µl TEMED, 100 µl APS (10%) 
Resolving gel (15%) 5 ml Acrylamid/Bisacrylamid (30%), 2,5 ml 1,5 M Tris-HCl pH 8,8, 100 µl 
SDS (10%), 2,3 ml ddH2O, 4 µl TEMED, 100 µl APS (10%) 
RIPA-Buffer 1% Triton X-100, 1% Desoxycholat, 0,1% SDS, 0,15 M NaCl, 20 mM Tris, 
10 mM EDTA, 10 mM Jodacetamid, 1mM PMSF, in ddH2O, pH 7,4 
Stacking gel (5%) 0,5 ml Acrylamid/Bisacrylamid (30%), 0,75 ml 0,5 M Tris-HCl pH 6,8, 30 µl 
SDS (10%), 1,7 ml ddH2O, 3 µl TEMED, 30 µl APS (10%) 
TNE-Buffer 25 mM Tris-HCl pH 7,4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0,2 
mM PMSF in ddH2O 
Transfer buffer 40 ml PAGE-Buffer, 20 ml Methanol, 0,6 ml SDS (10%), in 100 ml ddH2O 
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3.2 Methods 
3.2.1 Molecular biology 
3.2.1.1 Polymerase Chain Reaction 
The polymerase chain reaction (PCR) technique enables the exponential amplification of a specific 
DNA sequence in vitro.  
The standard PCR protocol entails the use of the DNA sequence to be amplified, of the nucleotide 
mixture (dNTPs), of the forward and reverse primers (namely Fw and Rw) and of the enzyme DNA 
polymerase. The PCR is carried out in a thermocycler machine that allows the fast change of 
temperature from one PCR step to the next. After the denaturation of the template, occurring in the 
first step of the reaction, the primers anneal with the DNA open strands and the new DNA copies are 
formed during the extension cycles. In the table below (Table 2) the reagent mixture protocol and 
the PCR scheme used for the amplification of the different HA transmembrane domain and 
cytoplasmic tail fragments are reported. 
Table 2: Standard PCR. Reagent volumes and the PCR scheme used for the amplification of the HA 
transmembrane domain and cytoplasmic tail.  
PCR reagents PCR scheme 
DNA template 50 ng CYCLE T (°C) Time (min) 
dNTPs 0,5 mM Initial Denaturation 94 5 
Taq-polymerase 5 U *Denaturation 94 1 
Fw-primer 1 µM *Annealing 52 1 
Rw-primer 1 µM *Extension 72 1 
PCR Buffer 10x Final Extension 72 10 
ddH2O to final volume= 50µl Cooling 4 10-o.n. 
*The denaturation-annealing-extention steps are repeated in this order for 30 times 
 
3.2.1.2 AB-PCR 
The mutation C49S and C71S in the XFP proteins have been inserted using an alternative PCR 
method, called AB-PCR or “overlap-extension PCR” (OE-PCR) [97,98]. To perform this kind of 
PCR, 4 primers are needed. Primers a1 and b1 are designed complementary to the region in which 
the desired mutation has to be inserted and contain in the middle the mutated sequence. Primers a2 
and b2 are external primers carrying two restriction sites (see Figure 15).  
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Figure 15: AB-PCR scheme. The AB-PCR procedure allows the insertion of point mutations using two 
subsequent PCRs. In the first PCR a couple of primers carrying in the middle the mutation (in the picture 
referred to as a1 and b1, reverse (Rw) and forward (Fw) respectively), is employed. The second couple of 
primers are complementary to the N- and C- terminus of the fragment of interest and they carry a restriction 
site used for the subsequent cloning into the vector. In the first step two PCRs are run in parallel, one entailing 
the use of primers a1 and a2 and the other b1 and b2, thus producing the fragments A and B respectively. These 
two PCR products together with the primers a2 and b2 are then used in the second PCR for the amplification 
of the sequence containing the desired mutation. 
 
The complete procedure consists of two sequential PCR. In the first part, two PCR are run in parallel 
using as Fw and Rw the primers a2 and a1 and b1 and b2, respectively. In the following PCR the 
“A” and “B” products serve as template for the amplification of the final DNA strain (A+B) 
containing the desired mutation. Primers a2 and b2 has to be used in order to generate at the N- and 
C- terminus of the fragment two restriction sites (Figure 15). The protocol and the reagents used are 
summarized in Table 3 and Table 4. 
Table 3: I and II PCR. First (I) and second (II) PCR schemes used in the AB-PCR method described above. 
I PCR II PCR  
CYCLE T (°C) Time 
(min) 
T (°C) Time 
(min) 
Initial  
Denaturation 
94 3 94 3 
*Denaturation 94 30 s 94 30 s 
*Annealing 50 30 s 50 30 s 
*Extension 68 40 s 68 1 
Final  
Extension 
68 10 68 10 
Cooling 4 10-o.n. 4 10-o.n. 
*The denaturation-annealing-extention steps are repeated in this 
order for 24 times. 
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Table 4: AB-PCR reagents summary. The reagents and the related volumes necessary for carrying out the 
AB-PCR are summarized. 
Reagent A PCR B PCR AB PCR 
DNA template 50 ng 50 ng 50 ng (A+B 
fragments) 
dNTPs 0,5 mM 0,5 mM 0,5 mM 
Taq- polymerase 5 U 5 U 5 U 
Fw-primer 1 µM (a2) 1 µM (b1) 1 µM (a2) 
Rw-primer 1 µM (a1) 1 µM (b2) 1 µM (b2) 
PCR Buffer 10x 10x 10x 
ddH2O to final V=50µl to final V=50µl to final V=50µl 
 
3.2.1.3 Quick change mutagenesis 
The Quick change mutagenesis strategy is based on the one developed by Stratagene. The point 
mutation is inserted into the dsDNA vector in one step and it does not require further purification, 
restriction and ligation. The primers are designed each complementary to opposite strands of the 
vector and they carry in the middle the desired mutation. HF-Phusion polymerase is used to extend 
the annealed primers during temperature cycling. The extension temperature is normally chosen 3 °C 
above the melting temperature (Tm) of the primers. The final product is a non-methylated nicked 
plasmid, which is then digested with the endonuclease DpnI (1 hour, 37 °C). This enzyme 
specifically digests methylated and hemimethylated DNA and it is therefore used to disrupt the 
parental DNA template. The mutated plasmid is then transformed into DH5α competent cells. In 
Table 5 the PCR scheme is reported. 
Table 5: Quick change mutagenesis. PCR scheme of the quick change mutagenesis steps for the insertion of 
point mutations. 
PCR scheme 
CYCLE T (°C) Time (min) 
Initial Denaturation 98 3 
*Denaturation 98 30 s 
*Annealing 74 30 s 
*Extension 72 3 
Final Extension 72 10 
Cooling 4 10-o.n. 
*The denaturation-annealing-extention steps are 
repeated in this order for 20 times 
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3.2.1.4 Oligonucleotides cloning 
Alternatively to PCR amplification, short DNA fragments can be designed as oligonucleotides. 
These peptides contain at the N- and C-terminus the complete restriction site used for further ligation 
into the plasmid of interest. Oligonucleotides are synthesized as complementary ssDNA, therefore 
they need to hybridize. Furthermore, in order to allow subsequent ligation, 5'-phosphate should be 
added. Thus, the two peptides are incubated with the enzyme T4 polynucleotide kinase for 1 hour at 
37 °C, in presence of ATP. Finally annealing occurs placing the polypeptides at 97 °C for 10 minutes 
followed by gradual cooling. This allows the oligos to find the "correct" lowest energy configuration 
at room temperature.  
3.2.1.5 DNA rescue and enzymatic cleavage 
In order to control the size, PCR products are run into 1% or 2% (for fragments under 1500bp) 
agarose gels. For visualization, the DNA is stained with 1x SYBR green before loading into the gel. 
Extraction of the DNA from the agarose gel is done using the QIAquick gel extraction kit. This 
passage is necessary to eliminate the PCR reagents that might interfere with the subsequent cloning 
steps. PCR fragments, oligonucleotides, as well as the vector in which the fragments should be 
inserted, are subjected to enzymatic cleavage with restriction enzymes. These enzymes cut the DNA 
within specific sequences, whose digestion leads to the formation of overlapping or "sticky" ends. 
Restriction occurs mixing the DNA with the suitable buffer and 1-2 µl of the enzymes in a final 
volume of about 10 to 30 µl. The reaction is incubated for 1 hour or even over night at 37 °C, 
depending on the percentage of activity of the enzymes in the selected buffer. In order to avoid self-
ligation, after digestion the vector has to be dephosphorylated using CIP (calf intestinal alkaline 
phosphatase), that catalyzes the removal of reactive 5'-phosphate. Before proceeding with ligation it 
is necessary to purify PCR fragments, oligonucleotides and vector from the restriction and the 
dephosphorylation reagents. Therefore, DNA is again run and extracted from agarose gel.  
3.2.1.6 Ligation of the DNA fragment and transformation 
Ligation occurs with the aid of the T4-DNA-ligase. This enzyme catalyzes the formation of a 
phosphodiester bond between juxtaposed 5' phosphate and 3' hydroxyl termini in duplex DNA or 
RNA. Thus, it joins blunt or cohesive ends, leading to the production of DNA molecules with the 
desired insert. The ratio fragment:vector should be 5:1 and the reaction occurs for 10 min at room 
temperature and then for 3 hours (to over night) at 16 °C.  
Ligated plasmids are then transformed into DH5α chemically competent bacteria. The ligation 
reaction is dilued to a final volume of 100 µl and incubated on ice for 30 min with 250 µl of 
bacteria. The transformation proceeds with 45 seconds "heat-shock", followed by fast transfer on ice 
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for 2 min. About 600 µl of LB-medium are then added and bacteria are shaken at 37 °C for 1 hour. 
Transformed cells are finally plated on Kanamycin-agar plates (Kanamycin final concentration 50 
µg /ml). 
3.2.1.7 Plasmid purification from bacteria 
For the purification of the plasmid from 3 ml of overnight culture in 50 µg /ml Kanamycin 
containing LB-medium, the QIAprep Spin Miniprep kit is used. The DNA is concentrated in 30-50 
µl of dd H2O. 
Extensive plasmid purification is carried out using the QIAgen Plasmid Maxiprep kit. The overnight 
bacteria culture is increased to about 200 to 400 ml of Kanamycin-LB medium (final concentation 
50 µg/ml). The DNA is concentrated in 800 µl of ddH2O. 
The DNA concentration is measured with a Biophotometer plus spectrophotometer. 
Plasmids were sent to Invitek (Invitek, Berlin, Germany) for sequencing and the following 
sequencing-primers were used: 
CMV for CGC AAA TGG GCG GTA GGC GTG 
TMD-HA for ACA TCG AGG ACG GCA GCG TGC AGC TCG CCG  
TMD-HA-VIL3A for TGC TGC CCG ACA ACC ACT ACC TGA  
 
3.2.2 Cell culture 
CHO-K1 and MDCKII cell suspensions (1 ml) are thawed in 13 ml DMEM supplied with 10% FBS 
and 5%PS (complete medium). After 5 min of centrifugation at 1000 rpm at room temperature, the 
cell pellet is resuspended in 12 ml of complete medium and transferred to a T75 flask. Cells are 
incubated at 37 °C and 5% CO2 till the density reaches 70% confluency. Confluent cells are first 
washed with 5 ml DPBS without Ca2+ and Mg2+ and detached from the flask with 2 ml 
Trypsin/EDTA (1 min at 37 °C and 5% CO2). Trypsin reaction is blocked with 10 ml DMEM 
complete and 1 ml of cells are transferred to a new flask supplied with 11 ml of fresh medium 
(dilution 1:12).  
CHO-K1 and MDCKII stable transfected cell lines are cultured in DMEM complete supplied with 
250 µg/ml Neomycin. 
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CHO-K1 cells used for microscopy and spectroscopy experiments are grown in DMEM without 
phenol red and supplied with 2mM L-Glutamine, 10% FBS and 5% PS (and 250 µg/ml Neomycin 
for stable transfected cell lines).  
CHO-K1 and MDKII cell lines stably expressing TMD-HA-YFP, TMD-HA-mYFP, GPI-CFP and 
GPI-mCFP are detached either using a cell scraper or diluting Trypsin/EDTA 1:2. 
For freezing, cells are detached from the flask, as previously described, transferred to a falcon tube 
and centrifuged for 5 min and 1000 rpm at room temperature. Cell pellet is then resuspended in 1,5 
ml of freezing medium composed of DMEM complete and cryo medium (3:1) and transferred to 
cryo-vials. The cryo medium is made of FBS and DMSO (2:1). The cryo-vials are stored in a 
polystyrene box at -80 °C, overnight and then moved to liquid nitrogen.   
3.2.2.1 Transient and stable transfection 
Transient transfection is done using Lipofectamine 2000. About 10 µl of reagent is necessary for 
transfecting one 35 mm dish with 90% confluent cells. Lipofectamine is diluted to a final volume of 
250 µl with DMEM pure (without FBS and PS) and incubated at room temperature for 5 min. For 
each transfection 4 µg of DNA plasmid is diluted in 250 µl of DMEM pure. Lipofectamine 2000 and 
DNA solutions are then combined and incubated for 20 min at room temperature. In the meanwhile 
cells are washed 2 times with DMEM pure, afterwards the Lipofectamine-DNA complexes are 
added. The plates are swirled carefully in order to homogeneously distribute the complexes before 
incubation at 37 °C and 5% CO2. After 4 hours the medium is changed with DMEM without FBS 
and PS. Imaging of cells is done 20-22 hours post-transfection. 
The stable transfection of CHO-K1 and MDCKII with the TMD-HA-YFP, TMD-HA-mYFP, GPI-
CFP and GPI-mCFP plasmids entails the aid of Lipofectin. Cells are seeded in 6 cm cell culture 
dishes and grown to 30-50% confluency. For transfection, 10 µl of Lipofectin and 2 µg DNA are 
diluted in 100 µl DMEM pure and incubated at room temperature for 45 min. Then the two solutions 
are mixed and incubated at room temperature for further 15 min. Before transferring the complexes 
to the cells, they are washed 2 times with DMEM pure and 1,8 ml of DMEM is added to the 
Lipofectin-DNA mixture. Finally, the plates are swirled carefully in order to homogeneously 
distribute the complexes before incubation at 37 °C and 5% CO2 for 24 hours. The day after 
transfection medium is substituted with DMEM complete. When transfected cells are 90% 
confluent, they are diluted 1:50, 1:20 and 1:10 in new 9,4 cm dishes and cultivated with selective 
medium (DMEM complete with 500 µg/ml Neomycin) at 37 °C, 5% CO2. Medium is changed every 
2-3 days and resistant clones are picked and transferred to 24 well plates with a cover slip. Cells are 
maintained in complete medium with 250 µg/ml Neomycin at 37 °C, 5% CO2 until they reach 70% 
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confluency. Then, the cells on the cover slip are fixed with paraformaldheyde and imaged for 
detection of fluorescent protein expression. Positive clones are transferred to T25 and subsequently 
to T75 flasks prior to freezing. For further cultivation of stable transfected cell lines DMEM 
complete with 250 µg/ml is used.  
3.2.2.2 Cell treatments 
Transfected cells are subjected to treatment with different substances. Dithiothreitol (DTT) is used to 
reduce TMD-HA-disulfide linked dimers localized in the plasma membrane. Cytochalasin D is a cell 
permeable fungal toxin whose binding to actin filaments causes their disruption and therefore it 
inhibits also their polarization [99]. This substance is employed to disrupt the cell cytoskeleton. 
Methyl-β-cyclodextrins are cyclic oligosaccharides composed of 7 α-D-glucopyranoside units. The 
highly hydrophobic cholesterol molecule is easily lodged inside the ring; therefore cyclodextrins are 
used as raft-perturbing agents for extracting cholesterol from the cell plasma membrane [100]. The 
different treatments are summarized in Table 6. 
Table 6: Cell treatments. 
Substance Concentration Incubation conditions 
DTT 10 mM (DPBS) 5 min, RT 
Cyochalasin D 1 µM (DMSO) 20 h, 37 °C 
Methyl-β-cyclodextrin 
(MβCD) 
5-10 mM (DPBS) 1 min, 4 °C 
30 min, 37 °C 
 
3.2.2.2.1 Cytochalasin D treatment  
CHO-K1 transfectants were incubated with a 1 µM solution of Cytochalasin D at 37 ºC for 20 hours. 
Cells were then washed with DPBS and supplied with DMEM without phenol red before 
measurement. 
3.2.2.2.2 DTT treatment  
CHO-K1 transfectants were incubated with a 10 mM solution of DTT for 5 min at room 
temperature. Cells were then washed with DPBS and supplied with DMEM without phenol red 
before measurement. 
3.2.2.2.3 Cholesterol depletion 
CHO-K1 cells were incubated at 4 ºC for 1 min with a 5 mM solution of methyl-β-cyclodextrin 
(MβCD) in DPBS. Alternatively cells were incubated for 30 min at 37 ºC with 5 or 10 mM MβCD. 
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3.2.2.3 Cellular polarization 
MDCK II are epithelial cells and therefore can be polarized. The plasma membrane of epithelial 
cells is divided into two domains: an apical domain. In order to allow MDCKII polarization, cells 
are grown in Transwells, permeable supports with microporous PET (Polyester)-membranes that 
permit cells to uptake and secrete molecules on both their basal and apical surfaces. The selection 
medium (250 µg/ml Neomycin) is changed every day for the next 10-18 days. Correct polarization 
of the cells is checked by confocal imging of the apical or basolateral membrane protein distribution 
(Figure 38). 
3.2.2.4 Giant Plasma Membrane Vescicles (GPMV) formation 
Cells are forced to produce giant plasma membrane vescicles (GPMVs) or "blebs" upon treatment 
with buffer containing DTT and formaldheyde as previously described [101,102]. Briefly, almost 
confluent cells seeded in T25 flasks are washed twice with GPMV buffer, then 1,5 ml of GPMV 
buffer containing 2 mM DTT and 25 mM formaldheyde are added and flasks are finally incubated at 
37 °C for 1 hour, under gently shaking (60-80 cycles per minute). GPMVs detached from cells are 
then collected from the bottom of the flask and decanted into a conical glass tube where they are 
allowed to sediment for about 30 min at 4 °C. For imaging of liquid disordered (ld) domains, about 
30 µl of vesicles are labeled with a 20 µM R18 solution and they are imaged in a ibidi-dish. Images 
of the equatorial plane of the blebs were taken at 10 °C and the temperature was controlled with a 
water circulating bath. 
3.2.2.5 Cell fixation and DAPI/Rho-Palloidin labelling 
DAPI and rhodamine-phalloidin labelling are used to stain the DNA and the cell actin cytoskeleton, 
respectively. Cells are grown in 35 mm dishes with glass cover slip. They are then washed twice 
with DPBS at 37 °C to remove the culture medium and residues of phenol red which might interfere 
with fluorescence imaging. Cells are fixed with 1 ml of 4% formaldehyde solution in DPBS, for 10 
min at room temperature. After fixation, cells are rinsed once with DPBS for 30 s and permealized 
with a 0,5% Triton X-100 solution for 5 min at room temperature. After a second wash step with 
DPBS for 30 seconds at room temperature, cells are stained with 200 µl of a 100 nM rhodamine-
phalloidin solution. Incubation is carried out in a humid chamber for 30 min at room temperature in 
the dark. Cells are then washed three times with DPBS prior to DNA counterstaining with 200 µl of 
100 nM DAPI (4´6-diamidino-2-phenylindole). Cells are finally rinsed once with DPBS and imaged. 
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3.2.3 Biochemistry 
Proteins are separated according to their size by SDS-polyacrylamide gel electrophoresis. Prior to 
application into the gel, samples are mixed with SDS-sample buffer (reducing or non-reducing) and 
heated at 95 °C for 5 min. The electrophoresis is run at a constant voltage of 180 V until complete 
resolution. Gels are then transferred to PVDF membranes (Western Blot) or they are fixed and dried 
for autoradiography.  
3.2.3.1 Gel Autoradiography 
Radioactive-labeled proteins subjected to electrophoresis can be revealed by autoradiography. After 
running, the gel is incubated over night in fixative solution, washed two times in ddH2O, incubated 
for 30 min with a 1 M salicylic acid solution and dried in a gel dryer. The decay emission pattern of 
the radioactive proteins (autoradiograph) is then obtained upon incubation of the gel with an X-ray 
film in a film-cassette at -80 °C for few days up to weeks, depending on the strength of the signal. 
3.2.3.2 Western Blot 
In Western Blotting (or immunoblotting), proteins are immobilized on a PVDF (Polyvinylidene 
fluoride) membrane prior to detection with monoclonal or polyclonal antibodies. The blotting of the 
proteins on the membrane occurs in a semi-dry transfer cell for 30 min at 15 V. The membrane is 
subsequently blocked for 1 hour with blocking buffer, to prevent any nonspecific binding of 
antibodies to the surface of the membrane. The membrane with the transferred proteins is incubated 
with the primary antibody for 1 hour up to over night, at room temperature under gently shaking. 
The membrane is washed 3 times with ddH2O or 1x PBS and incubated with the secondary antibody 
for 1 hour at room temperature under gently shaking. The secondary antibody is linked to an enzyme 
used for detection with the "ECL plus Western Blot Detection System". The membrane is moved to a 
cassette and incubated with a film for different times before developing and fixation.  
3.2.3.3 Isolation of membrane microdomains 
Treatment of cells with anionic cold detergent, such as Triton X-100, leads to the isolation of the so 
called “detergent resistant membranes” (DRMs) or lipid rafts. Proteins and lipids resistant to the 
extraction with Triton X-100 float in the lighter fractions in sucrose density gradient, while the other 
proteins distribute along the different gradient density solutions. Briefly, CHO-K1 transfectants 
expressing constructs are lysed on ice for 20 min in 1 ml of ice cold 1% Triton X-100 in TNE buffer 
and homogenized with a loose-fitting dounce homogenizer. The homogenates are mixed with 1,25 
ml of 80% sucrose prepared in TNE buffer and placed at the bottom of a centrifuge tube. The 
samples are then overlaid with 6 ml of 35% sucrose and 3 ml of 5% sucrose in TNE buffer and 
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centrifuged at 23000 rpm in a Beckman SW35 rotor, for 16 hours. Fractions (1 ml) are collected 
from the top of the gradient and subjected to trichloracetic acid (20% TCA) precipitation. For 
detection, analysis by Western blot with GFP-antibody was performed. As control, β-actin, caveolin, 
membrane and calreticulin antibodies were used. 
3.2.3.4 Plasma membrane purification  
Plasma membrane purification is necessary to carry out time resolved anisotropy measurments in 
cuvette. Stably transfected CHO-K1 cells expressing either GPI-mCFP or TMD-HA-mYFP were 
grown to about 90% confluence in T75 flasks. Cells were first washed with 2 ml DPBS, then 
collected from the flask using a cell scraper and centrifuged at 4 ºC for 5 min, at 1500x g. The pellet 
was resuspended in 2 ml DPBS and centrifuged again at 4 ºC for 5 min, at 1500x g. Cells were then 
resuspended in 800µl of lysis buffer and incubated on ice for 1 hour. Cells were homogenized using 
a loose-fitting dounce homogenizer and centrifuged at 4 ºC for 5 min, at 1500x g. The supernatant 
was mixed with about 2,1 ml 105% Nycodenz solution prepared in TNE buffer and placed at the 
bottom of an ultracentrifuge tube. The samples were overlaid with 7 ml of 58% Nycodenz solution 
and 2,7 ml of 8% Nycodenz solution in TNE buffer and centrifuged at 100000x g in a Beckmann 
SW 40Ti rotor for 18 hours at 4 ºC. One milliliter fractions were collected from the top of the 
gradient. Two hundred microliter of every fraction was subjected to TCA precipitation and 
subsequent Western Blot analysis with GFP-antibodies (monoclonal anti-GFP). In order to collect 
the purified plasma membrane 800 µl of the plasma membrane-containing fractions was diluted 10 
times with TNE buffer and centrifuged 2 h at 100000 g in a SW 70.1 Ti Beckmann rotor. The pellet 
was resuspended in 600 µl DPBS. Enrichment of cytoskeleton, endoplasmic reticulum and Golgi 
was checked by β-actin, calreticulin and α-membrine antibodies, respectively. 
3.2.3.5 Metabolic labelling experiments 
For the biological characterization of TMD-HA fusion proteins metabolic labelling with 3H-palmitic 
acid and 35S-methionine was carried out. Labelling experiments were started at approximately 24 h 
after transfection. Labelling with [9,10(n)3H]-palmitic acid (0.5mCi/ml of DMEM) and L-[35S]-
methionine (1000 Ci/mmol, 50 µCi/ml of DMEM without methionine) was done for 4 hours. For 
investigation of intracellular processing of TMD-HA, transfected cells were pulse-labeled with L-
[35S]-methionine for 2 hours (t0 = corresponds to the time after the 2 hours of labelling and before 
starting chasing) and chased by adding unlabeled methionine for 1 (t1), 2 (t2) or 4 (t4) hours. 
Subsequently cells were lysed with 800 µl ice-cold RIPA buffer and unlysed material was pelleted 
for 20 min at 14000 rpm. Anti-GFP antibody was added to the samples and incubated overnight at 4 
ºC. To bind antigen-antibody complexes, 40 µl of Protein A-sepharose was added to each sample and 
incubated for 2,5 hours at 4 ºC. The samples were then washed with RIPA buffer and boiled for 2 
  MATERIALS AND METHODS 
49 
min in 50 mM phosphate buffer with 0,1% SDS and with or without 0,5% mercaptoethanol 
(reducing and non-reducing conditions) and analyzed by SDS-polyacrylamide gel electrophoresis on 
a 12% polyacrylamide gel. For endoglycosidase H (EndoH) digestion, immunoprecipitated samples 
were boiled for 10 min in 1% Glycoprotein Buffer (0,5% SDS), divided into three aliquots and 
digested with EndoH or mock digested for 1 h at 37 ºC prior to electrophoresis and fluorography. 
3.2.3.6 3H-cholesterol efflux 
To estimate the amount of extracted cholesterol, (see par. 3.2.2.2.3), CHO-K1 cells stably expressing 
GPI-mCFP or TMD-HA-mYFP were labeled with [1α, 2α(n)-3H]-cholesterol (1mCi/ml) for 4 hours. 
Cells were then washed with DPBS and incubated with MβCD as described above. Subsequently, 
the supernatant was incubated with scintillation cocktail. Cells were lysed with a 0,1M NaOH 
solution for 20 min at 25 ºC and incubated with scintillation cocktail. Radioactivity (in counts per 
minute, CPM) was measured with a luminescence counter and the percentage of cholesterol 
extracted was calculated as CPMs/(CPMs + CPMc) where CPMs are the CPM in the supernatant 
and CPMc are the CPM in the cell lysate. The experiment was carried out in 35 mm glass dishes in 
order to minimize the absorption of cholesterol to the plastic dishes. To carry out background 
subtraction, empty dishes were also labelled and subjected to the same treatment as the samples. 
However, high radioactivity was measured in the supernatant of the control dishes, indicating that 
high amount of cholesterol was still absorbing to the glass. Therefore it was very difficult to estimate 
the real amount of cholesterol extracted from the cells and carry out a precise background 
subtraction. Thus, the reported values supply the indication that cholesterol efflux occurs but they 
represent only semi-quantitative values. 
3.2.4 Protein determination 
Total protein content in purified plasma membrane was determined using the micro-BCA protein 
assay kit. This assay allows the detection of protein concentrations in the range of 2-40 µg/ml taking 
advantage of the very well known bicinchoninc acid (BCA) formulation. Briefly, samples are 
incubated with the BCA reagent according to the manufacturer’s protocol for 2 hours at 37 ºC. The 
absorbance is read at 562 nm on a plate reader. Protein concentration of the unknown samples is 
determined using a standard curve.   
3.2.5 Confocal microscopy 
Intensity measurements as well as FRET measurements were carried out using an inverted FluoView 
1000 microscope and a 60x (1,35 N.A) oil-immersion objective at 25 ºC. Images with a frame size 
of 512 x 512 pixels were acquired. CFP was excited at 440 nm using a Laser Diode and detected in 
the range 460 – 490 nm. YFP was excited at 515 nm using an Argon Laser and detected in the range 
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535 – 575 nm. Selection of cells coexpressing both proteins was based on the fluorescence emission 
in the CFP and YFP channels after sequential excitation.  
3.2.5.1 Measuring protein expression in the plasma membrane  
TMD-HA- as well as GPI- protein expression levels were monitored by measuring the fluorescence 
intensity of proteins at the plasma membrane. Confocal images were collected after sequential 
excitation of CFP and YFP keeping all measurement conditions constant. The plasma membrane 
fluorescence intensity was analyzed by the Image J analysis program enabling selection and analysis 
of the same area for pictures taken sequentially. The mean intensity of the acceptor was taken as a 
measure of the amount of acceptor expressed, after subtraction of the background. In order to 
determine the amount of unquenched donor in the plasma membrane of cells expressing both 
acceptor and donor, the measured donor intensity ( DI ) had to be corrected for the fluorescence 
decrease of the donor due to FRET. To estimate the efficiency of energy transfer ( E ) for every 
single cell, the average lifetime of a cell coexpressing donor and acceptor and the mean average 
lifetime of 10 cells expressing the donor alone were used (see 3.2.5.2). The unquenched donor 
amount ( D ) is then calculated as )1/( EID D −= .   
3.2.5.2 FLIM-FRET imaging 
Fluorescence lifetime imaging microscopy (FLIM) was used to study energy transfer (FRET) 
between the GPI-CFP raft marker (donor) and the different TMD-HA-YFP variants (acceptor). 
FLIM images have been acquired using the time-resolved LSM upgrade Kit (PicoQuant, Berlin, 
Germany) based on the time-correlated single photon counting (TCSPC) technique. This method is 
based on the repetitive measurement of the time difference between the excitation (e.g. laser pulse) 
and the subsequent emission of a fluorescent photon. Only a single photon every 100 laser pulses is 
registered, therefore the measurement is repeated very often and the measured time differences are 
sorted into a histogram. This histogram of photon arrival times, which represents the fluorescence 
decay, can then be analyzed to extract the fluorescence lifetime. FLIM images of donor and donor in 
presence of acceptor were acquired upon excitation of the donor at 440 nm using a pulsed laser 
diode. The CFP lifetime of cells expressing only GPI-CFP was first measured. The fluorescence was 
detected by a single photon avalanche photodiode (SPAD) and a 470 ± 15 nm bandpass filter. 
Electrical signals were processed by the TimeHarp 200 PC card. The analysis of the FLIM images 
was performed using the SymPhoTime software (PicoQuant,) taking into account the instrument 
response function (IRF). FLIM pictures were accumulated for 90 seconds (60 frames with an 
average photon count rate of ∼2-4 x 104 counts/s) and the plasma membrane was selectively 
analyzed. The measured photons-per-pixels corresponding to the plasma membrane were combined 
into a decay curve which was further analyzed by fitting it using a non-linear least squares iterative 
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procedure, as the sum of two exponential terms. This kind of fitting is required since fluorescent 
proteins variants are known to show a multiple exponential decay [78]. For every single cell the 
average lifetime, or more precisely the amplitude weighted lifetime, of CFP was calculated using 
the equation 
i
i
iτατ ∑=
 
[78]  
For simplicity in the text this lifetime is referred to as τAV. Quality of fitting was judged by the 
distribution of the residuals and the χ2 value. 
In a typical FLIM-FRET experiment at least two probes are necessary: one sample transfected with 
the donor and the second with donor and acceptor. The donor lifetime is measured in both of the 
samples as described above and used for calculating the FRET efficiency (see 3.2.5.3). 
3.2.5.3 FRET efficiency calculation and data analysis 
The efficiency of FRET (E) was calculated using equation 
D
DAE
τ
τ
−= 1(%)
 
where DAτ  is the average lifetime of donor in presence of acceptor and Dτ  is the average lifetime of 
the donor expressed alone [78]. 
In order to assess whether FRET efficiency is independent from the acceptor concentration, the 
FRET efficiency E(%) of every cell co-expressing donor and acceptor was plotted against the 
fluorescence intensity of the acceptor FYFP in this cell, measured as described above. The data points 
were fitted according to the equation:  
DYFP
YFP
KF
FE
E
+
×
=
(%)(%) max  
assuming that E is a hyperbolic function of the amount of acceptor. Emax (in %) is the maximal FRET 
efficiency calculated from the fitting [96,103]. The equation gives the dissociation constant KD as a 
parameter to assess the associative properties of donor and acceptor since it represents the 
concentration of acceptors that cluster with the 50% of the donors. Indeed, when FYFP << KD, FRET 
efficiency is proportional to the acceptor surface density. When FYFP >> KD, FRET efficiency is 
independent from the acceptor density. In the former case donors and acceptors are mutually 
randomly distributed, whereas in the latter each donor is already clustered with at least one acceptor. 
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3.2.5.4 Steady-state and Time-resolved fluorescence 
spectroscopy 
The steady-state and time-resolved fluorescence instrumentation is the same as described in [104]. 
For steady-state fluorescence anisotropy measurements on purified plasma membrane suspensions at 
25 °C, excitation and emission wavelengths were 435 and 477 nm for CFP, and 515 and 535 nm for 
YFP, respectively. Fluorescence intensity and anisotropy decays were obtained by the single-photon 
timing technique. The excitation and emission wavelengths were 415 nm and 460-490 nm 
respectively (CFP channel) or 490 nm and 520-560 nm (YFP channel). For fluorescence anisotropy 
decay collection and analysis see de Almeida et al. 2006. Both fluorescence intensity and anisotropy 
decays were analysed with the TRFA software (Scientific Software Technologies Center, Minsk, 
Belarus). Based on rates of fluorescence anisotropy decay due to homoFRET the distance R between 
fluorophores was calculated according to [85,105] as described in [106]: 
ω
τ φ 2
1
1
=  
with 
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τκω  
1φτ = short rotational correlation time (see Results), κ² =2/3, and R0 = Förster radius obtained from 
[107].  
  RESULTS 
53 
4 RESULTS 
4.1 Construction of the raft markers   
The construction of a fluorescent raft marker was necessary in order to study in vivo colocalization 
of different proteins in membrane microdomains. The easiest way to produce such a marker is to 
fuse a signal peptide, necessary for the delivery of the protein to the plasma membrane (see 
Methods), directly to the N-terminus and a GPI-anchor signal directly to the C-terminus of the 
fluorophore. Hence, the fluorescent protein is recruited to sphingolipid and cholesterol enriched 
domains in the cell plasma membrane [108,109], as shown in Figure 16. 
 
Figure 16: The raft marker GPI-XFP. The GPI-anchor attaches the fluorophore (XFP indicates all the 
fluorophore variants used to produce the different raft markers, see Figure 17) to the external leaflet of the cell 
plasma membrane. GPI-anchored proteins partition preferentially into lipid microdomains enriched in 
sphingolipids and cholesterol (in yellow in the cartoon), the so called “lipid rafts”. 
The GPI-anchor signal of the decay accelerating factor (DAF) was designed as an oligonucleotide, 
based on the plasmid sequence GFP-GPI(DAF) kindly provided by Daniel Legler [109], and fused 
to the C-terminus of YFP and CFP. The signal peptide derived from the influenza virus strain 
A/FPV/Rostock/34 was fused to the N-terminus of YFP and CFP in order to produce the proteins 
GPI(DAF)-CFP and GPI(DAF)-YFP. The cDNAs of GPI-CFP and GPI-YFP were gently provided 
by Patrick Keller [95].  
Since it was reported that fluorescent protein variants (XFP) have a natural propensity to form 
dimers, the GPI-linked CFP was substituted with its monomeric form. As shown previously any 
potential of YFP and CFP for dimerization can be suppressed by the mutation A206K in the 
fluorescent proteins [96]. Therefore, the mutation A206K was inserted into the pECFP-N1 plasmid 
by the "quick change mutagenesis" adapted protocol (see 3.2.1.3). The monomeric form of CFP, 
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namely mCFP, was released from the vector as a SacII-BsrGI fragment and ligated into the GPI-CFP 
plasmid, yielding the GPI-mCFP plasmid. As shown in Figure 17 upon transfection in CHO-K1 
cells all raft markers are transported to the plasma membrane. Additionally, CHO-K1 cell lines 
stably transfected with GPI-CFP, GPI-mCFP and GPI-YFP were generated. 
 
Figure 17: GPI-XFP proteins localization. The different GPI-XFPs are transported to the plasma membrane 
upon transfection in CHO-K1 cells. 
4.2 Construction of TMD-HA fusion proteins 
In order to study in vivo the properties of the HA transmembrane domain (TMD) and cytoplasmic 
tail (CT) and its behaviour in the plasma membrane of mammalian cells, an artificial HA consisting 
of a fluorophore (XFP) replacing the HA ectodomain fused to the transmembrane domain and 
cytoplasmic tail fragment (TMD-CT) of the glycoprotein was made. Figure 18 depicts the scheme 
of the TMD-HA-XFP fusion protein.  
 
Figure 18: TMD-HA-XFP scheme. The HA transmembrane domain (TMD) and cytoplasmic tail (CT) were 
fused to the C-terminus of different fluorophores (XFP) to investigate the role of this fragment in the HA 
lateral organization in the plasma membrane of mammalian cells.  
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For enhancing the transport to the plasma membrane, the TMD and CT sequence including a 
glycosylation site (NNT in red in the b, c and d sequences reported in Figure 19), 38 amino acids 
ahead from the C-terminus of the TMD, was also used. Furthermore, two other constructs including, 
beside the NNT site, also a linker made of two residues (GS, in blue in sequence c reported in 
Figure 19) or 5 residues (LRPEA, in blue in sequence d reported in Figure 19), were made. In this 
way the protein should acquire more flexibility, factor important for the delivery to the plasma 
membrane. The protein scheme is summarized in Figure 19. 
 
Figure 19: TMD-HA-YFP variants. The different TMD-HA fusion proteins were produced fusing the HA 
transmembrane domain (TMD) and cytoplasmic tail (CT) fragment (TMD-CT) to the C-terminus of the 
fluorophore (YFP). The four fragments, are named TMD-HA (a), TMD-HA(NNT), including a glycosylation 
site (red residues in the sequence) (b), TMD-HA(GS), including beside the glycosylation site (in red) also a 2 
amino acid linker (blue residues in the sequence) (c), and TMD-HA(LRPEA), including beside the 
glycosylation site (in red) also a 5 amino acid linker (blue residues in the sequence) (d). In a, b, c, d, the TMD 
sequence is in green, the CT sequence (downstream of the TMD) is in balck and the palmitoylation sites are in 
orange. In b, c and d the sequence upstream of the TMD corresponds to 38 residues of the ectodomain.  
Although all the four TMD-HA constructs, TMD-HA-YFP, TMD-HA(NNT)-YFP, TMD-HA(GS)-
YFP and TMD-HA(LRPEA)-YFP were fluorescent and exported from the nucleus upon transfection 
in CHO-K1 cells, none of them was transported to the surface, instead they accumulated in the 
cytoplasm (Figure 20).  
 
Figure 20: Expression of TMD-HA-YFP variants in CHO cells. The four different TMD-HA fusion 
proteins are retained into the cytosol.  
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The fact that these proteins were not delivered to the plasma membrane was also confirmed by 
EndoH digestion upon labelling with 35S-Met. Glycosylated proteins allocated to the plasma 
membrane acquire resistance to this enzyme during their passage through the Golgi apparatus [110]. 
As shown in Figure 21, TMD-HA-YFP, TMD-HA(NNT)-YFP, taken as examples, were digested 
with EndoH (H) or not digested (-). The band pattern (pointed by the black arrow in Figure 21) 
presented by the proteins does not change upon incubation with EndoH (lines “H”, Figure 21), 
confirming that proteins never acquire this resistance. Finally, as expected, the control sample (last 
two lines from the right) shows the total absence of the TMD-HA proteins band.  
 
Figure 21: EndoH resistance assay. TMD-HA-YFP and TMD-HA(NNT)-YFP (pointed in the gel by the 
black arrow) do not acquire EndoH resistance, in agreement with the cytosolic localization of these proteins in 
CHO-K1 transfected cells. H = EndoH treated; “-“ = non-EndoH treated. 
It has been reported that the HA signal peptide is critical for the delivery and the transfer of the 
polypeptide across the membrane [17]. Therefore, this sequence was fused to the N-terminus of the 
TMD-HA fusion protein. Alternatively to the HA signal peptide, the signal sequence of the protein 
LPH (lactase phlorizin hydrolase), was used (Figure 22). The sequence a reported in Figure 22 A, 
as well as either SpHA or SpLPH (also indicated in Figure 22 A) were merged for the production of 
SpHA-TMD-HA(NNT)-YFP and SpLPH-TMD-HA(NNT)-YFP, which were efficiently transported 
to the plasma membrane (Figure 22 B) as confirmed also by EndoH resistance assay (Figure 22 C, 
band between 48 and 36 kDa. TMD-HA fusion proteins have a molecular weight of about 39 kDa).  
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Figure 22: Sp-TMD-HA(NNT)-YFP and SpLPH-TMD-HA(NNT)-YFP transport. A) The different TMD-
HA fusion proteins were produced fusing either the HA or the LPH signal peptide to the N-terminus of the 
fluorophore (YFP) and the HA transmembrane domain and cytoplasmic tail (TMD-CT) to the C-terminus. In a 
the TMD-CT sequence is reported (from the left: in black the 38 aa sequence of the ectodmain with in red the 
glycosylation site, in green the TMD sequence, in black the CT sequence and in orange the palmitoylation 
sites). B) SpHA-TMD-HA(NNT)-YFP and SpLPH-TMD-HA(NNT)-YFP localize in the plasma membrane of 
CHO-K1 cells; C) EndoH resistance assay shows that the two proteins acquire resistance to this enzyme. Two 
bands, indicated by the balck arrow, can be distinguished in lane two (from the left of the gel): the upper band, 
running as the non-treated proteins (thick black band in the first line) represents the proteins resistant to 
EndoH. The same is seen in line 3 and 4 for the protein SpLPH-TMD-HA-YFP. H = EndoH treated; “-“ = non-
EndoH treated. 
Thus, for cloning of different TMD-HA variants the protein SpHA-TMD-HA(NNT)-YFP was 
always used and simply named TMD-HA-YFP. Constructs TMD-HA-CFP, TMD-HA-mCer, TMD-
HA-mYFP, TMD-HA-mCFP were made replacing YFP with CFP, mCer, mYFP and mCFP 
respectively. Localization of the proteins in the plasma membrane was verified by confocal 
microscopy (Figure 23). 
 
Figure 23: TMD-HA-XFP variants. All the different TMD-HA fusion proteins are transported to the plasma 
membrane in CHO-K1 cells. 
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4.2.1 Construction of TMD-HA mutants lacking raft 
localization signals 
Palmitoylation is one of the most common post-translational modifications among proteins enriched 
into lipid domains. HA presents three conserved palmitoylated cysteines, two localized in the 
cytoplasmic tail and the third at the border between cytoplasmic tail and transmembrane domain. 
Therefore, to study the relevance of palmitoylation for lipid domain organization of TMD-HA, the 
corresponding mutant lacking the palmitoylation sites was made (see scheme in Figure 24, sequence 
in b).  
 
Figure 24: Scheme of TMD-HA fusion proteins lacking the raft signals. The TMD-HA sequences used for 
producing the mutants lacking the raft signals are shown. a is the sequence of the TMD-CT fragment wild type 
where residues in orange are the palmitoylation sites (cysteines) while in b these are substituted with serines 
(C3S mutation, see text), in pink. The sequence in c includes the mutation VIL3A (see text) underlined in 
violet and in the sequence in d both the C3S and VIL3A mutations are inserted (amino acids in pink and violet, 
respectively). 
As template, the cDNA encoding for the HA gene from influenza virus strain A/FPV/Rostock/34 
(H7N1) mutated at acylation positions 551, 559, 562 (C→S) [23] was used. The TMD-CT(C3S) 
PCR fragment was ligated into the TMD-HA-YFP plasmid generating the protein TMD-HAC3S-
YFP. The construct TMD-HAC3S-mCFP was made replacing YFP with mCFP. Other potential “raft 
localization signals” have been described by Takeda et al.[88]. They reported a study on different 
HA subtypes in which groups of three residues in the HA transmembrane domain were substituted 
with alanine residues. Several of these mutants presented a loss in DRM localization upon extraction 
with Triton X-100, pointing out the importance of specific amino acid sequences for the lateral 
organization of HA in lipid microdomains. Therefore, according to the above mentioned publication, 
the sequence VIL (amino acids 527-529 of the HA transmembrane domain) was substituted with 
AAA into the TMD-HA-YFP and TMD-HAC3S-YFP proteins in order to investigate the effect of 
this mutation on the lateral organization of the HA transmembrane domain (Figure 24, sequence in c 
and d). Proteins TMD-HA-AAA-mYFP and TMD-HAC3S-AAA-mYFP were produced as described 
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in Methods and used in FLIM-FRET experiments (see 4.4.3). In Figure 25 confocal pictures show 
the plasma membrane localization of the molecules. 
 
Figure 25: TMD-HA proteins lacking the raft signals. Confocal pictures showing that the TMD-HA variants 
lacking the raft signals are transported to the plasma membrane. 
4.2.2 Post-translational modification of TMD-HA-YFP and 
TMD-HAC3S-YFP 
To ensure that the absence of the ectodomain was not interfering with the TMD properties and that 
the mutation C3S indeed abolished palmitoylation, the TMD-HA-YFP and TMD-HAC3S-YFP 
fusion proteins were labelled with [3H]-palmitic acid. As control, proteins were in parallel labelled 
with [35S]-Met. Autoradiography (Figure 26) of the gel shows clearly that palmitoylation occurs in 
TMD-HA-YFP proteins while it is totally absent in the C3S mutant. Two bands are clearly 
distinguishable in lane 1 (from the left of the gel, black arrows), representing palmitoylation of wild 
type TMD-HA monomers and dimers (discussed below). [35S]-Met labelling ensures that both the 
proteins are expressed at the same level (see gel in Figure 26, last two lines from the left). Thus, 
TMD-HA fusion proteins preserve palmitoylation, a characteristic of the full length HA.  
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Figure 26: Palmitoylation of TMD-HA fusion proteins. TMD-HA and TMD-HAC3S proteins were labelled 
with [3H]-palmitic acid to ensure that palmitoylation of the construct containing the HA TMD wild type was 
still occurring (line 1). The arrows on the gel point to the monomeric and to the dimeric form of the protein 
(see text). As it is clearly visible, the C3S mutant does not present any band (line 2). As a control for 
expression, proteins were in parallel labelled with [35S]-Methionin (bands 3 and 4). 
4.2.3 TMD-HA variants localize in detergent resistant 
membranes (DRM) 
Hemagglutinin was one of the first proteins recovered in detergent resistant membranes (DRM). 
These sphingolipid-cholesterol domains or “rafts” can be biochemically isolated because of their 
insolubility in non-ionic detergents, such as Triton X-100, at low temperature [55]. Since HA is 
anchored to the lipid bilayer through its transmembrane domain, it was important to verify that 
TMD-HA constructs as well as the raft marker were still rescued in the raft fractions upon extraction 
with Triton X-100. TMD-HA-mYFP, TMD-HAC3S-YFP, GPI-mCFP, MyrPal-mYFP and HA-mCer 
were subjected to Triton X-100 extraction and sucrose gradient purification (see Methods). MyrPal 
anchors the fluorophore to the inner leaflet of the plasma membrane through myristoyl- and 
palmitoyl- residues. HA-mCer was made by fusing the fluorescent protein Cerulean to the 
cytoplasmic tail of the full length HA. Both these proteins were kindly provided by Stephanie Engel 
(Free University, Berlin). Proteins present in the different fractions were collected from the top of 
the gradient, precipitated with TCA and analyzed by Western Blot (see Methods). For detection of 
XFP linked proteins, GFP-antibody was employed. As control, β-actin (cytoskeleton marker), 
caveolin (protein forming lipid rafts), membrin (Golgi apparatus marker) and calreticulin (ER 
marker) antibodies were used. In Figure 27 the Western Blot results are depicted.  
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Figure 27: Triton X-100 extraction. Proteins subjected to Triton X-100 extraction were precipitated with 
TCA and analyzed by Western Blot. Proteins enriched in DRMs should localize in the top fractions (see text). 
The TMD-HA protein is partially rescued at the top of the gradient (in fractions 3 and 4) as well as the wild 
type full length HA. As control also GPI- and MyrPal- anchored proteins were subjected to the extraction and 
sucrose gradient. These proteins as well as the protein caveolin and the TMD-HA and HA proteins are partially 
localized at the top of the gradient (fractions 1-4). In contrast the TMD-HAC3S mutant is only found at the 
bottom of the gradient (in fractions 11-12), where also the proteins calreticulin, membrin and β-actin are 
localized. Numbers indicate the different fractions. 
Since DRMs are lighter than the rest of the membrane, they float at the top of the gradient. Hence 
proteins enriched in DRMs should be rescued in the top fractions. HA-mCer, TMD-HA-mYFP, GPI-
mCFP and the raft marker caveolin are localized both in fractions 9-12 (bottom of the gradient) and 
partially in fractions 3 and 4 (top of the gradient). This is in agreement with previous results reported 
for full length HA [88,111]. The inner leaflet raft marker MyrPal-YFP is also found at the top of the 
gradient in fractions 1 and 2 and at the bottom of the gradient in fractions 9-12 as the external leaflet 
raft marker GPI-mCFP. Finally, the TMD-HAC3S-YFP protein is rescued exclusively at the bottom 
of the gradient in fractions 11 and 12 as well as the controls β-actin, membrin and calreticulin. This 
result confirms that palmitoylation is an important determinant for DRM partitioning and that TMD-
HA fusion protein behaves like the full length HA. 
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4.2.4 TMD-HA fusion proteins form disulfide linked dimers 
and trimers 
Trimerization is a critical step for hemagglutinin. It has been reported that HA oligomerization is 
necessary for the delivery to the Golgi apparatus and that it strongly depends on the pool of available 
monomers. Only few monomers are found in the Golgi apparatus and HA localizes in the cell plasma 
membrane exclusively as a trimer [112]. Therefore it was studied whether TMD-HA has the ability 
to oligomerize. CHO-K1 cells were transfected with TMD-HA-YFP, and TMD-HAC3S-YFP and 
labeled with [35S]-Methionin. After immunoprecipitation, proteins were mixed with non-reducing 
loading buffer and applied to a 12% polyacrylamide gel. As shown in Figure 28, gel 
autoradiography revealed the clear presence of dimers and potential trimers, together with 
monomers, for both the proteins. 
 
Figure 28: TMD-HA-XFP forms oligomers. The arrows in the picture indicate the TMD-HA monomer (M, 
39 kDa), dimer (D, 78 kDa) and trimer (T, 117 kDa), respectively. 
However it has to be stressed that the monomer was the most abundant species and that dimers and 
trimers represent a minor population of TMD-HA proteins. In order to investigate the nature of this 
oligomerization, the experiment was repeated adding as a control the protein TMD-HA-mYFP. This 
was necessary to exclude that these oligomers were due to dimerization of the “non-monomeric” 
form of YFP (i.e. without A206K mutation, see Methods). Furthermore, samples were divided into 
two parts, which were mixed either with non-reducing or with reducing loading buffer to investigate 
whether oligomerization was driven by disulfide bond formation. The gel (Figure 29) showed the 
presence of dimers for all three proteins, which disappear under reducing conditions.  
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Figure 29: TMD-HA-XFP dimers. The mutation A206K was introduced in the fluorescent protein (producing 
the protein TMD-HA-mYFP) in order to avert the possible formation of dimers driven by the fluorophore. 
TMD-HA-YFP, TMD-HAC3S-YFP and TMD-HA-mYFP are compared. The gel clearly shows the presence of 
dimers (D, black arrow) even for the mutated protein (line 3 from the left, non-reducing conditions). The lower 
black arrow points to the monomer (M). n.r. = non-reducing conditions; r. = reducing conditions. 
It has to be noted that in this experiment a 15% acrylamide gel was used. Therefore trimers might be 
masked by dimers since 10 and 12% gels clearly revealed the presence of this species (see below and 
gel in Figure 28). This result confirms that the formation of TMD-HA oligomers is not due to the 
intrinsic propensity to dimerizing of XFPs and that they are disulfide linked. Even though the 
oligomers were due to disulfide linkages, this experiment enforced the hypothesis that HA 
oligomerization might be critical not only for the export from the ER but also for the transport to the 
cell surface. The rate of dimer and trimer formation was then investigated. CHO-K1 cells transfected 
with TMD-HA-mYFP were labeled with [35S]-Methionin for 2 hours (t0) and then pulse-chased for 1 
(t1), 2 (t2) or 4 (t4) hours (see 3.2.3.5). Autoradiography revealed that the formation of oligomers 
follows the same kinetics of monomer synthesis (Figure 30) and that the amount of protein per 
species remains more or less unaltered during the chasing time. However this experiment points out 
that the degradation of the protein starts approximately 30 hours post transfection (compare the 
bands thickness in line t4 with the other bands; t4 = corresponds to more or less 30 hours, since 
protein are [35S]-Met labeled 24 hours post transfection, for 2 hours and chased for 4 hours).  
  RESULTS 
64 
 
Figure 30: Pulse chase experiment. TMD-HA monomers (M), dimers (D) and trimers (T), indicated by the 
black arrows, are synthesized equally in the cell. The bands in line t4 are less pronounced than the bands in the 
other lines pointing to a reduction of the protein amount probably due to degradation. t0, t1, t2 and t4 indicate 
the chasing times, i.e. t0 corresponds to starting point of the chasing, t1, t2 and t4 correspond to 1, 2 or 4 hours 
chasing (for details see text). The gel was run under non-reducing conditions. 
4.2.4.1 TMD-HA-XFP CS mutants 
The TMD-HA-XFP fusion protein contains 7 cysteine residues in its sequence. As already outlined, 
three of these are palmitoylated and they are localized within the transmembrane domain and the 
cytoplasmic tail (Figure 31, orange C residues in sequences a and b and mutated to S, pink colored 
in sequences c and d). Two other cysteines are found at position 537 of the TMD (Figure 31, C 
mutated to S, blue colored in sequences b and d) and in the signal peptide of the protein (indicated in 
Figure 31 as C22S and blue colored). The remaining two cysteines are allocated in the fluorophore, 
precisely at position 49 and 71 (indicated in Figure 31 as C49S and C71S and coloured in blue). In 
order to elucidate the dimerization mechanism and the cysteines involved in disulfide bond 
formation, several CS (mutation of cysteine to serine) mutants were made (see molecule scheme in 
Figure 31).  
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Figure 31: Summary of CS mutants. The different mutations inserted into TMD-HA protein in order to 
abolish dimerization are reported. In the signal peptide cysteine 22 was mutated to serine (C22S in blue) and 
fused to TMD-HA-XFP (XFP stands for mCFP, YFP and mYFP, see abbreviations). Mutations C49S and C71S 
were also inserted into mYFP and mCFP (indicated as C49S and C71S in blue). Finally, a is the TMD-HA wild 
type sequence; b is the same sequence with the mutation C537S (S in blue in the sequence) in the 
transmembrane domain; c is the sequence of the TMD-HAC3S (serines in pink correspond to the cysteine in 
orange mutated from sequences a and b) and d the TMD-HAC3S sequence with the CS (S in blue in the 
sequence) mutation in the transmembrane domain. 
The cysteine 22 in the signal peptide was first mutated to a serine (namely SpCS mutation) 
generating the proteins SpCS-TMD-HA-YFP, SpCS-TMD-HA-mYFP and SpCS-TMD-HAC3S-
YFP (In Figure 31 indicated as C22S). Upon transfection, [35S]-Methionine labelling and 
immunoprecipitation, gel autoradiography (Figure 32) revealed that the C22S mutation in the signal 
peptide did not have any effect on the oligomerization of TMD-HA variants. Indeed a thick band 
between 85 and 49 kDa could still be seen under non reducing conditions and it disappeared under 
reducing conditions. Again, trimers were not distinguishable since a 15% gel was used (Figure 32). 
This experiment demonstrates that disulfide linked oligomers, in particular dimers, are formed even 
in absence of C22 in the signal peptide. 
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Figure 32: SpCS mutants form disulfide linked dimers. The mutation C22S did not have any effect since 
still disulfide linked oligomers are present under non-reducing conditions (n.r. bands between 85 and 49 kDa 
in lines l, 3, 5). Nore that under reducing conditions (r.) the dimer bands disapper (lines 2, 4 and 6). The black 
arrows point to the dimer (D) and monomer (M) bands.  
For further investigation, cysteine 537 in the transmembrane domain was mutated to a serine 
(indicated in blue in the TMD-CT sequence shown in Figure 31, sequence b). The protein TMD-CS-
HA-mYFP was generated in order to investigate the direct effect of the mutation. Furthermore, the 
protein SpCS-TMD-CS-HAC3S-YFP was also made to observe the effect of the mutation in a 
protein in which the only two cysteine residues left are localized within the fluorophore β-barrel 
(note, this protein contains the C22S mutation in the signal peptide and the C537S mutation in the 
transmembrane domain; furthermore the palmitoylation sites were also mutated to serines). 
Autoradiography (Figure 33) revealed that these two mutants still form dimers under non reducing 
conditions, since a faint band between 85 and 49 kDa was visible (compare lines 2, 4 and 6, Figure 
33). However, in contrast to other experiments, the dimer signal was not that strong, even for the 
control protein TMD-HA-mYFP (e.g. compare the dimer band (D) in Figure 33 with the one in 
Figure 30, line t0). Due to this, also the presence of trimers could not be confirmed since a band at 
about 117 kDa was not clearly visible. 
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Figure 33: TMD-CS mutants form disulfide linked dimers. The CS mutation in the transmembrane domain 
did not abolish the formation of disulfide linked dimers (band between 49 and 85 kDa, pointed by the black 
arrow) as can be seen from the gel. The black arrows indicate the dimer (D) and monomer (M) bands. n.r. = 
non-reducing conditions; r. = reducing conditions.  
The protein TMD-HA-mYFP and TMD-CS-HA-mYFP were also subjected to EndoH digestion in 
order to elucidate whether the mutation might affect the transport to the plasma membrane. The 
experiment was carried out under non-reducing conditions in order to distinguish between 
monomers, dimers and trimers (Figure 34). Only TMD-HA monomers, of both of the variants, were 
not resistant to EndoH digestion as can be seen from the bands between 34 and 49 kDa, in lines 1 
and 3 (namely H). In fact, proteins not sensitive to EndoH should move in the gel as the non 
digested proteins (bands between 34 and 49 kDa in lanes 2 and 4, indicated with “–“). Therefore the 
monomeric form of TMD-HA variants is not delivered the cell surface. This result is in agreement 
with previous data showing that no full length-HA monomers are embedded in the cell plasma 
membrane [112]. Thus this experiment confirms that the artificial HA forms disulfide linked 
oligomers, irrespectively from the presence of the cysteine residue in the transmembrane domain and 
it also emphasizes that oligomer formation is a fundamental prerequisite for the transport of the 
TMD-HA proteins to the plasma membrane.  
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Figure 34: TMD-CS mutant. The TMD-HA mutant carrying the C537S mutation in the transmembrane 
domain as well as the TMD-HA wild type forms disulfide linked oligomers. Only oligomers (T and D 
indicated by the black arrows) of both of the variants are resistant to EndoH digestion (line 1 and 3), while the 
monomeric form (M, lower black arrow) are sensitive to this treatment. H = EndoH treated; “-“ = non-EndoH 
treated. 
According to the above results, it was hypothesized that TMD-HA oligomerization might be driven 
by disulfide bond formation between C49 and C71 in the XFP protein (as previously shown by Jain 
et al.[113]). Therefore, the double mutation C49S-C71S was introduced in the TMD-HA-mYFP 
sequence. CHO-K1 cells were transfected with TMD-HA-mYFP-C49S-C71S and labeled with [35S]-
Methionine. Samples were also subjected to EndoH resistance assay carried out under non reducing 
conditions. Surprisingly, oligomers (see gel in Figure 35 A, line 4 (n.r.)) of TMD-HA-mYFP-C49S-
C71S were still visible, but none of the species was EndoH resistant (Figure 35 B, compare M, D 
and T bands in lines 2 and 4). These proteins retain the ability to oligomerize but they are not 
transported to the plasma membrane. Indeed, in this case, not only monomers were not EndoH 
resistant, but also dimers and trimers, (see gel Figure 35 B, compare bands in lines 3 and 4), 
reported to be always EndoH resistant for all other TMD-HA variants discussed. Furthermore, 
confocal imaging of cells transfected with this construct revealed the total absence of fluorescence 
suggesting the uncorrect folding of YFP. Previous results also showed that C49 and C71 mutations in 
CFP and YFP led to the misfolding of the fluorophores [113]. Therefore due to defected folding, the 
protein undergoes uncorrect processing reflected in the lack of EndoH resistance. It has to be 
stressed that even in absence of both of the cysteines tought to be responsible for the oligomer 
formation, TMD-HA fusion proteins were still forming dimers and trimers (see protein C49SC71S in 
the gel in Figure 35, lines 3 and 4).  
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Figure 35: TMD-HA fusion proteins with mutations in the fluorophore form disulfide linked dimers. 
Mutations of residues C49 and C71 in the fluorophore, considered responsible for oligomerization did not 
abolish the formation of dimers and trimers (black arrows, T= trimer, D=dimer, M= monomer). In A the gel 
autoradiography of TMD-HA-mYFP and TMD-HA-C49SC71S under reducing (r.) and non reducing (n.r.) 
conditions, is shown. Oligomers (T and D pointed by the balck arrows) of the C49S-C71S mutant are still 
clearly visible under non reducing conditions (compare line 3 and 4 and also with line 1 and 2 of the wild type 
protein). In B the two proteins were subjected to EndoH digestion. Again in both cases, three different bands, 
representing the monomers (M), dimers (D) and trimers (T) are clearly distinguishable. TMD-HA-mYFP 
monomers (line 2 from left, lower band) only and in contrast, all the three TMD-HA-C49SC71S species (line 4 
from left) were sensitive to EndoH digestion. H = EndoH treated; “-“ = non-EndoH treated. 
Single C49S or C71S mutations were also inserted and CHO-K1 cells were transfected with the 
constructs. Again confocal imaging showed the total absence of fluorescence probably due to the 
misfolding of the fluorophores. Hence, for this reason and since even the absence of both these 
residues was not enough for abolishing oligomerization, these proteins were not further studied. 
4.2.4.2 Quantification of TMD-HA oligomers 
Previous results showed that TMD-HA monomers form oligomers, mainly dimers and trimers. The 
amount of monomers, dimers and trimers produced, varies among the different TMD-HA mutants. 
To investigate this further, CHO-K1 cells were transfected with TMD-HA variants and labeled with 
[35S]-Methionine. Immunoprecipitated proteins were then subjected to EndoH digestion and gel 
electrophoresis under non-reducing conditions. The result is reported in Figure 36 and summarized 
in Table 7.  
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Figure 36: TMD-HA fusion proteins form different amounts of oligomers. The cartoons on the right side 
show the TMD-HA variants carrying different mutations, either in the transmembrane domain (TMD-CT, 
C537S in blue) or in the signal peptide (Sp, C22S in blue). In pink the S residues substituting the 
palmitoylation sites and in violet the mutation VIL3A are shown. The scheme of the TMD-HA wild type (wt) 
fusion protein is also depicted. The mutants as well as TMD-HA wild type, were subjected to EndoH digestion 
under non-reducing conditions, in order to elucidate which of the synthesized species, monomers (M), dimers 
(D), and trimers (T), indicated by the black arrows in the gels, and the relative amount effectively reaching the 
plasma membrane. In A, the SpCS with the C22S mutation in the signal peptide and the TMD-CS with the 
C537S mutation in the transmembrane domain are compared to the TMD-HA wild type. It is evident that the 
amount of trimers (T) formed by the two mutants is significantly decreased with respect to the trimers formed 
by the wild type protein. In B, the mutations C22S and C537S were inserted in the C3S protein (lacking 
palmitoylation sites). The gel shows the result of this experiment. Again it is visible that the C22S mutation in 
the signal peptide leads to the reduction or even absence of trimers. In C proteins with the VIL3A mutation in 
the transmembrane domain are shown. This mutation did not affect the oligomerization process, however it 
beared on the transport of the different species to the plasma membrane. H = EndoH treated; “-“ = non-EndoH 
treated.  
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Table 7: Percentage of TMD-HA monomers, dimers and trimers. Monomer (M), dimer (D) and trimer (T) 
percentage of TMD-HA variants. The (H) indicates the EndoH sensitive subgroup of the species. Numbers 
represent the percentage of the species calculated on the total amount of protein (Ptot = T+D+M). 
Densiometric analysis of the bands was carried out using the Image J analysis program (see 3.2.5.1). 
Oligomer wt* (%) wt-
SpCS*  
(%) 
wt-
tmdCS* 
(%) 
C3S* 
(%) 
C3S-
SpCS* 
(%) 
C3S-
SpCS-
tmdCS* 
(%) 
wt-
VIL3A* 
(%) 
C3S-
VIL3A* 
(%) 
M - 41 - 12 42 23 - - 
M(H) 31 29 41 16 21 26 35 34 
D 49 30 51 50 37 51 32 31 
D(H) - - - - - - 19 17 
T 20 - 8 22 - - 14 17 
T(H) - - - - - - - - 
*wt = TMD-HA; wt-SpCS = SpCS-TMD-HA; wt-tmdCS = TMD-CS-HA; C3S = TMD-HAC3S; C3S-SpCS 
= SpCS-TMD-HAC3S; C3S-SpCS-tmdCS = SpCS-TMD-CS-HAC3S; wt-VIL3A = TMD-HA-AAA; C3S-
VIL3A = TMD-HAC3S-AAA 
 
For simplicity, the full name of the different proteins is abbreviated in the text and in Table 7, but it 
is reported in Figure 36 with the corresponding abbreviation on the right of the molecule scheme. 
In general, apart from monomers, all the TMD-HA variants formed oligomers. Of these, usually 
dimers are more abundant than trimers, when present. Furthermore, in most cases, monomers do not 
show EndoH resistance, indicating that they are not transported to the plasma membrane. In contrast, 
oligomers always reach the cell surface. 
wt TMD-HA forms 31% monomers, 49% dimers and 20% trimers (Table 7) whereas the C3S 
mutant presents 28% monomers (12% EndoH resistant, 16% (H) non EndoH resistant), 50% dimers 
and 22% trimers (Table 7). Interestingly, the protein C3S (lacking palmitoylation sites) formed 
monomers, which were partially transported to the plasma membrane (12%) in comparison to the 
total amount of wt monomers (31%), EndoH sensitive. However, the fraction of monomers, dimers 
and trimers was very similar for both TMD-HA variants (Table 7). Therefore, this result assured that 
FLIM-FRET (see 4.4.3.1) data could be directly compared. Surprisingly, monomers carrying the 
SpCS point mutation (C22S mutation in the signal peptide, see above), wt-SpCS, C3S-SpCS and 
C3S-SpCS-tmdCS, were partially delivered to the cell surface (Table 7, line M(H)). Moreover, these 
mutants do not form trimers. This indicates that probably trimerization occurs exclusively when the 
C in the signal peptide is present. Indeed, in the protein wt-tmdCS, carrying the C537 mutation in 
the transmembrane domain but not the C22S mutation in the singal peptide, trimerization was 
partially restored (8% of trimers were formed). The abolished trimerization of SpCS mutants was 
reflected in an increase of monomers with respect to the non mutated variants. In particular, the 
monomeric form (M) of wt represents the 31% of the whole protein, while the 70% (divided in 29% 
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M(H) and 41% M, Table 7) of the corresponding SpCS mutant (wt-SpCS) is monomeric. Likewise, 
the C3S-SpCS protein formed 63% of monomers (divided in 21% M(H) and 42% M, Table 7) 
whereas C3S only the 38% (16% M(H) and 12% M, Table 7). Thus, the reduced oligomerization, 
reflected in the total absence of trimers, is strongly related to the lack of the cysteine in the signal 
peptide. Mutation C537S in the transmembrane domain (TMD-CS) led to a slight decrease of trimer 
production. In particular, wt formed 20% of trimers, while the corresponding mutant carrying the 
TMD-CS mutation (wt-tmdCS) showed only 8% of trimers (Table 7). This result suggests that also 
the cysteine in the transmembrane domain might be involved in trimerization, but that its presence or 
absence is not as critical as the presence of the cysteine in the signal peptide. Finally, the VIL→AAA 
mutation (527-529 residues in the transmembrane domain, named VIL3A) did not affect the fraction 
of monomers, dimers and trimers compared to those observed for the wt and C3S proteins. 
Nevertheless, the amount of dimers transported to the plasma membrane was decreased. Indeed the 
wt-VIL3A dimers were only partially delivered to the plasma membrane (32% D and 19% D(H), see 
Table 7). Also the amount of C3S-VIL3A dimers reaching the plasma membrane was reduced to 
only 2/3 of the dimer fraction (31% D and 17% D(H), see Table 7). 
4.2.4.3 Mutations in the HA-TMD do not affect protein stability  
In order to investigate whether the C3S and VIL3A mutations could affect the stability and the 
transport of the proteins to the cell surface, TMD-HA-mYFP, TMD-HAC3S-YFP, TMD-HA-AAA-
mYFP and TMD-HAC3S-AAA-mYFP were labeled with [35S]-Methionine and pulse-chased for 1, 2 
and 4 hours. The different samples were then subjected to EndoH resistance assay. This experiment, 
shown in Figure 37, revealed no significant differences in the synthesis of the four TMD-HA 
variants, thus confirming that the insertion of the mutations either alone (TMD-HAC3S or TMD-
HA-AAA), or together (TMD-HAC3S-AAA) do not interfere with the correct folding of the 
proteins. As can be seen in Figure 37 the oligomerization process of all four proteins follows the 
same kinetics. Furthermore, also the amount of monomers, dimers and trimers produced is 
comparable among the different TMD-HA species (Figure 37). As already pointed out, the 
monomeric form of some of the TMD-HA variants never acquires EndoH resistance. The formation 
of dimers occurs probably during the synthesis of the proteins (line 0 or t0, corresponding to about 
26 hours after transfection. In all gels, the dimer band is indicated by a black arrow, between 80 and 
58 kDa) and they acquire EndoH resistance after one hour of chasing (1 or t1). In contrast, the 
trimeric form of all proteins is totally absent at t0 and trimers (band between 80 and 175 kDa) appear 
only at t1 showing EndoH resistance. It has to be outlined that while both monomers and dimers 
present an EndoH sensitive form, this is not the case for trimers. Hence, this result might indicate 
that while the formation of dimers occurs during the folding of the proteins (shown by EndoH 
sensitivity of the dimers at time 0), trimerization might start when proteins have already passed 
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through the ER, either during the transport to the plasma membrane or directly into the plasma 
membrane. 
 
Figure 37: Absence of raft signals does not affect the synthesis and the intracellular transport of TMD-
HA fusion proteins. Gel A and C show the EndoH pulse-chase experiment of the protein TMD-HA and its 
variant lacking the raft localization sequence VIL. Gel B and D report the result of the same experiment 
carried out with the TMD-HAC3S protein and its variant TMD-HAC3S-AAA. All four proteins present the 
same kinetics. The monomeric form is found to be sensitive to EndoH at all chasing times (0, 1, 2, 4), meaning 
that monomers are not transported to the plasma membrane. Although dimers are present at t0, they acquire 
EndoH resistance only at t1 (compare bands between 80 and 58 kDa, lines 0 H and 1 H). Finally trimers seem 
to be produced only secondly, since they apper only at t1. 0 = t0; 1 = t1; 2 = t2; 4 = t4 (for more details see 
3.2.3.5). Monomers (M), dimers (D) and trimers (T) are indicated by the black arrows. 
4.3 Cell polarization and apical localization of GPI 
and TMD-HA proteins 
MDCKII cells were transfected with TMD-HA-mYFP, TMD-HAC3S-YFP, GPI-YFP and MyrPal-
mYFP and polarized in transwell plates. MyrPal-mYFP (kindly provided by Stephanie Engel) was 
used as control for apical transport. As shown in Figure 38 the four proteins were all transported to 
the apical membrane. As known, GPI-YFP and MyrPal-mYFP localize exclusively at the plasma 
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membrane, while TMD-HA variants are also abundant in the ER (compare Figure 17 with Figures 
22, 23 and 25). 
 
Figure 38: Cellular distribution of fluorescent constructs in polarized cells. CHO-K1 cells transfected with 
different constructs were polarized in order to investigate whether TMD-HA-YFP and TMD-HAC3S-YFP 
were apically transported.  
4.4 Fluorescence lifetime imaging microscopy (FLIM)  
In a living system it is impossible to know the local concentration of a fluorophore and also 
controlling its expression level. Furthermore, when samples are excited with a continuous laser 
beam, photobleaching leads to fluorescence intensity decrease. Therefore, quantitative studies based 
on intensity measurements become not reliable and very difficult to interpret. In contrast, 
fluorescence lifetime imaging microscopy (FLIM) measures the lifetime of a fluorophore, property 
typically independent of the probe concentration (see 1.4). FLIM is a very useful tool for measuring 
FRET since close proximity between donor and acceptor is reflected in a variation of the donor 
lifetime. Thus, FLIM-FRET was used to investigate in vivo the lateral organization of GPI-XFP 
proteins and TMD-HA-XFP variants. In Figure 39, typical FLIM images are shown for a cell 
expressing donor only (Figure 39 A, C), and a cell expressing both donor and acceptor (Figure 39 B, 
D) (A, B – whole cells, C, D – region of interest (ROI) corresponding to the plasma membrane). As 
evident from pseudocoloring the average lifetime of the donor in the plasma membrane was 
significantly reduced in the presence of the acceptor. This could be attributed to FRET from the 
donor to the acceptor. 
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Figure 39: FLIM images. Typical examples of FLIM images are shown. A cell expressing only the donor 
(CFP) presents a significantly different coloring (A and C) compared to a cell coexpressing donor and acceptor 
(GPI-CFP and TMD-HA-YFP) as can be seen in B and D. The selection of the plasma membrane (C and D) 
allows calculating the lifetimes of the donor at different conditions. Experiments were carried out at 25 °C. 
4.4.1 Monitoring donor and acceptor expression levels  
Even if lifetime measurements are independent of protein levels, FRET efficiencies depend strongly 
on the acceptor concentration. Thus, in order to compare the results obtained from different cells, it 
had to be verified that the protein amount on the cell membrane was stable and comparable among 
the different experiments. Therefore, the expression level of different TMD-HA variants was 
monitored by measuring the fluorescence intensity of the proteins at the plasma membrane (see 
Methods). Figure 40 shows the mean intensity ratio between donor and acceptor (D/A ratio) for 
different donor and acceptor pairs. The standard error of estimate is low indicating that the scattering 
between individual cells is relatively small. Data set were obtained averaging the fluorescence 
intensity of donors and acceptors of about 30 to 50 cells. Only the D/A ratios of the most relevant 
D/A pairs are reported. 
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Figure 40: D/A ratio. The picture compares the donor to acceptor ratios of diverse pairs. As can be seen there 
is no significant difference within the probes, therefore FLIM-FRET experiments can be directly compared. 
Columns represent mean ± SEM. 
4.4.2 Clustering of GPI-anchored proteins detected by FLIM-
FRET 
GPI-anchored fluorophores were used as raft markers to study in vivo the TMD-HA variants lateral 
organization. Therefore, it had first to be verified that GPI-anchored fluorescent proteins are raft 
associated. Transfection of CHO-K1 cells was carried out always under the same conditions and 
protein expression levels monitored as described above. Cells were transfected either with GPI-CFP 
or cotransfected with GPI-CFP and GPI-YFP (both proteins provided by Patrick Keller, [95]). In 
Figure 41 the results of typical experiments for various donor-acceptor pairs are shown. Each point 
refers to a single cell. As can be observed, the average lifetime (τAV) of cells expressing only the 
donor varies in a range, which does not significantly overlap with the τAV of donor-acceptor 
coexpressing cells. The lifetime of GPI-CFP was shorter when the protein was coexpressed with the 
acceptor GPI-YFP indicating FRET (Figure 41). Furthermore, to ensure that energy transfer was due 
to clustering into lipid microdomains and not to dimerization of the fluorophores, CHO-K1 cells 
were transfected either with GPI-mCFP or with GPI-mCFP and GPI-YFP and the donor lifetime was 
measured (Figure 41). No significant variation in energy transfer was detected between the different 
donor-acceptor pairs, confirming that the clustering of the molecules was not caused by possible 
CFP dimerization.  
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Figure 41: τAV measured in cells expressing GPI-CFP or GPI-mCFP and coexpressing GPI-YFP either 
with GPI-CFP or with GPI-mCFP. The result of a typical FLIM-FRET experiment is shown. FRET was 
measured pre and post incubation for 1 min at 4 °C, with a 5 mM solution of methyl-β-cyclodextrine (MβCD). 
Experiments were carried out at 25 °C. The t-test confirmed that the difference between the GPI-CFP lifetimes 
measured without or with acceptor are statistically significant (***p<0,0001). Each point refers to a single cell. 
The mean average lifetime of about 10 cells was taken and the FRET efficiency E was calculated 
(see Material and Methods). FRET efficiency values vary between 10 and 12%, which are in 
agreement with previous data [106]. In order to disrupt rafts, plasma membranes were depleted of 
cholesterol by preincubation of cells with MβCD as described in Materials and Methods. Under 
those conditions 12 ± 1% (n = 4) of cholesterol was extracted from cells. Cholesterol depletion by 
MβCD of GPI-CFP/GPI-YFP coexpressing cells led to an increase of GPI-CFP lifetime (Figure 41) 
and to a reduction of the FRET efficiency (Figure 42), which dropped to 2-4%. The same set of 
experiments was repeated with the donor-acceptor pair GPI-mCFP/GPI-YFP and comparable results 
were obtained (see Figure 41 and Figure 42).  
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Figure 42: FRET efficiencies measured for GPI-XFP donor acceptor pairs in different conditions. FRET 
efficiency is drastically lowered upon extraction of cholesterol with MβCD, confirming raft localization of the 
proteins. Numbers in brackets indicate the number of experiments carried out. ***p<0,0009 between GPI-
CFP+GPI-YFP and GPI-CFP+GPI-YFP(MβCD); ***p<0,0004 between GPI-mCFP+GPI-YFP and GPI-
mCFP+GPI-YFP(MβCD). Columns represent mean ± SEM. The measurements were carried out at 25 °C. 
Thus, these experiments not only confirmed that GPI-CFP localizes into rafts [93,106,114], but also 
ensured that FLIM-FRET is sensitive for measuring protein proximity in such a system. 
4.4.3 Clustering of GPI- and TMD-HA proteins detected by 
FLIM-FRET 
FLIM was used to study FRET between the GPI-CFP raft marker (donor) and the different TMD-
HA-YFP variants (acceptor). To exclude that FRET was due to dimerization of the fluorophores, 
constructs with mutated residue 206 of CFP and YFP to lysine were also measured. Again, we could 
not detect any difference between constructs with wild type (CFP, YFP) and mutated fluorescent 
proteins (mCFP, mYFP) (compare sets of data in Figure 43 and Figure 44). The coexpression of 
TMD-HA-YFP or TMD-HA-mYFP with GPI-CFP or GPI-mCFP led to a significant shortening of 
donor lifetime (Figure 43). When cells coexpressing donor and acceptor were treated with MβCD, 
CFP lifetime increased very likely due to lipid raft disruption and increased distance between the 
fluorophores. 
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Figure 43: τAV distribution of GPI- and TMD-HA proteins. FLIM-FRET experiments were carried out in 
cells expressing GPI-CFP and GPI-mCFP, either alone or coexpressed with TMD-HA-YFP or TMD-HA-
mYFP, respectively. Measurements were done at 25 °C. ***p<0,0001. Each point refers to a single cell. 
As for the donor-acceptor pair GPI-CFP/GPI-YFP, the mean average lifetime of about 10 cells was 
taken and the FRET efficiency E was calculated. In Figure 44 the average E is shown. Upon 
cholesterol depletion, a decrease of E between GPI- donors and TMD-HA-acceptors was observed 
(Figure 44, see also Figure 42).  
 
Figure 44: FRET efficiencies measured in cells coexpressing GPI-XFP and TMD-HA-XFP. Numbers 
within parenthesis indicate the number of experiments carried out. Measurements were done at 25 °C. 
***p=0,0005 and **p=0,0024. Columns represent mean ± SEM.  
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Although FRET efficiencies would not be affected by diminishing the donor concentration, it was 
probed whether MβCD was extracting GPI-CFP. Cells were incubated with 5 mM MβCD for 1 min 
at 4 °C and the CFP fluorescence in the supernatant was measured. The fluorescence intensity was in 
the range of a few percent (3%) of the total CFP intensity, showing that the donor was stably 
anchored to the membrane. Moreover, CFP lifetime in cells expressing only the donor was not 
affected by MβCD treatment (τAV 2,37 ± 0,07 ns, in non treated cells and 2,33 ± 0,07 ns after MβCD 
treatment; values represent mean ± SD). Pretreatment of cells with the cytoskeleton disrupting agent 
cytochalasin D (as described in Methods) did not affect the lifetimes and thus the FRET efficiency 
between GPI-mCFP and TMD-HA-mYFP (as reported in Figure 45 A and B).  
 
Figure 45: τAV and FRET efficiencies measured in cells treated with the cytoskeleton disrupting agent 
cytochalasin D (cyt D). The lifetime distribution (A) as well as the FRET efficiency (B) is not affected by the 
disruption of the cell cytoskeleton, which therefore might not be involved in the protein lateral organization. 
***p<0,0001. In A each point refers to a single cell. In B numbers above bars refer to the number of 
independent experiments; columns represent mean ± SEM. Measurements were carried out at 25 °C. 
Hence, it could be hypothesized that the cellular cytoskeleton might not play a critical role in the 
partitioning of TMD-HA fusion proteins into lipid enriched microdomains. Finally, DAPI (in blue in 
Figure 46) and Rhodamine-Phalloidin (in red in Figure 46) staining confirmed that the cytoskeleton 
was disrupted after cytochalasin D incubation without inducing cell death or affecting at the same 
time TMD-HA-mYFP distribution at the cell surface (see Figure 46 D, in green). However, it has to 
be noted that cells adopt a more elongated form upon treatment.   
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Figure 46: CHO cells treated with cytochalasin D. CHO-K1 cells and CHO-K1 cells stably expressing the 
TMD-HA-mYFP protein were stained with Rho-Pahlloidin (red) and DAPI (blue) pre (A and C) and post (B 
and D) cytochalasin D incubation. As can be seen in figure B and D the cytoskeleton depolarized under the 
effect of cytochalasin D, as indicated by the increased numbers of dotted structures and the absence of a real 
filamentous network (as in pictures A and C).  
Coexpression of GPI-CFP with a fluorescent raft marker in the inner leaflet of the plasma membrane 
(MyrPal, provided by Stephanie Engel, Free University, Berlin) did not lead to any change in GPI-
mCFP lifetime 2,43 ± 0,03 ns and 2,40 ± 0,06 ns in presence and absence of MyrPal-mYFP, 
respectively. Therefore the shortening of CFP lifetime in the presence of TMD-HA-YFP is not 
simply due to coexpression of a raft marker.  
In principle, since energy transfer occurs between GPI-(m)CFP and TMD-HA-(m)YFP, FRET 
should have been observed also for the donor-acceptor pair TMD-HA-CFP and GPI-YFP. 
Surprisingly, in this case the difference between the lifetimes of the donor without and with the 
acceptor (Figure 47 A), as well as the FRET efficiency (Figure 47 B) was less pronounced in 
comparison to the pair GPI-CFP and TMD-HA-YFP (compare Figure 44 and Figure 47 B). Again 
the coexpression of TMD-HA-mCFP with GPI-YFP provided essentially the same results; therefore 
this pair was not studied further. 
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Figure 47: FRET between TMD-HA-CFP and GPI-YFP. In (A) the τAV distribution of TMD-HA-CFP 
expressed alone or coexpressed with GPI-CFP is reported. It can be noted that TMD-HA-CFP presents a 
shorter lifetime than GPI-CFP (see Figure 44). This is due to dimerization of the donor (described in the text). 
Nevertheless, FRET was measured (B). Although efficiencies were lower than normally calculated (see Figure 
44), they were reproducible and they were decreased upon extraction of cholesterol (MβCD). ***p<0,0001 
and **p<0,0069. In A each point refers to a single cell. In B columns represent mean ± SEM and numbers 
above bars refer to the number of independent experiments. Measurements were carried out at 25 °C. 
Notably, TMD-HA-CFP lifetime was much shorter than that of GPI-CFP when expressed in the 
absence of the respective YFP acceptor (compare Figure 43 and Figure 47 A). As discussed above, 
TMD-HA fusion proteins are organized as dimers in the plasma membrane. Thus, CFP molecules of 
TMD-HA-CFP are in very close proximity and may undergo self-quenching (also named pseudo-
homoFRET, see 5.1.1) [115] or larger aggregates may even change the local refractive index, which 
may strongly affect CFP average lifetime [116]. 
4.4.3.1 Clustering of GPI- and TMD-HA mutants detected by 
FLIM-FRET 
To investigate the role of palmitoylation in lateral organization, the non-palmitoylated mutant, TMD-
HA-C3S-YFP, was coexpressed with GPI-CFP. In that case the lifetimes were longer than those 
measured for GPI-CFP in TMD-HA-YFP coexpressing cells (compare Figure 43 and Figure 48 A).  
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Figure 48: FRET efficiency and τAV of samples coexpressing GPI-CFP and TMD-HAC3S-YFP. GPI-CFP 
lifetime does not change when coexpressed with TMD-HAC3S-YFP (A), leading to a very low FRET 
efficiency (B) which did not change upon preincubation with MβCD. ***p<0,0002 between GPI-CFP+TMD-
HA-YFP and GPI-CFP+TMD-HAC3S-YFP; ***p<0,0009 between GPI-CFP+TMD-HA-YFP and GPI-
CFP+TMD-HAC3S-YFP(MβCD). In A each point refers to a single cell. In B columns represent mean ± SEM 
and numbers above bars refer to the number of independent experiments. Measurements were carried out at 25 
°C. 
The FRET efficiency was only about 2% (Figure 48 B). Depletion of cholesterol by treatment of 
cells with MβCD-extraction did not show any effect on lifetimes (Figure 48 A), and thus on the 
FRET efficiency (Figure 48 B) in contrast to the sample expressing TMD-HA-YFP (Figure 44). 
Therefore this result confirms the importance of palmitoylation for lipid raft localization of TMD-
HA fusion proteins.  
In order to study the effect of raft signal abolishment (see above) on the TMD-HA sequence, GPI-
mCFP was also coexpressed with TMD-HA-AAA and TMD-HAC3S-AAA mutants. As expected, 
mCFP lifetime did not vary when coexpressed with the acceptor (Figure 49 A) and no significant 
energy transfer was measured in both cases, underlining the critical role played by this sequence as 
raft-localization signal (see Figure 49 B). 
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Figure 49: FRET between GPI-mCFP and TMD-HA mutants. GPI-mCFP lifetime did not change upon 
coexpression with the TMD-HA mutants, TMD-HA-AAA-mYFP and TMD-HAC3S-AAA-mYFP (A). 
Therefore no significant energy transfer was measured (B). ***p<0,0001. In A each point refers to a single 
cell. In B columns represent mean ± SEM, and numbers above bars refer to the number of independent 
experiments. Experiments were carried out at 25 °C. 
4.4.3.2 FRET efficiency as a function of the acceptor intensity 
In order to verify that energy transfer was indeed due to clustering, FRET efficiencies were plotted 
against the acceptor intensity and fitted with a one-site hyperbola function (as described in 
Methods). In Figure 50 A and C the result for the donor-acceptor pairs GPI-CFP/TMD-HA-YFP and 
GPI-mCFP/TMD-HA-mYFP and GPI-CFP/GPI-YFP and GPI-mCFP/GPI-YFP is reported. As can 
be observed, increased acceptor levels did not lead to an increase in FRET efficiencies, thus assuring 
that the FRET efficiency fluctuations are not directly proportional to the acceptor amounts. This 
result is also reflected in the KD value (Table 8), significantly smaller than the averaged acceptor 
intensity. Therefore, the influence of the acceptor expression level on the calculation of the FRET 
efficiencies could be neglected and the cells cotransfected with different combinations of donor-
acceptor pairs directly compared. In Figure 50 B and D the fitting was done for the same donor-
acceptor pairs after extraction of cholesterol. The curve acquires a more linear shape, pointing to a 
higher dependence of FRET from the acceptor concentrations. Furthermore, the KD value was about 
4 times higher (Table 8), indicating less clustering of the molecules due to lipid rafts disruption.   
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Figure 50: One site hyperbola fitting of FRET efficiencies vs acceptor concentration. In pictures A and C 
the fitting was done for the donor-acceptor pairs GPI-CFP/TMD-HA-YFP (o) and GPI-mCFP/TMD-HA-
mYFP (*), GPI-CFP/GPI-YFP (o) and GPI-mCFP/GPI-YFP (*). Curves reach a plateau and clearly, increasing 
the acceptor concentration does not lead to an increase in FRET efficiency. In contrast, upon extraction of 
cholesterol (B and D) the residual FRET depends from the acceptor concentration as demonstrated by higher 
KD values (see text). E(%) = FRET efficiency in %; FYFP = acceptor concentration. 
Table 8: KD values. FRET efficiencies and acceptor intensities of the donor-acceptro pairs GPI-CFP/TMD-
HA-YFP and GPI-mCFP/TMD-HA-mYFP, GPI-CFP/GPI-YFP and GPI-mCFP/GPI-YFP were fitted with a 
one-site hyperbola function (see Methods). The KD values calculated from the fitting indicate the reduced 
clustering between the proteins upon exctraction of cholesterol (MβCD). For more details see text and 
Methods. n= number of cells analized. 
D-A couple KD KD (MβCD) 
GPI-CFP/GPI-YFP 
GPI-mCFP/GPI-YFP 
81 (n = 52) 475 (n = 48)  
GPI-CFP/TMD-HA-YFP 
GPI-mCFP/TMD-HA-mYFP 
94 (n = 59) 366 (n = 56) 
 
This kind of fitting was not carried out when both donor and acceptor were TMD-HA variants. Since 
they form disulfide linked oligomers, the curve as well as the KD values would reflect the 
oligomerization state and therefore would not give further information about the clustering of the 
proteins in lipid microdomains. 
 
4.4.4 Clustering of TMD-HA and TMD-SFV detected by FLIM-
FRET 
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Unlike influenza virus, semliki forest virus (SFV) does not appear to utilize lipid rafts as recruitment 
site of its components [117,118]. No enrichment of virus spike proteins in detergent resistant 
fractions was found [40]. In order to generate a protein acting as a non raft marker, a transmembrane 
domain based on the SFV glycoprotein E2 was fused to mCFP. Potential palmitoylation sites were 
replaced to abolish any residual interaction with raft-like lipid domains. FLIM-FRET experiments 
were carried out in cells coexpressing SFV-E2-mCFP and either TMD-HA-mYFP or GPI-YFP. As 
shown in Figure 51 B, in both cases no significant energy transfer was detected as well as no 
significant variation of mCFP lifetime was measured (Figure 51 A). Thus, these results indicate that 
the spike proteins of SFV do not associate preferentially with cholesterol enriched domains and 
enforce the hypothesis of a preferential localization of TMD-HA fusion proteins into lipid rafts 
domains. The comparison between the donor-acceptor pairs TMD-HA-CFP+GPI-YFP and SFV-E2-
mCFP+GPI-YFP shows that indeed the energy transfer measured for the former pair is due to 
clustering into lipid domains and not to random interaction. We can also exclude that the higher 
FRET is due to higher expression levels of the proteins since the D/A ratio presented by the two 
different couples is similar (see Figure 40). 
 
Figure 51: Energy transfer does not occur between the non raft protein SFV-E2-mCFP and TMD-HA-
mYFP. SFV-E2-mCFP coexpressed either with TMD-HA-mYFP or with the raft marker GPI-YFP, did not 
show significant FRET (B) or a shortening of SFV-E2-mCFP lifetimes (A). Indeed there is a clear difference 
between FRET efficiencies measured when TMD-HA-mYFP is coexpressed with GPI-mCFP or SFV-E2-
mCFP (***p<0,0003), as well as when GPI-YFP is coexpressed with TMD-HA-CFP or SFV-E2-mCFP 
(***p<0,0006). In A each point refers to a single cell. In B columns represent mean ± SEM, and numbers 
above bars refer to the number of independent experiments. Experiments were carried out at 25 °C. 
4.4.5 TMD-HA protein clustering  
FLIM-FRET was also used to investigate clustering of TMD-HA molecules with each other. To this 
aim, several combinations of different TMD-HA donor-acceptor pairs were coexpressed and energy 
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transfer was measured. Surprisingly, FRET was observed in all cases (summarized in Table 9, 
numbers are FRET efficiencies given in %), even upon MβCD treatment. Figure 52 reports the 
lifetimes and FRET efficiency of selected TMD-HA pairs. FRET efficiencies oscillate between 10 
and 18% and it was measured even between TMD-HA variants previously demonstrated to localize 
in different regions of the cell plasma membrane (e.g. between TMD-HAC3S-YFP and TMD-HA-
CFP, see Figure 52). It has also to be stressed that upon extraction of cholesterol FRET efficiency 
increases. This result is totally in contrast with the above results showing a decrease of energy 
transfer in cells treated with MβCD.  
 
Figure 52: TMD-HA fusion proteins form oligomers. Upon coexpression of TMD-HA-XFP proteins high 
energy transfer was measured. Explanation for this behaviour is given by the fact that the proteins form 
disulfide linked dimers and trimers. In A the lifetimes for the most significant experiments (***p<0,0001) are 
reported and in B the corresponding FRET efficiencies are shown. In A each point refers to a single cell. In B 
columns represent mean ± SEM, and numbers above bars refer to the number of independent experiments. 
Experiments were carried out at 25 °C. 
Table 9: FRET efficiencies between TMD-HA constructs expressed in CHO cells. The table reports the 
experiment carried out with different TMD-HA donor-acceptor pairs. In red samples subjected to MβCD 
extraction. The numbers within parentheses refers to the number of experiments. n.m. = not measured. 
Acceptor 
Donor 
TMD-HA-YFP TMD-HA-mYFP TMD-HAC3S-YFP 
TMD-HA-CFP 12 ± 2 (5) / 18 ± 1 (2) 17 13 ± 1 (4) 
TMD-HA-mCFP n.m. 10 ± 2 (4) 12 ± 1 (2) 
TMD-HAC3S-YFP 9 n.m. 8 / 8 
Different observations led to the hypothesis that TMD-HA fusion proteins are forming stable 
oligomers. The first observation concerned CFP lifetimes, which varied significantly when the 
fluorophore was fused either to GPI or to TMD-HA. In Table 10 the lifetimes (in ns) for the 
different donor proteins are reported.  
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Table 10: Fluorescence lifetime of different CFP constructs. The numbers within parentheses refer to the 
number of experiments. In every experiment about 10 to 12 cells were measured. Numbers represent mean ± 
SD. Measurements were carried out at 25 °C. 
GPI-CFP TMD-HA-CFP GPI-mCFP TMD-HA-mCFP 
2,37 ± 0,03 (8)* 1,97 ± 0,03 (10)* 2,49 ± 0,04 (8)* 1,99 ± 0,06 (4)* 
 
The lifetime of both GPI-CFP and GPI-mCFP is longer than the one of TMD-HA-CFP and TMD-
HA-mCFP. The shortening in lifetime for TMD-HA fused donors is probably due to pseudo-
homoFRET or self-quenching (see Discussion), which can occur only when fluorophores are in very 
close proximity (e.g. due to oligomer formation). The second observation was based on experiments 
in which cotransfected cells were depleted of cholesterol. As shown above, extraction of cholesterol 
from cells expressing GPI-/GPI- and GPI-/TMD-HA- CFP/YFP pairs leads to a decrease of FRET 
efficiencies. In contrast, this was not observed when the treatment was applied to cells coexpressing 
TMD-HA fusion proteins (Table 9). In particular, significant energy transfer was measured when 
TMD-HAC3S-CFP was coexpressed either with TMD-HA-YFP or with TMD-HAC3S-YFP (Table 
9). Notably, no clustering between GPI-CFP and TMD-HAC3S-YFP (4.4.3.1) was observed. Finally 
it has also to be stressed that the FRET efficiency between coexpressed donor-acceptor pair TMD-
HA-CFP and TMD-HA-YFP was higher than for the pair TMD-HA-YFP and GPI-CFP. Finally, in 
order to investigate FLIM-FRET between TMD-HA monomers, cells transfected with TMD-HA-
mCFP and TMD-HA-mYFP were incubated with DTT (10 mM). As shown in Figure 53, the 
treatment did not have any effect on the TMD-HA-mCFP lifetimes. However, it has to be stressed 
that the DTT solution used was only 10 mM, 40 times less concentrated than the one normally used 
in protein electrophoresis to disrupt disulfide bonds. Therefore, it cannot be proved that DTT really 
disrupted the disulfide linkages between the proteins. A 400 mM DTT solution led to cell death and 
thus could not be used.  
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Figure 53: TMD-HA-mCFP lifetime is not affected by DTT treatment. Incubation of cells coexpressing 
TMD-HA-mCFP and TMD-HA-mYFP or GPI-YFP with a 10mM DTT solution did not affect mCFP lifetime. 
Each point refers to a single cell. Experiments were carried out at 25 °C. 
Taken together all these observations strongly supported the hypothesis of a direct neighborhood of 
TMD-HA-constructs. Thus the measured FRET efficiency indicates lipid domain independent 
association of the constructs. To sustain this conclusion time resolved anisotropy measurements were 
performed (see below). 
4.4.6 Time-resolved fluorescence spectroscopy of purified 
plasma membranes 
To assess lateral organization of fluorescent GPI and TMD-HA constructs by an independent 
technique, we performed homoFRET measurements by measuring time-resolved anisotropy. I.e., in 
samples containing only donor (GPI-mCFP) or only acceptor (TMD-HA-mYFP), energy 
homotransfer could be assessed from picosecond resolution fluorescence anisotropy decays, which is 
translated to information on the aggregation state of the donor and the acceptor separately, an 
important knowledge to rationalize the heteroFRET data. This approach should give in principle 
equivalent results, since FRET efficiency is based on FLIM measurements where 1) a ROI was 
selected containing only the plasma membrane pixels; 2) the photons collected in those pixels were 
summed up to obtain a fluorescence intensity decay with a large number of counts (as in a cuvette 
experiment), and 3) the data from a large number of cells from several independent samples were 
used to compute the final values. For this purpose, plasma membranes of CHO-cell lysates 
expressing either GPI-mCFP or TMD-HA-mYFP, or coexpressing GPI-mCFP and TMD-HA-mYFP 
were purified by Nycodenz step-gradient. As shown (Figure 54) top fractions used for 
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measurements are enriched of TMD-HA and GPI- fluorescent proteins and contain only minor 
amounts of ER and Golgi membranes as proven by Western Blot analysis (Figure 54).  
 
Figure 54: Plasma membrane purification. Fractions collected after fractionation in Nycodenz gradient were 
subjected to TCA precipitation and Western Blot analysis. TMD-HA-mYFP as well as GPI-mCFP was found 
almost exclusively at the top of the gradient. Those fractions were subsequently used in time-resolved 
fluorescence measurements. As a control for purity, antibodies against β-actin (cytoskeleton marker), 
calreticulin (ER marker) and membrine (Golgi apparatus marker) were used.  
For each sample, due to the amount required, plasma membrane from a very large number of cells 
was obtained. Nevertheless, as in the case of FLIM, independent samples were analysed. In Table 
11, the values of the lifetime components, their amplitudes, the average lifetimes, the steady-state 
anisotropy and the rotational correlation times (obtained from the fluorescence anisotropy decays) 
are given for GPI-CFP and GPI-mCFP samples without and with MβCD pre-treatment of cells (GPI-
CFP and GPI-mCFP are indicated in Table 11 simply as CFP and mCFP). The fluorescence intensity 
decays are described by three exponentials, where a short component contributes very little to the 
average lifetimes. This component is usually not detected, and in the present case it was probably 
due to scattering. The two main components were similar to those previously published by others 
[116] and to those recovered from the FLIM data analysis obtained from in vivo measurements. In 
addition, the amplitude weighted lifetime (2,4-2,5 ns) was also coincident with the FLIM results, 
validating the FLIM data analysis. Also in agreement with the FLIM studies, the average 
fluorescence lifetime of GPI-CFP and GPI-mCFP (in the absence of acceptor) does not change with 
addition of MβCD, and thus the shortening observed in the presence of acceptor (see below) can be 
directly related to FRET.  
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Table 11: Time resolved anisotropy decay. Parameters describing the fluorescence intensity decays of 
purified plasma membrane suspensions from CHO cells expressing either GPI-CFP (CFP) or GPI-mCFP 
(mCFP), untreated (-MβCD) or treated (+ MβCD) with MβCD to extract cholesterol. αn- amplitude; τn- 
lifetime; τAV- amplitude-averaged fluorescence lifetime; <τ>- fluorescence lifetime; χ2- chi square; χ2tot- 
global chi square. The rotational correlation times (φ1 and φ2) retrieved from the fluorescence anisotropy 
decays and the steady-state fluorescence anisotropy <r> are also shown. 
Sample α1 τ1 
(ns) 
α2 τ2 
(ns) 
α3 τ3 
(ns) 
τAV 
(ns) 
<τ> 
(ns) 
χ2 φ1 
(ns) 
φ2 
(ns) 
χtot2 <r> 
CFP 0,17 0,45 0,36 1,70 0,47 3,75 2,45 3,14 1,25 n.d. n.d. n.d. n.d. 
CFP 0,16 0,34 0,34 1,51 0,50 3,68 2,43 3,15 1,21 n.d. n.d. n.d. n.d. 
CFP 0,14 0,65 0,32 1,66 0,53 3,49 2,49 2,99 1,14 0,80 34,9 1,06 0,33 
CFP 0,13 0,49 0,31 1,66 0,56 3,52 2,54 3,06 1,08 0,75 34,8 1,13 0,33 
CFP + 
MβCD 
0,12 0,55 0,32 1,57 0,57 3,48 2,53 3,03 1,16 1,09 36,6 1,19 0,33 
mCFP 0,19 0,42 0,33 1,80 0,48 3,90 2,54 3,30 1,27 1,93 31,1 1,17 0,31 
mCFP 0,19 0,63 0,33 1,92 0,48 3,65 2,50 3,06 1,09 1,16 33,3 1,20 0,33 
mCFP 0,15 0,50 0,33 1,71 0,53 3,57 2,51 3,07 1,11 1,15 33,3 1,17 0,32 
mCFP 
+MβCD 
0,16 0,58 0,35 1,84 0,49 3,63 2,51 3,06 1,17 ---- 32,4 1,23 0,34 
 
The steady-state anisotropy <r> values are very similar in all samples studied, ranging from 0,31 to 
0,34 (Table 11). However, among the rotational correlation times φ1 (short rotational correlation 
time) and φ2 (long rotational correlation time), significant differences were found. The long 
rotational correlation time can be interpreted as the wobbling of the GPI-linked (m)CFP moiety. It is 
around 34 ± 3 ns. Since it depends only on the size and shape of the fluorophore and viscosity of the 
medium, it is not surprising that no significant changes were detected. Regarding the short rotational 
correlation time, however, it cannot be related to the movement of a large chromophore such as 
(m)CFP, but it is rather due to a process of energy homotransfer or energy migration (homoFRET, 
see e.g. [106]). In the case of mCFP, it has a value of 1,2-1,9 ns, indicative of proximity of the 
chromophores corresponding to a distance between two GPI-mCFP of about 33 Å (for calculation 
see 3.2.5.4). Pretreatment of cells with MβCD led to a loss of homoFRET and, hence, of the short 
compontent φ1 of the fluorescence anisotropy decay, showing that the average distance between GPI-
mCFP increased and that the large majority of the chromophores are no longer within FRET 
distance. As expected, the φ1 value in case of CFP was shorter (0.80-0.75) and treatment with MβCD 
led only to an increase of the short rotational parameter. This behaviour can be related to dimer 
formation of the fluorophores lacking the A206K mutation. Therefore, CFP proteins are in closer 
proximity reflected in a short φ1 value, which does not totally disappear upon extraction of 
cholesterol simply because fluorophores are in an oligomeric state. The above results are in 
agreement with previous homoFRET studies, [106] confirming the cholesterol sensitive lateral 
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organization of raft marker GPI-mCFP. Purified plasma membranes of cells coexpressing GPI-mCFP 
and TMD-HA-mYFP were also employed. As for FLIM-FRET experiments, also in suspension 
samples of plasma membrane vesicles, GPI-mCFP fluorescence lifetime decreased in the presence of 
TMD-HA-mYFP. In Table 12, the parameters describing the fluorescence intensity decays of GPI-
mCFP in the presence of acceptor and the corresponding average lifetimes for a typical sample are 
given.  
Table 12: FLIM-FRET in GPI-mCFP and TMD-HA-mYFP containing- plasma membranes. The results 
obtained from measurements carried out in cuvette with plasma membrane suspentions of cells coexpressing 
GPI-mCFP (mCFP) and TMD-HA-mYFP (mYFP) were in agreement with the ones measured in living cells 
(FLIM), thus confirming previous results. αn- amplitude; τn- lifetime; τAV- amplitude-averaged fluorescence 
lifetime; <τ>- fluorescence lifetime; χ2- chi square; χ2tot- global chi square 
Sample α1 τ1 (ns) α2 τ2 (ns) α3 τ3 (ns) τAV(ns) <τ> (ns) χtot2 
mCFP + mYFP 0,24 0,41 0,31 1,51 0,25 3,79 2,27 3,17 1,21 
 
The calculated FRET efficiency was about 10%, a value similar to those obtained from living cells 
by FLIM (for the same FRET pair). To confirm the close proximity of TMD-HA-constructs, the 
steady-state and time resolved fluorescence anisotropy (in Figure 55 anisotropy decays of GPI-
mCFP and TMD-HA-mYFP are compared) of purified CHO plasma membrane suspensions 
containing TMD-HA-mYFP, were investigated. 
 
Figure 55: Fluorescence Anisotropy decays. Typical anisotropy decay curves of GPI-mCFP (A) and TMD-
HA-mYFP (B) proteins are reported in the graph. As can be seen, the curves can be divided into two 
components, one referred to as fast, characterized by a small slope, which correspond to the φ1 parameter and 
the other component much slower corresponding to the φ2 parameter (see Table 11 and Table 13). Experiments 
were carried out at 25 °C. 
In this case, it is clear first that the long rotational correlation time is similar to the one observed for 
GPI-mCFP (Table 11), which is expected, because the size and shape of the two chromophores is 
identical; and second that the short rotational correlation time is below 0,5 ns, pointing also to a 
close proximity. Indeed, the intermolecular distance can be estimated to about 40 Å (see 3.2.5.4). 
The TMD-HA-mYFP amplitude weighted lifetime measured in plasma membrane extracts was 
about 2,87 ± 0,11 ns (average calculated on a number of 6 experiments), highly comparable to the 
one measured in vivo (2,86 ± 0,12 ns, average calculated on a number of 15 cells) Notably, the 
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homoFRET contribution to the integrated steady-state anisotropy is larger in comparison to GPI-
mCFP. Furthermore, the steady-state anisotropy is essentially independent of the surface density (cF) 
of TMD-HA-mYFP (Table 13). Both observations are in agreement with a stable association 
between TMD-HA-mYFP molecules. Furthermore, as reported in Table 13, pre-incubation with 
MβCD did not lead to any significant change in the φ1 and φ2 values.  
Table 13: TMD-HA-mYFP time resolved anisotropy parameters. Rotational correlation times retrieved 
from the fluorescence anisotropy decays, chi-square of the fitting, and steady-state fluorescence anisotropy of 
purified plasma membrane suspensions from CHO cells expressing TMD-HA-mYFP, untreated (- MβCD) or 
treated with MβCD (+ MβCD) to extract cholesterol. The total protein concentration cP, the fluorescence 
intensity IF (indicative of fluorescent protein amount) and cF = IF / cP indicative of fluorescent protein 
concentration are given. The rotational correlation times (φ1 and φ2) retrieved from the fluorescence anisotropy 
decays and the steady-state fluorescence anisotropy <r> are also shown. 
Sample cP (µg/ml) IF (a.u.) cF (IF/cP) φ1 φ2 χtot <r> 
- MβCD 50 1000 20,4 0,29 43 1,17 0,33 
- MβCD 565 940 1,7 0,32 34 1,22 0,32 
+ MβCD 227 540 2,4 0,41 24 1,23 0,32 
+ MβCD 216 507 2,3 0,21 43 1,28 0,32 
 
4.4.7 Lateral organization of TMD-HA- and GPI- fusion 
proteins in GPMVs 
As a complementary approach, lateral organization of TMD-HA- and GPI- fusion proteins was 
studied in giant plasma membrane vesicles (GPMVs) or “blebs”. Since blebs derive from chemically 
induced vesiculation of the cell plasma membrane, they provide a suitable biological system for 
studying partitioning of lipids and proteins. Indeed, in contrast to lipid domains of mammalian 
plasma membranes, which are of submicroscopic size [76] and cannot be visualized directly in vivo, 
GPMVs separate in micrometer-scale phases at temperatures below ~ 25 °C [101]. Blebs were 
formed from CHO-K1 cells stably transfected either with GPI-mCFP or with TMD-HA-mYFP. As a 
control, blebs obtained from CHO-K1 cells transfected with HA-mCer (kindly provided by 
Stephanie Engel, Free University, Berlin), were used. R18 was employed as marker for liquid 
disordered (ld) domains since it preferentially partitions in the ld-like phase in GPMVs [119]. A 
micrometer-scale separation of fluid phase domains was induced in GPMVs by lowering the 
temperature (10 °C). In Figure 56 typical pictures of blebs are reported. As can be clearly seen, 
while both TMD-HA-mYFP and TMD-HA-mCer show the same fluorescence distribution as R18, 
the full length HA-mCer presents a preferential but not exclusive partition into ld domains. In 
contrast, GPI-mCFP localized exclusively into lo domains as shown by the distribution of the raft 
marker complementary to the one of R18. These results might seem in contrast with the previous 
FLIM-FRET experiments demonstrating lipid raft partitioning of TMD-HA fusion proteins. 
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However it has to be reminded that GPMVs extrude from the cell plasma membrane and although 
they maintain the lipid composition, they might not preserve the lipid bilayer architecture. 
 
 
Figure 56: Lateral organization of TMD-HA- and GPI- constructs in GPMVs. Giant plasma membrane 
vesicles formed from CHO-K1 cells transfected with different proteins. A and B correspond to GPMV 
expressing TMD-HA-mYFP or TMD-HA-mCer. These proteins show the same lateral organization as R18, 
which preferentially enriches in ld domains. In contrast, GPI-mCFP (C) shows complementary localization to 
that shown by R18. Finally, HA-mCer (D) despite of presenting enrichment into ld domains, it also partially 
localizes into lo domains. Measurements were done at 10 °C. 
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5 DISCUSSION 
In the present study the lateral organization of the transmembrane domain (TMD) and cytoplasmic 
tail (CT) of HA (TMD-HA constructs) in the plasma membrane of living mammalian cells was 
investigated. To date, essentially biochemical assays based on detergent insolubility and 
immunoelectron microscopy [40,88] have provided evidences that HA is localized to lipid domains 
enriched in cholesterol, saturated phospholipids and/or glycosphingolipids, so-called rafts. To enable 
measurement on living cells the TMD-HA constructs and the well established raft marker GPI were 
tagged with the fluorescent proteins YFP and CFP, respectively and their interaction was assessed by 
FLIM-FRET. While previous approaches [91] tagged the CT of HA with variants of fluorescent 
proteins, here the HA ectodomain was replaced by a fluorescent protein. Thereby, any interference of 
the fluorophore with a role of the CT in lateral organization of HA is avoided. Indeed, previous 
studies indicated that mutations in the TMD and the CT of HA reduce association with detergent-
resistant fractions [38,87,88,120] 
HeteroFRET can be assessed in living cells by FLIM or by steady-state measurements of the donor 
intensity. In the latter case bleaching of the acceptor which is required to investigate FRET may be 
incomplete or even affect the stability of the donor. For example, previous studies on GPI linked 
fluorescent proteins using acceptor bleaching did not detect any significant heteroFRET beyond 
noise [103,106,121]. In contrast, homoFRET measurements revealed clustering of GPI constructs 
[106]. In line with the latter, significant heteroFRET between GPI-CFP and GPI-YFP by FLIM was 
measured in this work, indicating that this technique is superior to acceptor bleaching based 
experiments. HeteroFRET studies also revealed a cholesterol dependent arrangement of GPI-CFP 
and TMD-HA-YFP constructs in mammalian cells. As a complementary approach to extract 
information on lipid domain organization of TMD-HA, time resolved anisotropy measurements were 
also carried out. In particular, strong homoFRET between TMD-HA proteins was observed, in 
agreement with a tight association of constructs. This is also corroborated by heteroFRET observed 
between TMD-HA-CFP and TMD-HA-YFP, and by the absence of any effect of cholesterol 
depletion on FRET efficiency. Furthermore the very low FRET efficiency between TMD-HA and the 
SFV-E2 constructs strongly indicate that TMD-HA forms specifically homodimers, but not 
heterodimers. 
5.1 CHARACTERISATION OF TMD-HA CONSTRUCTS 
TMD-HA fluorescent constructs were generated fusing the HA transmembrane and cytoplasmic 
domain to the C-terminus of YFP. However the subsequent addition of the HA signal peptide to the 
N-terminus of the fluorophore was found to be essential for the delivery of the proteins to the plasma 
membrane, otherwise accumulating into the cytosol (see Figure 19). Indeed, it was previously 
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demonstrated that HA mutants lacking this sequence were retained in the cytoplasm [17]. Thus, 
since in general this signal peptide mediates the cotranslational insertion of the nascent protein into 
the ER membrane [122], it is likely that due to its absence the polypeptide synthesis is redirected 
from ER bound ribosomes to free ribosomes. In contrast, TMD-HA proteins, fused to the signal 
peptide (SpHA), were palmitoylated and transported to the plasma membrane (see Figures 22, 23 
and 26). In a similar manner, except for palmitoylation, the mutant TMD-HAC3S was processed and 
delivered to the cell surface (see Figure 25 and Figure 26). Upon Triton X-100 extraction and 
sucrose gradient centrifugation, TMD-HA but not TMD-HAC3S, was partially enriched in the DRM 
fractions, in agreement with what observed for full length HA ([87] and Engel et al., unpublished 
data). Although nowadays this biochemical approach is considered to generate controversial results, 
it assured that the artificial TMD-HA variants maintained in principle the characteristics of the full 
length HA. Furthermore, it was also investigated whether TMD-HA constructs form oligomers. 
Indeed the HA native structure is homotrimeric and recent studies reported that synthetic TMD-HA 
peptides form heat stable oligomers [32,123,124]. However, whether in vivo the three TMD of a 
single HA form a coiled coil structure in the membrane, still remains unclear. Radioactive labelling 
of TMD-HA proteins and subsequent polyacrylamide gel electrophoresis under reducing and non 
reducing conditions revealed that the constructs form disulfide linked dimers and, in a minor extent, 
trimers (Figure 28 andFigure 29). Finally treatment of the proteins with EndoH probed that TMD-
HA constructs are transported to the plasma membrane exclusively in a dimeric or trimeric form 
(Figure 34 and Figure 36). This is in agreement with previous results showing that only HA trimers 
are transported to the plasma membrane but not monomers [20,125].  
5.1.1 Investigation of TMD-HA oligomerization 
The TMD-HA-YFP sequence contains seven cysteines: C22 in the signal peptide, C49 and C71 in 
the fluorophore, C537 in the transmembrane domain and the three palmitoylation sites, C551, C559 
and C562, one at the border between transmembrane domain and cytoplasmic tail and two in the 
cytoplasmic tail. In order to elucidate which of these cysteines are involved in the disulfide bond-
mediated oligomerization, several different mutants were produced. In every case, cysteines were 
substituted with serines. A priori, it was excluded that the palmitoylation sites are responsible for 
dimerization, since the protein TMD-HAC3S forms oligomers (Figure 36 B). Thus, proteins 
carrying the C537S mutation in the transmembrane domain were generated as well as mutants with 
the C22S mutation in the signal peptide, although this sequence should be cleaved upon 
translocation into the ER lumen. Finally, the C49S and C71S point mutations were inserted in the 
fluorophore. The C22S mutation placed either alone or together with the mutation in the 
transmembrane domain, abolished trimerization, but not dimerization (Figure 36 A and B). The 
mutation C537S in the transmembrane domain affected only partially the assembly of trimers. 
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Interestingly, the mutant lacking the cysteine in the signal peptide, in the transmembrane domain and 
the three palmitoylation sites, forms dimers. Hence, it was hypothesized that TMD-HA dimerization 
was due to disulfide bond formation between C49 and C71 in the fluorophore. Indeed it was reported 
that secretory forms of GFP produce, prior to complete folding, disulfide linked oligomers in 
endocrine cells [113]. Surprisingly, when the C49S and C71S mutations were inserted into the TMD-
HA-mYFP protein, dimers and trimers were still visible even though none of the species was EndoH 
resistant (Figure 35) and no fluorescence was detected upon transfection in CHO cells. This result, 
reported also by Jain et al. [113], is probably the consequence of the misfolding of the fluorophore, 
due to the double point mutation. Taken together these results led to the hypothesis that TMD-HA 
oligomer formation is a process in which at least two to four of the seven cysteines are involved. 
Formation of dimers results from the cooperation of at least two cysteines, while trimers are formed 
from the association of a dimer with a monomer, mediated by C22. In absence of C22 and C537, the 
cysteines in the fluorophore are likely to be the responsible for formation of stable dimers. However, 
when residues C49 and C71 in the fluorophore were mutated, dimers and trimers were probably due 
to disulfide bonds between the other two cysteines, i.e. in the signal peptide and in the 
transmembrane domain. Disulfide linked dimers and trimers are likely to form in the ER, 
nevertheless it is not clear whether dimer and trimer formation follows the same kinetcs. Infact, 
pulse chase experiments have shown that while monomeric and dimeric TMD-HA proteins are 
equally synthesized, and dimers acquire EndoH resistance about 27 hours post-transfection (Figure 
37), trimers appear to be generated only subsequently to the export of the proteins from the ER, 
since they start to be visible only after 1 hour of chasing (Figure 37, t1). This indicates that trimers 
might be assembled during the transport to the Golgi apparatus, e.g. from the association of dimers 
with monomers. In general, monomers never acquire EndoH resistance hence they are not delivered 
to the cell surface. This indicates that the organization of TMD-HA constructs in oligomers is a 
prerequisite for the transport to the plasma membrane. In support to this conclusion is the 
observation that the full length HA trimerizes shortly after synthesis, before the transfer of HA0 to 
the Golgi apparatus, and that no monomers have been detected at the cell surface [20]. In contrast, 
the monomeric form of TMD-HA proteins carrying the C22S mutation was found to be partially 
EndoH resistant (Figure 36). It could be hypothesized that these monomers originate from the 
dissociation of oligomers that might occur subsequently to the delivery of the proteins to the plasma 
membrane. 
Finally, it has to be stressed that oligomer formation between SFV and HA transmembrane domains 
was not observed. This result (discussed in details in 5.2.1) indicates that oligomerization of TMD-
HA proteins reflects specific properties, e.g. the presence in the TMD of particular amino acidic 
sequences, that induce the specific interaction between TMD-HA molecules. Hence, we surmise that 
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disulfide bond formation is simply a consequence of the close proximity driven by the strong affinity 
of the transmembrane domain fragments. 
Oligomerization of TMD-HA constructs was investigated in parallel by FLIM-FRET imaging and 
time resolved anisotropy. Energy transfer was measured for different TMD-HA donor-acceptor pairs, 
e.g. TMD-HA-CFP was coexpressed either with TMD-HA-YFP or with TMD-HAC3S-YFP, mutant 
lacking the palmitoylation sites, or viceversa TMD-HAC3S-CFP was coexpressed either with TMD-
HA-YFP or TMD-HAC3S-YFP. Significant FRET was detected for every couple, indicating that 
TMD-HA protein interaction is mainly driven by disulfide bond formation. In addition, fluorescence 
anisotropy measurements carried out on plasma membrane preparations, revealed strong homoFRET 
between TMD-HA-constructs. Indeed the very short rotational correlation time (φ1) obtained from 
the anisotropy decay, is the result of the close proximity between fluorophores, suggesting tightly 
association between TMD-HA proteins. Based on the distance of about 39 Å between the fluorescent 
proteins of two associated TMD-HA constructs (calculated as described in 3.2.5.4) revealed by 
homoFRET, and the Förster radius of 49 Å for a CFP-YFP pair [107], the FRET efficiency E should 
be in the order of 60 to 70%. Nevertheless, one has to keep in mind that apart from heterodimeric 
TMD-HA constructs also homodimeric constructs (TMD-HA-CFP/TMD-HA-CFP and TMD-HA-
YFP/TMD-HA-YFP) are formed and homodimers by itself do not contribute to heteroFRET. 
Therefore, the expected FRET efficiency, in the order of about 20% is in agreement with the values 
measured for TMD-HA wild type constructs (Table 9). However, it has to be outlined that 
preincubation of transfected cells with the cholesterol extracting agent, MβCD, led to an increase of 
FRET efficiency. Based on these results it was hypothesized that extraction of cholesterol might 
eliminate physical boundaries between TMD-HA wild type proteins, leading to the formation of 
large aggregates. Palmitoylation might play a central role in this mechanism. Indeed it was reported 
that palmitic acid residues attached to the HA transmembrane domain and cytoplasmic tail, might 
interact with each other and with residues attached to other neighboring HA molecules. Furthermore 
palmitoylation might also modulate the HA cytoplasmic tail conformation in order to support the 
interaction of the glycoproteins with other viral proteins [23], a fundamental step in viral assembly. 
Therefore, due to cholesterol extraction, the palmitic acid residues might drive the association of 
several TMD-HA molecules, reflected in an increased FRET efficiency. In agreement with this 
hypothesis is also the observation that cholesterol extraction from cell cotransfected with mutants 
lacking palmitoylation did not have any effect on FRET efficiency (Table 9). 
At last, it has to be pointed out that CFP lifetime was significantly shorter when the fluorophore was 
fused to TMD-HA rather than to GPI. This effect, referred to as “pseudo-homoFRET”, is due to the 
oligomerization of the HA transmembrane domain, which brings the CFP molecules in close 
proximity, so that energy is transferred from one fluorophore to the other. However, in general 
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homoFRET has no effect on lifetimes and it is normally detected by anisotropy measurements. 
Nevertheless, due to the oligomerization, the chromophores might assume new conformations 
associated to slightly different emission spectra and thus to diverse populations of CFP, some acting 
as donors and some as acceptors. In this situation energy is transferred from one population of 
donors (blue shifted) to the other (red shifted) resulting in a decrease of the CFP fluorescence 
lifetime [115]. 
5.2 Recruitment of TMD-HA proteins to raft domains 
FLIM-FRET was used to investigate in vivo the lateral organization of TMD-HA and GPI constructs. 
Control experiments with the GPI-(m)CFP/GPI-YFP donor-acceptor pair (where “m” stands for 
monomeric, see 4.4.3) were first carried out in order to establish the sensitivity of the method. The 
calculated FRET efficiency (E) was in the order of 12% (Figure 42). This magnitude of E has been 
also reported for other membrane proteins recruited to rafts [126]. As expected, preincubation of 
cells with MβCD led to a significant decrease of FRET efficiency, indicating cholesterol dependent 
organization of GPI fluorescent proteins (Figure 42). In agreement with these results, Sharma et al. 
[106] have shown that in the plasma membrane of CHO-K1 cells cholesterol sensitive clusters of 
GPI-GFP and other GPI-linked protein are present. The typical size of these clusters is only about 5 
nm, and they contain about 4 to 5 GPI linked protein molecules. Significant energy transfer was 
measured for the donor-acceptor pair GPI-(m)CFP/TMD-HA-(m)YFP (where “m” stands for 
monomeric, see 4.4.3). Although FRET efficiencies were slightly lower than for GPI-protein pairs, 
they substantially decrease upon extraction of cholesterol (Figure 44). This is consistent with the 
recruitment of TMD-HA-(m)YFP to rafts since the association is abolished upon disintegration of 
rafts by cholesterol depletion. FRET efficiencies were also plotted against the acceptor intensities 
(Figure 50). These graphs showed that increasing the amount of acceptor, does not significantly 
increase the FRET efficiency and that the dependence of the latter from the acceptor concentration 
becomes more punctuated upon extraction of cholesterol. This acknowledges that energy transfer 
between TMD-HA and GPI-proteins arise from the clustering of the molecules in lipid 
microdomains and it is not just the result of overexpression or random interactions. Based on the 
above observation of cholesterol sensitive FRET between GPI-(m)CFP and TMD-HA-(m)YFP it is 
speculated that TMD-HA constructs recruit to those nanoclusters. Since the fraction of those clusters 
has been found to be less than 30% [106] a large pool of GPI-linked fluorescent proteins and TMD-
HA constructs is outside of these clusters explaining the limited FRET efficiency.  
Similar FRET efficiencies for the GPI-mCFP/TMD-HA-mYFP pair in the plasma membrane of 
intact cells and in plasma membrane extracts used in time resolved anisotropy measurements, were 
obtained (see 4.4.6). Very likely, plasma membrane purification perturbs the cytoskeleton of cells. 
Hence, this result would indicate that the cytoskeleton has no major influence on association of 
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TMD-HA constructs with cholesterol sensitive lipid domains, at least with those of the exoplasmic 
leaflet. This is also supported by the observation that pre-treatment of cells with the cytoskeleton 
disrupting agent cytochalasin D did not affect the FRET efficiency between GPI-CFP and TMD-HA-
YFP (Figure 45 B), although cytoskeleton was indeed perturbed by the treatment (Figure 46). 
Interestingly, it has been reported that the HA cytoplasmic tail does not contain signals known to 
interact with the intracellular structures and that it might be too short to associate with the 
cytoskeleton [127,128]. 
When employing GPI-YFP as an acceptor and TMD-HA-CFP as a donor, a lower but significant 
FRET efficiency, in comparison to the pair GPI-CFP and TMD-HA-YFP, was observed. This might 
be related to fact that in the former case the donor is organized as a dimer while in the latter the 
donor is organized as a monomer. Aggregation of TMD-HA proteins might confine GPI molecules at 
the border of the cluster, causing a virtual decrease of GPI-YFP available for energy transfer. Indeed 
it has been suggested that the HA transmembrane domain might promote the accumulation of HA 
molecules in order to increase the affinity for lipid rafts [88]. Hence, since FRET efficiency depends 
essentially on the concentration of acceptor available for the donor, FRET is lower when TMD-HA 
serves as a donor. In that case donors organized as dimers are shielded somewhat from the acceptor 
(Figure 57 B). 
 
Figure 57: FRET between different donor-acceptor pairs. FRET efficiency between GPI-CFP and TMD-
HA-YFP (A) is higher compared to that calculated for the TMD-HA-CFP and GPI-YFP couple (B). This 
situation is probably related to the oligomerization and clustering of TMD-HA proteins. Indeed, while GPI-
CFP molecules are all equally available for the acceptors (A), only a part of TMD-HA-CFP proteins are in 
contact to GPI-YFP (B). In addition while GPI-CFP molecules surround a cluster of acceptors, the restriction 
of GPI-YFP proteins to the periphery of the TMD-HA-CFP bunch, lower the amount of acceptors available for 
FRET. 
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5.2.1 TMD-HA and SFV-E2 clustering 
Very low energy transfer was measured upon coexpression of SFV-E2-mCFP and TMD-HA-mYFP 
or GPI-YFP. This result not only confirms the different localization of the proteins in the plasma 
membrane, but also indicates that oligomerization between SFV-E2 and TMD-HA does not occur. 
Thus, it is possible that formation of TMD-HA oligomers might be driven by specific properties of 
the transmembrane fragment that brings the proteins in close proximity. In case of full length HA 
this process would allow non-covalent homotrimer production, while for TMD-HA proteins this 
mechanism favours disulfide bond formation. In support to this hypothesis is the observation that 
anchor-free HA molecules do not require trimer formation for efficient cell surface transport [129], 
while full length HA trimerization shortly after synthesis is a prerequisite for the subsequent 
transport to the Golgi apparatus and then to the plasma membrane [130].  
Finally, this experiments also assures that the reduction of lifetime observed when TMD-HA is 
coexpressed with GPI raft marker has to be related to FRET due to close proximity of the molecules 
and thus due to clustering into lipid raft domains.  
5.3 Recruitment of TMD-HA mutants to raft domains 
Support for the localization of TMD-HA in rafts is also given by the observation that the non-
palmitoylated variant of TMD-HA (TMD-HAC3S-YFP) shows a much lower FRET efficiency. 
Palmitoylation is considered to be important for association of HA with cholesterol enriched lipid 
domains [38,131,132]. The low affinity of TMD-HAC3S-YFP to rafts is also corroborated by the 
observation that cholesterol depletion did not affect the FRET behaviour between GPI-CFP and 
TMD-HAC3S-YFP (Figure 48 B). The different affinity of TMD-HA-YFP and TMD-HAC3S-YFP 
for rafts is also reflected by the difference in DRM partitioning (Figure 27). These results confirm 
that palmitoylation contributes to raft targeting. Beside palmitoylation, other residues in the HA 
transmembrane domain might play a critical role in lipid raft targeting, e.g. the first three aminoacids 
of the HA transmembrane domain might represent an important raft signal [88]. Indeed when TMD-
HA-AAA and TMD-HAC3S-AAA mutants were coexpressed with the raft marker, no significant 
energy transfer was detected (Figure 49), thus confirming the importance of these sequence for the 
lateral organization of HA molecules. It has to be pointed out that the TMD-HA mutants lacking the 
raft signals have a tendency to accumulate intracellularly, although they follow the same kinetics as 
the wild type (Figure 37) and they are still efficiently transported to the plasma membrane (Figure 
25). It has been observed that the same mutation inserted in the full length HA not only diminished 
the affinity of the glycoprotein for lipid rafts, but it also resulted in a remittal surface transport of the 
proteins (Stephanie Engel, unpublished data). In particular, the substitution of the amino acids VIL 
with three small, less hydrophobic alanines decreased the hydrophobicity and caused the physical 
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shortening of the HA transmembrane domain. The change in the transmembrane length might lead to 
a reduced affinity for lipid microdomains (Stephanie Engel, unpublished data), supposed to form in 
the Golgi apparatus [93] and functioning as platform for the delivery of different proteins to the 
apical membrane [133,134]. Thus, the lack of raft association might explain why TMD-HA-AAA 
and TMD-HAC3S-AAA mutants accumulate in the cytosol, enforcing the hypothesis that rafts might 
function as transport platforms for the accumulation of HA at the budding site and that the HA 
transmembrane domain length might be critical for this to occur. 
5.4 Lateral distribution of TMD-HA proteins in GPMVs 
Controversial to what shown in vivo, TMD-HA fusion proteins localize exclusively in ld domains in 
GPMVs (Figure 56). However one has to keep in mind that very likely the lateral organization of 
the plasma membrane in blebs is altered. Furthermore, GPMVs undergo domain formation at 
temperature far below from physiological or room temperature [101]. Therefore, assuming that 
TMD-HA proteins have a weak affinity for lipid microdomains, or even, that they are placed at the 
border of rafts, the tight lipid packaging induced by lowering the temperature would result in the 
total exclusion of the proteins from lo domains. In agreement with this hypothesis is the observation 
that TMD-HA molecules are only slightly enriched in DRMs upon Triton X-100 extraction (Figure 
27). Notably, the raft marker, GPI-CFP, partitions almost exclusively in DRM fractions (Figure 27) 
and shows lo preference in GPMVs (Figure 56). Finally, the full length HA protein seems to 
distribute both in lo and ld domains, although it accumulates preferentially in ld phase (Figure 56). 
As well as for TMD-HA and GPI-CFP the distribution of HA in blebs resembles its partitioning in 
DRMs (Figure 27). Indeed a higher amount of full length HA is localized in DRM fractions with 
respect to TMD-HA. We surmise that the different behaviour of the two proteins might be related to 
the different association between the transmembrane domains. As previously discussed, TMD-HA 
oligomers are disulfide linked, whereas trimerization of full length HA is mediated by electrostatic 
interactions between the ectodomains [30]. Thus, the non-covalently bound transmembrane domains 
might have more flexibility, feature that might not only confer more stability to the protein, but it 
may also allow to adapt to different lipid packing properties and, hence, to increase the affinity for 
lipid rafts. 
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6 CONCLUSION 
Influenza virus spike protein hemagglutinin (HA) is one of the best characterized viral glycoproteins 
with respect to its structure and function. However, still little is known about the role of its 
transmembrane domain and cytoplasmic tail. Several studies indicate that this fragment is far from 
acting simply as an anchor for the ectodomain, indeed it is critical for complete fusion to occur 
[25,135] and it might also be responsible for the lateral organization of HA in the host cell plasma 
membrane [87]. In this study we have shown that the membrane anchor of HA can be recruited to 
previously characterized [106] cholesterol-sensitive nanoclusters in the plasma membrane of CHO-
K1 cells and that palmitoylation might be critical not only for the association to lipid rafts, but also 
for the association of HA molecules with each other, a mechanism supposed to guide viral assembly. 
In support of this observation, Polozov et al. [136] proposed that palmitic acid residues might induce 
the accumulation of HA molecules and cholesterol in order to increase viral stability. Whether 
clusters of similar size exist in the plasma membrane of native host cells of influenza virus still 
remains to be elucidated. If so, such small clusters have to be merged in order to form a virus 
budding site. This can be accomplished by interaction of the viral matrix protein M1 with the 
cytoplasmic tails of HA and of NA [42,137] on one side, and by the polymerization of M1 [138] on 
the other. The initial small size of clusters and, hence, the low number of proteins in such a cluster, 
as well as the specific interaction of M1 with viral proteins, might provide a mechanism to 
specifically enrich viral proteins in merged clusters and expel non-viral membrane proteins. In 
addition, we demonstrated that association of few HA molecules in lipid microdomains might occur 
already in the Golgi apparatus and that further coalescence in large aggregates might be mediated by 
the merging of several HA-lipid domains. Indeed rafts seem to function as carriers for transporting 
TMD-HA proteins to the cell surface, since mutants lacking palmitoylation or specific sequences in 
the transmembrane domain (referred to as raft signals) are either slowly transported or even 
intracellularly retained. However, although important, association to lipid microdomains does not 
seem to be fundamental for transport of TMD-HA proteins to the plasma membrane. Nevertheless, 
while TMD-HA wild type proteins exploit both raft-mediated and non-raft mediated transport, HA 
molecules lacking the raft signals (i.e. VIL sequence in the TMD and palmitoylation sites) cannot 
take advantage of the former system. We hypothesize that, subsequent to the fusion of the raft 
domain carrying TMD-HA molecules with the membrane bilayer, neighboring TMD-HA proteins 
form large aggregates due to the interaction between palmitic acid residues and between the 
cytoplasmic tails of the molecules. This process involves all proximal TMD-HA, either raft- or non-
raft associated. Indeed it was demonstrated that clustering of HA occurs at all accessible length 
scales [91]. This is also supported by the observation that extraction of cholesterol in cells 
expressing TMD-HA proteins leads to an increase of FRET efficiency, indicating enhanced 
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aggregation. We further propose that TMD-HA molecules might be simply displaced at the border of 
lipid rafts. This organization might explain the limited FRET efficiency measured when TMD-HA-
YFP is coexpressed with the raft marker GPI-CFP. We have observed that GPI-anchored 
fluorophores accumulate preferentially in lipid rafts or in liquid ordered domains as indicated not 
only by their enrichment in DRMs, but also by the absolute exclusion from ld in GPMVs. Therefore, 
according to the above proposed hypothesis, the decrease of FRET efficiency observed upon 
extraction of cholesterol may not be due to the displacement of both TMD-HA- and GPI- molecules 
from rafts, but it might be only related to the dispersion of GPI-CFP proteins. The different affinity 
of TMD-HA for lipid rafts is also reflected in the behaviour of this protein in GPMVs. While at 
physiological temperature HA might be distributed at the border of rafts, at 10 ºC, temperature in 
which lo domains are induced, lipids become too tightly packed, thus excluding TMD-HA proteins. 
Furthermore, it has to be underlined that while in vivo lipid rafts are a mixture between lo and ld, in 
GPMVs these two domains are strictly separated. Finally, the limited FRET efficiency detected for 
GPI donor-acceptor couples might be related to two factors. First, it is likely that GPI proteins are 
not the exclusive inhabitants of lipid rafts, second it was demonstrated that not more than 40% of 
GPI anchored proteins are organized in lipid microdomains [106]. 
We also surmise that TMD-HA mutants lacking the raft signals may be simply spread in the plasma 
membrane and that neither they distribute at the border of lipid microdomains, nor they aggregate. 
This assumption is supported by two important observations. First, FRET efficiency between TMD-
HA mutants and the raft marker was very low; second, the extraction of cholesterol from cells 
coexpressing TMD-HAC3S proteins as donor-acceptor couple did not have any effect on FRET 
efficiencies.  
Collectively, our results suggest the following model for assembly and budding of influenza virus 
(Figure 58). 
1. HA molecules associate with lipid rafts in the Golgi apparatus and they are transported to the 
plasma membrane. Lipid rafts function as carriers mediating the fast delivery of the spike 
proteins to the plasma membrane. 
2. Raft transporting HA fuses with the lipid bilayer. Subsequently HA proteins form large 
aggregates by dint of the association between palmitic acid residues of molecules localized 
inside or outside of rafts. Cholesterol and raft lipids are entrapped into these complexes, but their 
role in HA clustering becomes marginal. As a consequence, HA complexes might be displaced 
from membrane rafts and they may create new domains showing characteristics of rafts and non-
raft domains. 
3. The very bulky ectodomain of the spike proteins induces the bending of the plasma membrane 
and the subsequent fission and budding of the new particles. 
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Figure 58: Model of influenza virus assembly. Association of HA proteins with lipid rafts occurs in the 
Golgi apparatus. Membrane microdomains mediate the delivery of HA to the plasma membrane, although 
association of HA with rafts is not essential for the transport (1). Once in the plasma membrane, HA molecules 
aggregate by means of the interaction between palmitic acid residues (2). Finally, the very bulky HA 
ectodomain induces the bending of the membrane (3). For simplicity, palmitic acid residues have been 
designed only on some molecules. 
 
Cholesterol in the viral envelope may be used by the virus to reduce the high packaging induced by 
the spike proteins, which might form a structure similar to solid domains (so). As suggested by 
Polozov et al. [136], cholesterol might disrupt so domains rather than inducing the formation of lo 
domains from ld domains, thus maintaining fluidity in the viral envelope. The presence of lo-like 
domains in the envelope may be important for the formation of HA fusion complexes during viral 
infection as demonstrated by the reduced infectivity of viral particles formed from cholesterol 
depleted cells [139]. Nevertheless at late stages of assembly, the role of lipid domains might become 
marginal as shown by enhanced budding of influenza virus from cholesterol depleted cells [140]. 
In summary, the above presented model is one possible way to interpret our data. However we are 
aware that much uncertainty arises from such a new assumption and that further investigation and 
more experiments are needed to support this hypothesis. Therefore, the TMD-HA-constructs may be 
used in the future as a basis to elucidate the proposed role of HA in recruiting the viral components 
to the viral budding site. In particular coexpression of TMD-HA constructs with other labelled viral 
components, e.g. vRNPs, might unravel important functions of the HA cytoplasmic tail.  
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